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Advanced neural interfacing technologies have the ability to communicate with the central 
nervous system (CNS) and provide researchers with valuable information about the complex 
physiology of the brain. Traditional neural electrodes interact with nervous tissue electrically, 
either through recording or stimulation, but are limited in their potential to chemically interface 
with the CNS. This dissertation describes the development of a conductive neural biomaterial 
with the capability of recording neurochemical signals in addition to providing both immobilized 
and soluble chemical cues to influence cell behavior. 
The material consists of a graphene oxide/conducting polymer (GO/CP) nanocomposite 
deposited onto the surface of metal or carbon electrodes for improved, multimodal interfacing 
capabilities with neurons and neural stem cells (NSCs). The GO/CP nanocomposite 
demonstrated good biocompatibility with neurons and NSCs and improved neuronal 
differentiation and neurite outgrowth as a result of its chemical and morphological properties. 
Additionally, the GO nanosheets present at the nanocomposite surface enabled patterning with 
bioactive molecules to further influence cell growth. The electrochemical properties of the 
GO/CP nanocomposite enabled highly controllable, on-demand drug delivery, and the chemical 
properties contributed by the GO nanosheets created a platform for highly sensitive and selective 
dopamine detection. With an eye toward developing a highly customizable device that 
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incorporates the versatile chemical interfacing capabilities of GO/CP with the electrical 
recording ability of planar multielectrode arrays, this body of work concluded with the 
characterization of an in vitro cultured neuronal network (CNN) damage model for investigating 
the pathobiology of neuronal injury. A crush injury applied to the CNN interrupted the normal 
activity patterns of the network and the addition of NSCs to the injury site demonstrated the 
ability to protect the network from developing dysfunctional circuitry, making the model an 
exciting platform for exploring neuronal regeneration. While the work here focuses solely on the 
potential of the nanocomposite in neural interfacing applications, its uses are not limited to the 
CNS but span all systems in the body and, as a result of its extremely unique chemical and 
electrical properties, extend to fields outside biomedicine. 
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1.0  INTRODUCTION 
While tremendous progress has been made in the fields of neuroscience and neurorehabilitation 
in the past several decades, the brain remains the most uncharted organ in the body. Composed 
of billions of electrically excitable neurons that form precise and intricate connections with each 
other, the brain embodies a high level of complexity that will require decades of work to unravel. 
Advanced neural interfacing technologies that have the ability to interact with the nervous 
system will be able to assist this endeavor by providing information about the physiology 
underlying the complex set behaviors and cognition characteristic to humans. Ultimately, 
advances in this area will generate the knowledge that is necessary to create life-changing 
therapeutics for nervous system damage and disease. The overarching goal of this dissertation is 
to further the efforts towards understanding the enigmatic brain physiology and creating 
therapeutics for injury and disease by developing and characterizing a novel neural material that 
can improve the ability to chemically interface with the nervous system.  
1.1 INTERFACING WITH THE NERVOUS SYSTEM 
Neural interfacing technologies can provide scientists and engineers a window into complex and 
intricate physiology of the brain. Traditionally, glass or metal electrodes have been used to 
record electrical signals from the central nervous system (CNS) in behaving animals, and these 
1 
types of recordings have been the basis for our current understanding of the neural control of 
behavior and cognition [1-3]. Additionally, neural electrodes are being developed for brain-
machine interfaces that can restore function to the nervous system by electrically stimulating 
dysfunctional circuitry or by translating recorded signals to drive prosthetic devices. The state-
of-the-art neural electrode systems are multi-channel arrays composed of metal that have the 
ability to simultaneously sample from or stimulate populations of neurons [4, 5]. The electrodes 
function by transducing the electrical signals that occur at the neuron-electrode interface, a 
process that is mediated by the transfer of charge between the electrode surface and the 
surrounding electrolyte solution [6]. While great progress has been made for neural interfacing 
devices in their ability to record electrical signals from nervous tissue, these devices lack the 
capability of multimodal interfacing. The goal of this dissertation is to describe a material that 
was developed as a neural electrode modification that will create the means to interface 
chemically with cells in the CNS by providing cues, either immobile or soluble, and by detecting 
neurochemical signaling. The novel nanocomposite material consists of graphene oxide (GO) 
nanosheets embedded in a conducting polymer (CP) matrix that has unique chemical and 
electrical properties amenable to chemical interfacing with nervous tissue. The following 
sections will introduce the unique properties of CPs and GO separately and briefly summarize 
their bioapplications. 
1.2 CONDUCTING POLYMERS 
The first reported synthesis of intrinsically conducting polymers (CPs) occurred in the mid-
nineteenth century when British chemist, Henry Letheby, described the electrochemical 
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oxidation of polyaniline [7]. Since their modern development in the 1970s, CPs have found a 
wide range of applications in electronics [8], fuel cells [9], sensors [10, 11], biointerfacing [12], 
and tissue engineering [13]. Because of their intrinsic conductivity of both electrons and ions, 
CPs lend themselves particularly well to neural interfacing applications, in which responsiveness 
to electrical signaling is a necessary component of interfacing materials [14-19]. Two of the most 
commonly studied CPs, and the two which will be the focus of this dissertation, are polypyrrole 
(PPy) and poly(3,4-ethylenedioxythiophene) (PEDOT) (Figure 1.1). 
 
 
Figure 1.1. Structure of CPs (a) PEDOT and (b) PPy. Both have the characteristic conjugated π 
backbone that is partially responsible for the conductivity of the polymers.  
 
1.2.1 Synthesis 
One of the attractive properties of CPs is their inexpensive and facile processing, which can be 
carried out either chemically or electrochemically. The polymerization reaction is induced by 
oxidation of the monomers in solution and then proceeds by free radical polymerization to create 
insoluble polymer precipitates [20]. Chemical polymerization utilizes strong oxidizing agents, 
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such as ammonium peroxydisulfate, permanganate ions, or hydrogen peroxide, that are either 
added in bulk to a solution of monomer to create a CP suspension, or coated onto a surface to 
induce the formation of a thin CP film [21]. In general, chemical polymerization of CPs is 
beneficial for applications in which large quantities of polymer are desired because of the 
scalability of the reaction; however, poor control over the uniformity of the final CP product 
limits the use of this method for applications requiring thin films. On the other hand, 
electrochemical polymerization of CPs is a highly controllable reaction and is more widely used 
for creating thin films of polymer. In this method, an oxidizing current or voltage is passed 
through an electrode immersed in an electrolyte solution of monomer to initiate free radical 
polymerization, and the synthesized CP deposits preferentially at the electrode surface to create a 
thin film. All of the work described in this dissertation utilizes electrochemical synthesis of thin 
CP films at the surface of electrodes and, as such, will be the focus here. 
The benefit of electrochemical polymerization lies in the ability to finely control the type 
of electrical stimulation applied through the electrode, which will ultimately lead to a high level 
of control over the properties of the synthesized polymer film. In general, there are three 
methods of electrochemical deposition: potentiodynamic, potentiostatic, and galvanostatic [22]. 
In the potentiodynamic method, the electrode potential is cycled through a wide range that 
includes the oxidation potential of the monomer. When the electrode potential surpasses the 
oxidation potential, polymer is synthesized and deposited at the electrode surface, and when the 
potential is swept back below that potential, deposition ceases, resulting in a thin layer of 
polymer. As the deposition continues, additional thin layers are deposited onto the surface of the 
previous layer, enabling control over the final thickness of the CP film. However, the repeated 
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cycling allows solvent molecules to be entrapped between layers of the CPs, creating a 
disordered structure in the final CP film.   
Alternately, the potentiostatic and galvanostatic methods hold the electrode potential or 
current, respectively, at a point above the oxidation potential of the monomer during the entire 
duration of the synthesis. In these methods, CP is continuously deposited onto the surface of the 
electrode and the thickness and morphology of the final film is controlled by the total length of 
the deposition and the magnitude of applied electrical stimulation [14, 23]. The polymerization 
reaction can be described by the following equation: 
 (𝑛𝑛 + 2)𝐻𝐻𝐻𝐻𝐻𝐻 → 𝐻𝐻𝐻𝐻(𝐻𝐻𝑛𝑛)𝐻𝐻𝐻𝐻(𝑛𝑛𝑛𝑛)+ + (2𝑛𝑛 + 2)𝐻𝐻+ + (2𝑛𝑛 + 2 + 𝑛𝑛𝑛𝑛)𝑒𝑒−            (1) 
 
where HMH is the starting species, and x is the doping level of the specific CP, which generally 
falls between 0.25 and 0.4 [22]. According to Equation (1), the amount of polymer formed 
during the reaction is directly related to the number of electrons consumed during the reaction. 
As such, controlling the current during CP deposition by using the galvanostatic method provides 
the most reliable means of controlling the CP film growth because the current is fixed at a 
particular magnitude for the duration of the reaction. On the other hand, with the potentiostatic 
method, the current can fluctuate throughout the course of the deposition reaction, resulting in 
inconsistencies in the total amount of charge passed during a particular time period and a 
decrease in the repeatability of the reaction. While the galvanostatic method has the benefit of 
repeatability, the potentiostatic method has been demonstrated to produce CP films that exhibit 
higher conductivity and lower impedance that possibly results from a larger surface area created 
during the non-uniform deposition [24]. Each of the deposition techniques exhibit benefits and 
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drawbacks, but ultimately, the electrochemical synthesis methods provide a huge level of control 
over the final film properties, allowing the CPs to be tailored to a wider array of potential 
applications. 
1.2.2 Electrical Properties 
CPs are unique among polymeric materials because they exhibit intrinsic conductivity, while 
most other polymers are insulating in nature.  The excellent ability of CPs to conduct electrical 
current was first explored in the 1970s with the characterization of polysulfur nitride and 
polyacetylene. These early studies found that these polymer materials could behave like metals, 
and their conductivity could be increased by orders of magnitude after oxidation into their 
polymeric cation form [25-27]. The conductivity of CPs arises from 1) their conjugated 
backbone, and 2) the formation of polarons and bipolarons in their structure as the ionized 
backbone is neutralized by ionic dopant molecules.  
The conjugated structure consists of alternating single and double bonds between the 
carbon atoms in their backbone. The double bonds in the structure contain delocalized π-bonds 
that overlap and can share electrons, creating a continuous supramolecular orbital though which 
the electrons freely move [28]. In parallel to the conjugated structure, the doping process of the 
CP improves its conductivity. During synthesis by electrochemical oxidation, the CP is produced 
in its ionized form, with net positive charges accumulating on its backbone. Any negatively 
charged species present in the aqueous polymerization environment moves into the growing CP 
to neutralize the charge and stabilize the CP structure. This dopant molecule then creates holes in 
the electronic structure of the CP and creating polarons and bipolarons, mobile charge carriers 
consisting of loosely localized electrons surrounded by lattice distortions [29]. When an 
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electrical voltage is applied to the CP film, the polarons and bipolarons move, leading to the 
passage of current through the polymer. The conductivity of CPs can vary hugely, and is largely 
dependent on the type of dopant molecule or synthesis method used [22, 24, 30, 31]. 
1.2.3 Redox Properties 
A unique property of CPs is their ability to switch between their oxidized and reduced forms in 
response to electrical stimulation. After synthesis via galvanostatic or potentiostatic methods, the 
CP exists in its oxidized state, carrying positive charges on its backbone that are balanced by 
negatively charged dopant molecules. With the application of a reducing voltage potential, the 
CP will switch to its reduced state and small, mobile anionic dopants will exit the film as the 
backbone neutralizes [28]. In the case where CP has been doped with large, immobile dopants 
that are sterically restricted from moving out of the film, cations will instead move into the film 
to neutralize the immobile dopant during CP reduction. The reversible redox properties of CPs 
have been used as a method to achieve controllable release of various drug molecules for 
applications in biomedicine [32-37]. 
1.2.4 CP Bioapplications 
The type of dopant molecule used in CP systems can have a huge impact on both the electrical 
and physiochemical properties of the CP film. A wide range of different dopants have been 
investigated for CP applications, from small ions such as chloride or phosphate, to large 
polymers such as poly(styrenesulfonate) (PSS), and bioactive molecules such as hyaluronic acid 
and nerve growth factor [38-44]. Because of the versatility of potential dopant molecules and the 
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consequent ability to control the electrical, morphological, and chemical properties of the 
resultant film, CPs have been widely investigated as customizable substrates for a variety of 
biomedical applications [10, 13, 34, 45-47].  
In the past decade, CPs have generated excitement within the field of neural engineering 
because their unique electroactivity opens the possibility of interfacing with the electrically 
excitable cells of the CNS [16]. Neural electrodes coated with CPs exhibit a much rougher 
surface morphology that creates a larger effective surface area and can lead to improved 
electrical properties. Ideal neural electrodes have a very small size profile that will enable single 
cell interfacing and reduce damage that occurs during insertion into tissue [5]; however, as their 
size decreases, their electrochemical impedance increases, reflecting the smaller surface area that 
will result in low signal-to-noise ratios [4, 48]. Electrochemical impedance spectroscopy, a 
common method of measuring the charge transfer that occurs at an electrode surface, indicates 
how well a particular electrode will perform and is often used as a method to evaluate neural 
electrodes. After being coated with CP, electrodes can exhibit decreases in impedance by an 
order of magnitude or more, reflecting the potential of these modifications to create improved 
interfaces for neural recording [14, 15, 17, 19, 41, 49]. A common problem faced during chronic 
neural recordings in vivo is the inflammatory tissue response that ultimately leads to the failure 
of the implanted electrode [5]. However, CPs can be doped with bioactive molecules that combat 
this reaction and have the potential to improve the lifespan of implanted electrodes [16, 38, 40, 
42, 50]. In sum, the ability to create high surface area interfaces with favorable electrical 
properties, along with their ease of customization, have rendered CPs a popular material for uses 
in neural interfacing. 
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1.3 GRAPHENE AND GRAPHENE OXIDE 
Carbon nanomaterials and graphene family materials, in particular, have been widely 
investigated in recent years for a variety of applications in electronics, optics, and medicine 
because of the unique properties that arise from their nanostructures. Graphene (G) is the basic 
unit of all carbon materials and is composed of a tightly packed honeycomb carbon lattice that is 
exciting because of its 2-dimensional structure. First synthesized in 2004, true G measures a 
single atom in thickness (ca. 0.3 nm), leading to its quantum behavior that creates exceptional 
conductivity, mechanical strength and optical properties [51]. To produce G, several methods 
have been used, with chemical exfoliation of graphite becoming popular because of its low cost 
and scalability, and because it creates an opportunity for chemical modification that allows for a 
wider range of applications [52]. In reality, the chemical method of synthesis creates a product 
that is not true, pristine G because it contains residual oxygen functional groups, but it exhibits 
similar properties and can be processed as a colloidal solution, which improves the ease of 
handling. The chemical exfoliation method is carried out by oxidizing graphite platelets with 
strong oxidizing agents, such as sulfuric acid and potassium permanganate, to create graphite 
oxide [53, 54]. The oxidation reaction creates multiple oxygen containing functional groups on 
the graphite oxide layers, and results in a stacked structure of hydrophilic graphene oxide (GO) 
nanosheets that are intercalated by water molecules and can be easily mechanically exfoliated 
with sonication treatment into few-layer or single nanosheets measuring from hundreds of 
nanometers to a few microns in diameter (Figure 1.2). By itself, GO is an insulating material 
because the ballistic electron transport that is observed in G is interrupted by defects in the lattice 
structure formed during the addition of oxygen functional groups. However, GO can be further 
processed into reduced GO (RGO) through chemical, thermal or electrochemical reduction to 
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produce a final product that has similar properties to G. While this chemical synthesis method 
was originally intended to create the final conductive RGO product as an analog to G, much 
attention has been focused on the intermediate GO after the observation of its interesting 
chemical properties and ease of functionalization. 
 
 
Figure 1.2. GO is a Single-Layered Nanosheet. Atomic force microscopy image of exfoliated GO 
sheets and corresponding height profiles showing the sheet-like structure of the nanomaterial and its single 
atomic layer thickness (ca. 1 nm). Image reproduced with permission from [55] © 2007 Elsevier. 
 
1.3.1 GO Structural and Chemical Properties 
While the structure of GO is still under debate, it is generally accepted that during the oxidation 
from G, several types of oxygen functional groups are added to the structure, creating mixed 
domains of sp2- and sp3-bonded carbon (Figure 1.3) [53, 56]. The most widely accepted 
structural model of GO is the Lerf-Klinowski model that includes hydroxyl (C-OH) and epoxide 
(C-O-C) functional groups, with a lesser amount of carboxyl (C-O-OH) functional groups 
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localized to the edge of the sheets [57], though other models have recently emerged to include 
lactol rings and tertiary alcohols [58]. The oxygen content of GO can vary considerably 
depending on the method of oxidation and may be a contributing factor to the dissension over its 
structure [53]. 
 
 
Figure 1.3. Structure of GO Based on a Variation of the Lerf-Klinowski Model. The honeycomb 
carbon structure exhibits domains of sp2-bonded carbon (blue) interspersed with sp3 carbon bonded with 
oxygen (red). GO contains carboxyl, epoxide and hydroxyl functional groups that endow the nanomaterial 
with a high level of chemical reactivity. Image adapted with permission from [53] © 2010 The Royal Society 
of Chemistry. 
 
The functional groups on the GO structure have the benefit of adding chemical reactivity 
to the nanomaterial, which renders it suitable for a variety of applications, especially in the field 
of chemistry and bioscience. With its highly reactive structure, GO has been explored for use as 
a metal-free catalyst in synthetic reactions and electrochemistry [59, 60]. The “carbocatalyst” 
demonstrates catalytic oxidation of alcohols and alkenes, hydration of alkynes, and ring opening 
of epoxides [61, 62]. Along with its catalytic activity, the unique chemistry of GO can 
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additionally be used as a method to functionalize the nanomaterial to create biohybrids for 
medical applications. Both the carboxyl group and the epoxide group are amenable to simple 
reactions that can be utilized to introduce small molecules or polymers onto the structure of GO 
[53, 63, 64]. The existing sp2 domains on the GO structure not interrupted by functional groups 
during oxidation can participate in non-covalent interactions such as π-π stacking or van der 
Waals interactions and have been utilized as additional methods of functionalizing the 
nanomaterial. By taking advantage of the ease of covalent and non-covalent modifications, GO 
nanosheets have been functionalized with a variety of molecules, for example, polyethylene 
glycol (PEG) and other polymers to improve dispersibility and biocompatibility, folic acid or 
magnetic particles for targeted drug delivery, fluorescent probes for cellular imaging, and 
aptamers, enzymes or DNA for biosensor applications [63-65]. 
1.3.2 Neural Engineering Applications 
Within the field of neural engineering, much recent work has focused on adapting the exciting 
electrical and chemical properties G and GO to create functional neural electrodes or to drive the 
behavior of neurons and NSCs. There has been interest in fabricating G-based neural recording 
electrodes because of the exceptional conductivity of the material that arises from the entirely 
sp2-bonded carbon structure, which creates a delocalized π-electron orbital that extends over the 
entire nanomaterial allowing for the ballistic transport of electrons [66]. Additionally, RGO can 
be formed into flexible, freestanding conductive ribbons, which could be of use in in vivo neural 
recording applications where compliant electrode designs are being pursued in order to reduce 
inflammatory tissue reaction [67, 68]. A flexible G electrode incased in insulating 
polydimethylsiloxane (PDMS) has demonstrated the ability to record electrical signals from both 
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cardiac and neural cells with a high signal-to-noise ratio [69]. Alternately, metal neural recording 
electrodes were modified with layers of G and exhibited lowered impedance and increased 
conductivity that suggests the modified electrode would perform well in neural recording 
applications [70]. Conductive G and RGO substrates have additionally been used as substrates 
for neuron growth and have demonstrated biocompability [71-74], the potential for patterned cell 
growth [75], and the ability to improve neuron cell-cell interactions with the application of weak 
electric fields [76]. A recent intriguing study found that NSCs differentiated on the surface of G 
electrodes exhibited not only an improved amount of differentiation to the neuronal lineage, but 
also improved functional maturation into electrically active neurons [77]. This work indicates 
that the conductive substrate may provide cues to the developing cells that reinforce their 
electrical connections and may have implications for neural tissue engineering and regeneration 
applications.  
While the potential of G and RGO has been investigated for tissue engineering, very few 
studies have evaluated the use of GO for this application. Neurons growing on the surface of GO 
modified with amine groups [78] or choline-like units [79] exhibited healthy morphology and 
neurite extensions without reduced viability, indicating that these modifications create 
biocompatible scaffolds based on GO nanomaterials and these studies demonstrate their potential 
for neural tissue engineering.  
1.4 DISSERTATION ORGANIZATION 
The work described in this dissertation explores a GO/CP nanocomposite as a material for 
communicating with cells in the nervous system. While CPs have been extensively studied as 
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neural interfacing materials over the past decade, and several recent studies have evaluated the 
use of G/GO nanomaterials for neural tissue engineering, few have evaluated the potential of 
GO/CP nanocomposites for interacting with the nervous system. By creating a composite of 
these two materials, the chemical functional groups present on the GO that can be utilized for 
functionalization or chemical catalysis are combined with the unique electrical and redox 
properties of the CP, and the result is a highly versatile neural interfacing material that has 
multiple applications.  
In Chapter 2 and Chapter 3, neurons and NSCs are seeded on the surface of a 
GO/PEDOT nanocomposite to evaluate its potential as a scaffolding material for neural tissue 
engineering. These chapters additionally demonstrate a simple, yet effective, method of 
immobilizing bioactive cues onto the surface of the nanocomposite film using carbodiimide 
chemistry. The results of the experiments indicate that the GO/PEDOT nanocomposite has 
potential as a scaffolding material for both neurons and NSCs. This work has implications in 
tissue engineering applications where controlled cell growth or differentiation is necessary to 
achieve a desired therapeutic effect. The work described in Chapter 2 was published in [80] and 
is reproduced by permission of The Royal Society of Chemistry. 
Chapter 4 demonstrates that conventional CP drug release systems can be significantly 
improved with the addition of GO nanosheets as co-dopants in the drug-loaded CP film synthesis 
reaction. The unique structure of the GO nanosheets enables an increase in the amount of drug 
loaded into the film, and creates a means to fine tune the release properties of the drug delivery 
platform. These results have implications in clinical applications where precise, temporally 
controlled drug delivery can minimize systemic side effects and maximize drug effectiveness. 
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The work in this chapter was published in [81] and is reproduced by permission of the American 
Chemical Society.  
In Chapter 5, the GO/PEDOT nanocomposite was evaluated for its potential as a 
dopamine (DA) sensor.  Glassy carbon electrodes modified with the nanocomposite detected DA 
with a higher level of sensitivity and reduced the amount of interference from a competing 
analyte. The unique structure of the GO nanosheets created a chemical environment at the 
electrode surface that resulted in the improved detection properties. The promising results of this 
work suggest that the GO/PEDOT composite may be applied to in vivo chemical detection 
applications, were current devices suffer from poor sensitivity to the low physiological levels of 
DA present in the brain.  
Finally, Chapter 6 characterizes an in vitro model of neuronal injury and regeneration 
that integrates electrophysiological recordings to monitor the changes in neuronal firing patterns 
in response to injury. Preliminary work suggests that the injury model has potential use as a lab-
on-a-chip method for testing pharmaceuticals and cell therapies, or as a platform to gain basic 
knowledge about cellular processes that occur following brain injury. This work provides the 
foundation for the development of a multifunctional device consisting of a multielectrode array 
(MEA) with GO/PEDOT-modified electrodes capable of simultaneous electrical and chemical 
recordings, drug delivery, and surface patterning. 
The work presented in this dissertation demonstrates the huge amount of versatility the 
GO/CP nanocomposite embodies, with applications in cell scaffolding, drug delivery and 
chemical sensing, among others. While the work here focuses solely on the potential of the 
nanocomposite in neural interfacing applications, its uses are not limited to the CNS, but span all 
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systems in the body and, as a result of its extremely unique chemical and electrical properties, 
extend to fields outside biomedicine. 
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2.0  PURE GRAPHENE OXIDE DOPED CONDUCTING POLYMER 
NANOCOMPOSITE FOR BIO-INTERFACING 
2.1 INTRODUCTION 
With advances in the preparation and characterization of graphene (G) and graphene oxide (GO), 
there has been exponentially growing interest in these materials because of their outstanding 
electrical, physical and chemical properties [82-84]. The application of G [85-90] and GO [91-
94] for interacting with biological systems has only recently been explored, though it has
demonstrated great potential for fields such as biosensing, tissue engineering, and drug delivery 
[64, 65]. To date, studies evaluating the biocompatibility of G and GO have been inconclusive, 
with some reports demonstrating severe dose-dependent toxicity [95, 96], while others indicate 
that G nanomaterials may enhance cell growth [93, 97]. These conflicting results suggest that the 
biocompatibility of G and GO depends heavily on their specific chemical and physical states as 
well as their preparation methods, and further investigation is warranted [98, 99]. 
Another class of conductive organic material, conducting polymers (CPs), has been 
extensively studied in biological and biomedical fields such as biosensors, neural tissue 
engineering and neural electrodes [17, 46, 49, 100, 101]. In these applications, it is desired to 
immobilize biomolecules to the polymer in order to impart functionalities specific for interfacing 
with the biological systems. Such modification often requires the substrate material to have at 
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least one derivatizable functional group, which many of the CPs, such as 
polyethylenedioxythiophene (PEDOT), lack. In order to add functional groups to PEDOT, 
generally two strategies have been adopted. One is the direct addition of functional groups to the 
monomer 3,4-ethylenedioxythiophene (EDOT), followed by polymerization of the modified 
EDOT monomer [102-108]. This method requires tedious synthesis and purification procedures 
for the modified EDOT monomers, and the added functional groups may pose electronic and 
steric limitations during polymerization [109]. The other strategy is the copolymerization of 
EDOT with other monomers or molecules that possess functional groups [110-112]. Although 
considerably simple, this method is still unsatisfactory because the existence of these molecules 
may impair the conductivity and stability of the resultant PEDOT. Another method of imparting 
bioactive function to PEDOT is to dope the polymer with the bioactive molecules directly. 
Peptides, drugs and proteins have been directly incorporated in PEDOT for neural interfacing or 
controlled drug delivery [38, 101, 113, 114]. However, only negatively charged biomolecules 
can be used as dopants and most of them are poor dopants because of their weak charge and 
large size. Poor dopants lead to difficulty in electropolymerization and low conductivity of the 
resulting polymer. Furthermore, the biomolecules are entrapped throughout the film, limiting the 
exposure of the functional domain at the surface. 
GO possesses many oxygen containing functional groups, such as carboxyl, hydroxyl and 
epoxide, rendering it hydrophilic and dispersible in aqueous solutions [53, 115, 116]. This 
property, along with its abundance of negatively charged carboxyl groups, makes it an excellent 
dopant for the electropolymerization of conducting polymers. Additionally, GO has recently 
been shown to act as a promoter of neuronal growth and maturation, making it an interesting 
candidate as a neural interfacing material [73, 117, 118]. CP/GO nanocomposites have exhibited 
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favorable electrical properties, energy storage and stability [90, 119]; however, the performance 
of GO/PEDOT nanocomposites as biomaterials has yet to be substantially characterized. In this 
work, we report the straightforward electrochemical synthesis of a PEDOT material doped 
exclusively with GO and demonstrate its in vitro compatibility with neuronal cells. The GO 
sheets are partially entrapped by PEDOT on the surface of the nanocomposite and many of the 
carboxyl functional groups of GO on the surface are exposed freely, enabling biomolecule 
decoration on the GO/PEDOT film surface via carbodiimide conjugation. We achieve successful 
covalent immobilization of peptide RNIAEIIKDI (p20), the functional neurite outgrowth domain 
of extracellular matrix protein, laminin [44, 50, 120, 121], and this immobilization procedure 
may be universally applied to bioactive proteins and peptides for a variety of bio-interfacing 
applications. 
2.2 MATERIALS AND METHODS 
2.2.1 Materials 
Graphite powder was purchased from Bay Carbon Inc. (SP-1, Bay City). 3,4-
Ethylenedioxythiophene (EDOT), poly(sodium-4-styrenesulfonate) (PSS, MW ~ 70,000), 
phosphate buffered saline (PBS, pH 7.4, 10 mM sodium phosphate and 0.9% NaCl), 
glutaraldehyde (25% in H2O), osmium tetroxide (OsO4, 4 wt.% in H2O), hexamethyldisilazane 
(HMDS), 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), and N-Hydroxysuccinimide 
(NHS) were purchased from Sigma-Aldrich. The peptide RNIAEIIKDI (p20) was synthesized at 
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the University of Pittsburgh Peptide Synthesis Facility. All other chemicals were of analytical 
grade, and Milli-Q water from a Millipore Q water purification system was used throughout.     
2.2.2 Electrodeposition  
GO was synthesized through the oxidization of graphite powder according to the modified 
Hummers method [54, 122], and characterized using transmission electron spectroscopy (TEM) 
(JEOL JEM-2100F). GO/PEDOT films were electrodeposited onto platinum/iridium (Pt/Ir) 
microelectrodes (standard tip, diameter: 2-3 µm, MicroProbes, Gaithersburg, MD) for 
electrochemical characterization or gold sputtered plastic microscope coverslips (macroelectrode 
area: 0.38 cm2) for surface characterization and cell culture using a Gamry Potentiostat, 
FAS2/Femtostat (Gamry Instruments, Warminster, PA) with Gamry Framework software. A 
conventional three-electrode system with the Pt/Ir or gold electrode acting as the working 
electrode, a platinum foil as the counter electrode, and a silver/silver chloride (Ag/AgCl) 
reference electrode (CH Instruments, Austin, TX) was used.  The GO/PEDOT was 
electropolymerized from an aqueous solution containing 0.02 M EDOT and 10 mg mL-1 GO. 
PEDOT/PSS films were synthesized from an electropolymerization solution containing 0.02 M 
EDOT and 0.1 M PSS. A constant potential of 1.0 V was applied to achieve a charge density of 
200 nC total for microelectrodes or 100 mC cm-2 for macroelectrodes.                                 
2.2.3 Modification of GO/PEDOT with p20 
The peptide p20 was covalently immobilized on the surface of the GO/PEDOT coated electrodes 
through an amine reaction between carboxyl groups on the GO and amine groups on the peptide. 
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The GO/PEDOT electrodes were incubated in a solution of 0.2 mg mL-1 p20, 0.2 M EDC and 0.2 
M NHS in sterile H2O for 3 h at room temperature, and then thoroughly washed with sterile PBS 
to remove any free p20, EDC or NHS. In another set of samples, GO/PEDOT films were 
incubated with p20 in the absence of EDC/NHS as a control for physical adsorption. The amount 
of p20 on the surface of the covalently modified GO/PEDOT film was quantified using amino 
acid hydrolysis followed by high performance liquid chromatography as previously described 
[44]. 
2.2.4 Electrochemical Impedance Spectroscopy 
The electrochemical impedance spectroscopy (EIS) was measured with an Autolab 
potentiostat/galvanostat, PGSTAT128N (Metrohm Autolab) with Nova 1.8 software using a 
three-electrode system with a platinum foil counter electrode and Ag/AgCl reference electrode. 
The EIS was measured in PBS in the frequency range from 10 Hz to 100 kHz using an 
alternating current sinusoid of 20 mV in amplitude with the direct current potential set to 0 V.  
2.2.5 GO/PEDOT Film Surface Analysis 
The surface of PEDOT/GO films was characterized using Fourier transform infrared (FTIR) 
spectroscopy, scanning electron microscopy (SEM) and x-ray photoelectron spectroscopy (XPS). 
FTIR measurements were carried out using a Bruker Vertex 70 spectrometer equipped with a 
Hyperion 2000 microscope. A 20x attenuated total reflectance (ATR) objective was employed to 
record the spectra of deposited thin films. The ATR spectra were converted to transmittance 
spectra via the standard method within the spectrometer operation software package, OPUS 6.5.  
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The surface morphologies and microstructures of the GO/PEDOT films were examined 
with an XL30 SEM (FEI Company) operated at 10 kV. Samples with neurons growing on the 
surface were analyzed with the same SEM, but at a lower operating potential of 5 kV. Samples 
with cells were treated with 2.5% glutaraldehyde and 1% OsO4, both for one hour in sequence, 
followed by dehydration. The dehydration was performed by soaking the samples in 30% and 
50% ethanol in PBS, 70% and 90% ethanol in water, and 100% ethanol in sequence for 15 min 
each, followed by immersion in HMDS for 15 min. 
XPS analysis of GO/PEDOT films after treatment with p20 in the presence or absence of 
EDC/NHS was performed with a K-Alpha XPS system (Thermo Scientific) equipped with a 
monochromated Al Kα source (1486.68 eV). High resolution scans of the C1s and N1s regions 
were taken at two locations on each sample. 
2.2.6 Primary Neuron Culture 
GO/PEDOT coated macroelectrodes were fixed to the surface of 24-well culture plates with 
Kwik-Sil (World Precision Instruments) and sterilized with exposure to UV light for 15 min. 
Following sterilization, the polymer surfaces were washed with sterile PBS. Cortical tissue was 
isolated from E18 Sprague-Dawley rat embryos and treated with 0.025% Trypsin in a digestion 
buffer containing 137 mM NaCl, 5 mM KCl, 7 mM Na2HPO4, and 25 mM HEPES. Neurons 
were dissociated with gentle tritruation and maintained in Neurobasal medium (Invitrogen, 
21103-049) supplemented with B27 (Invitrogen, 17504-044), GlutaMax (Invitrogen, 35050-061) 
and Antibiotic-Antimycotic (Invitrogen 15240-062). For neuron growth assays, cells were 
seeded on GO/PEDOT and PEDOT/PSS surfaces at a density of 100k cells per electrode and 
grown for 3 days. For neuron viability and death assays, polymer samples were cut to fit into 96-
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well plates and seeded with neurons at a density of 10k per well. For the cell cultures intended to 
assess the p20 functionalization on GO/PEDOT films, similar procedures were followed. In 
order to measure the neurite length easily by preventing the formation of very long and 
interconnected neurites, neurons were seeded on the GO/PEDOT surfaces at a density of 100k 
cells per electrode and grown for only 24 h before fixation and immunocytochemical analysis. 
2.2.7 Immunofluorescence Staining and Quantification 
Neurons growing on the polymer surfaces were fixed in 4% paraformaldehyde in PBS for 15 min 
and washed several times with PBS. The cells were immersed in a blocking buffer (5% goat 
serum/0.2% triton-X in PBS) for 20 min followed by incubation in mouse monoclonal antibody 
against β-III-tubulin (TuJ1, 1:1000, Sigma) for 1 h. After washing in PBS, the cells were 
incubated in goat anti-mouse Alexa Fluor 488 (1:1000, Invitrogen) secondary antibody for 1 h, 
washed in PBS and counterstained for nuclei using Hoechst 33342 (Invitrogen). 
TuJ1-immunoreactive cells were imaged using a fluorescence microscope. For each 
experimental group, 10 random 10x images were collected from each sample (n = 3). Neuron 
density was quantified by counting the number of TuJ1-immunoreactive cells that extended at 
least one neurite that measured longer than the width of the cell body. Neurite analysis was 
performed using the NeuronJ plugin for ImageJ (http://rsbweb.nih.gov/ij/). Neurites extending 
from each TuJ1+ cell body were traced and measured, and the average neurite length was 
calculated.  
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2.2.8 Neuron Viability and Toxicity Assay 
The viability of neurons growing on the GO/PEDOT composite and PEDOT/PSS films, as 
indicated by their mitochondrial activity, was assessed with the MTT Cell Proliferation Assay 
Kit (Molecular Probes). The ratio of absorbance signal at 570 nm to 630 nm (reference 
wavelength) was used to assess metabolic activity. All polymer samples were normalized to a 
blank containing the polymer sample with no cells, and compared to a positive control 
containing cells growing on the tissue culture polystyrene (TCP) well surface.  
Percentage of cell death was assessed using the propidium iodide (PI) assay. PI fluoresces 
after binding to the nuclear material of dead cells, while the plasma membrane of healthy cells 
excludes the dye. Polymer samples were prepared and neuron culture performed as in the MTT 
assay. Fluorescence was evaluated in a spectrometer with an excitation at 530 nm and emission 
at 618 nm. Polymer samples were normalized to controls containing the same polymer with 
100% dead cells, and compared to cells growing on the TCP control surface. 
2.2.9 Statistical Analysis 
All statistical analyses were carried out in SPSS software. Student’s t-tests were utilized for 
comparisons of two experimental groups and one-way analysis of variance (ANOVA) tests 
followed by Bonferroni’s post hoc analysis were utilized for comparisons of more than two 
experimental groups. Statistical significance was considered for p < 0.05 (*) and p < 0.01 (**). 
All data is presented as the mean (± SEM). 
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2.3 RESULTS AND DISCUSSION 
2.3.1 Synthesis and Characterization of GO/PEDOT Film 
GO was synthesized using the modified Hummers method and its microsheet morphology was 
confirmed with transmission electron microscopy (TEM) (Figure 2.1). For GO/PEDOT film 
synthesis, electropolymerization of EDOT was carried out in aqueous solution containing only 
EDOT and GO. 
 
 
Figure 2.1. TEM Micrograph of the Prepared GO. 
 
No additional electrolyte was used in order to avoid the involvement of any dopant other 
than GO. In the presence of the negatively charged GO, EDOT could be successfully 
electropolymerized on the electrode surface, indicating that GO, itself, acts to sufficiently dope 
the polymer film. To maintain a conductive polymerization solution, a GO concentration of 10 
mg mL-1 was utilized. Because solutions containing lower amounts of GO resulted in slower or 
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less charge passage during the polymerization reaction, a high concentration of GO was selected 
to ensure adequate film growth. The resulting film is uniform, and the incorporated GO created a 
network-like surface morphology (Figure 2.2). 
 
 
Figure 2.2. SEM images of the Electrodeposited PEDOT/GO. Images illustrate the rough, network-
like morphology of the surface. The film was electropolymerized at 1.0 V for 600 s in 0.02 M EDOT solution 
containing 10 mg mL-1 GO. Scale bar in (a) is 5 µm. Scale bar in (b) is 1 µm. 
 
FTIR analysis of the synthesized GO sheets and the GO/PEDOT films verified successful 
incorporation of GO into the film (Figure 2.3). Pure GO exhibits peaks at 3396 cm-1, 1726 cm-1, 
1404 cm-1, 1283 cm-1, and 1058 cm-1 that represent carboxylic O-H stretching and vibration, 
carboxylic C=O stretching and vibration, O-H deformation, epoxy C-O stretching and vibration, 
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and alkoxy C-O stretching and vibration, respectively [90, 123]. The spectrum of the 
electrodeposited GO/PEDOT nanocomposite contains the characteristic peaks for C=O 
stretching and vibration of carboxyl groups at 1744 cm-1 and O-H deformation at 1410 cm-1. The 
PEDOT polymer does not contain either carboxyl or hydroxyl functional groups, so these must 
be attributed to GO, the sole dopant in the polymerization solution, indicating that the GO sheets 
have been successfully incorporated into the polymer film. Notably, the presence of the 
carboxylic carbonyl peak indicates that the film contains carboxylic acid functional groups 
provided by the GO sheets that can be utilized for biomolecule immobilization with 
carbodiimide cross-linking. The carboxylic O-H stretching and vibration band that should be 
apparent around 3400 cm-1 is absent in the GO/PEDOT spectrum, and is likely obscured by the 
tail of the ~ 1 eV bipolaron absorption band, a typical attribute of conductive polymers [41].   
 
 
Figure 2.3. FTIR Spectra of GO and GO/PEDOT Nanocomposite. 
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2.3.2 Cytotoxicity of GO/PEDOT Nanocomposite 
Although PEDOT doped with various molecules, such as heparin [124], poly(styrene sulfonate), 
(PSS) [18] and adhesive peptides [125] has been shown to be non-cytotoxic, and soluble GO has 
demonstrated inconsistent toxicity effects [93, 96, 99], the biocompatibility of GO incorporated 
in conducting polymers has not previously been studied. To explore the cytocompatibility of the 
GO doped conducting polymer film, the viability and death of neurons growing on the 
GO/PEDOT surface after 24 h were evaluated with the MTT viability and propidium iodide (PI) 
exclusion assays and compared to PEDOT films containing the commonly and extensively 
studied dopant PSS. To isolate the effects of the polymer surface directly on the cell 
viability/death, the surfaces were not coated with laminin, an extracellular matrix protein widely 
used to promote neuron attachment and growth on various surfaces [126, 127]. There was no 
significant difference in viability between the GO/PEDOT and PEDOT/PSS films, with each 
group exhibiting greater than 96% of the metabolic activity of neurons growing on a control TCP 
surface (Figure 2.4a). Neurons growing on the GO/PEDOT surface did not undergo a higher 
percentage of death than the cells on the PEDOT/PSS surface (GO: 12.79 ± 5.0; PSS: 20.61 ± 
3.78, Figure 2.4b). 
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 Figure 2.4. Cytotoxicity Assessment of PEDOT Films. (a) Viability and (b) death of neurons growing 
on PEDOT films doped with GO or PSS at 24 h in culture. GO/PEDOT films perform similarly to control 
PEDOT/PSS films, exhibiting no loss of viability and minimal cell death. Error bar represents SEM (n = 5). 
 
The mechanism of soluble GO cytotoxicity shown in previous reports remains unclear, 
but multiple processes have been suggested, including uptake into the cell or adsorption onto the 
cellular membrane and consequent apoptosis or death, disruption of membrane integrity and 
cellular exchange, interference with cell adhesion, or induction of oxidative stress [95, 96, 128, 
129]. The absence of significant cytotoxicity caused by GO/PEDOT films in the current study 
may arise from the entrapment of the GO sheets within the film, hindering their ability to diffuse 
within the culture media and interact freely with the neurons. Cells growing on the surface of the 
film are largely contacting the PEDOT polymer, which has demonstrated biocompatibility with 
neuronal cells [18]. The minimal toxicity of GO/PEDOT films indicates that the nanocomposite 
has potential as a neural interfacing material. However, long-term toxicity studies must be 
performed to determine the full cytocompatibility of the material.  
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 Figure 2.5. SEM Image of a Neuron Growing on the GO/PEDOT Surface at 1 d in Culture. The cell 
exhibits extensive neurite branching and forms contacts with other cells, demonstrating the biocompatibility 
of the GO/PEDOT film. 
2.3.3 Neuron Growth on the GO/PEDOT Nanocomposite 
To evaluate the neural biocompatibility of the GO/PEDOT composite, films were 
electrochemically deposited on gold sputtered coverslips, and the resulting GO/PEDOT coated 
coverslips were used as substrates to grow primary neuron cultures. SEM imaging revealed that 
neurons exhibited healthy growth on the surface of nanocomposite films in the absence of 
laminin treatment (Figure 2.5). Cells spread and flattened on the composite surface and 
interconnected with other neurons, demonstrating that the surface supported neural attachment 
and maturation. Due to the specific network-like microstructure of the GO/PEDOT film, some of 
the smaller processes of neurons intimately grew along or around the partially exposed GO 
ridges on the surface of the film, potentially using the film morphology as a guidance cue for 
neurite outgrowth. Representative fluorescent images show neuron attachment and growth on 
GO/PEDOT and PEDOT/PSS films after 3 d in culture (Figure 2.6a, b). The neurons grew on the 
surface of the GO/PEDOT film at a density comparable to that of PEDOT/PSS, indicating that 
the GO is not specifically contributing any obstruction to the attachment of cells (Figure 2.6c). 
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While previous GO biocompatibility studies have indicated that GO initiates downregulation of 
adhesion proteins, such as laminin, fibronectin, and focal adhesion kinase-1, leading to a 
decrease in cellular adhesion [96], our data suggest that GO entrapped in the polymer matrix may 
not have such adverse effects on neuron attachment. This agrees with a proposed mechanism for 
decreased cell adhesion that attributes altered gene expression to the activation of intracellular 
pathways after GO nanoparticles adhere to the cell membrane [96]. GO sheets embedded in the 
PEDOT polymer matrix may be restricted from interacting with the cell membrane in a way that 
would initiate changes in gene expression, rendering the GO/PEDOT film a favorable surface for 
cell attachment and growth. 
Neurons growing on the GO/PEDOT film exhibited significantly longer neurites than 
cells growing on the PEDOT/PSS film (Figure 2.6d, GO: 36.4 ± 2.0 µm; PSS: 22.5 ± 1.8 µm, p < 
0.01). This finding is supported by previous work demonstrating that pure GO surfaces promote 
neurite outgrowth in hippocampal neurons [73], and soluble GO can enhance neurite outgrowth 
in SH-SY5Y neuroblastoma cells by potentially shuttling adsorbed proteins into the cell body 
during uptake [118]. Although the GO from the GO/PEDOT film is likely not being taken into 
the neuron cell body due to its entrapment within the polymer matrix, its ability to strongly 
physically adsorb proteins, a consequence of the huge surface area of its single-layer carbon 
structure, may attract components of the cell media to the surface of the polymer film, enhancing 
growth cone outgrowth. Additionally, neurons have been shown to be extremely responsive to a 
variety of topographical cues, and in particular, surface roughness has been shown to promote 
neurite extension [128, 129]. The rough, network-like surface morphology of the GO/PEDOT 
film (Figures 2.2 and 2.5), compared to the smooth and featureless surface of PEDOT/PSS at the 
same scale (previously reported in [50]) may contribute to the longer neurite outgrowth in  
 31 
 Figure 2.6. Neuron growth on PEDOT surfaces doped with GO and PSS at 3 d. Representative 20x 
fluorescent images of β-III-tubulin immunofluorescent reactivity (green) of neurons growing on (a) GO and 
(b) PSS doped PEDOT. Blue color is Hoechst nuclear counterstain. Scale bar represents 100 µm. (c) Neuron 
density and (d) average neurite length (± SEM; n = 3) of cells growing on the polymer surfaces. GO doped 
PEDOT films support neurons with longer neurite extensions than PSS doped PEDOT films (** p < 0.01). 
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 GO/PEDOT as compared to PEDOT/PSS. Regardless of the mechanism, the desirable effect on 
neurite outgrowth demonstrates that GO/PEDOT films are an amenable material for supporting 
neuronal growth and maturation, and may be useful substrates for neural tissue interfacing 
applications. 
2.3.4 Bioconjugation of GO/PEDOT Films with p20 Peptide 
The GO sheets on the top layer of the GO/PEDOT films are partially embedded, as demonstrated 
by the network-like morphology of the film (Figure 2.2), and the exposed portions of the GO, 
rich in carboxyl groups (Figure 2.3), provide the GO/PEDOT films with many free functional 
groups. Utilizing carbodiimide conjugation to modify these functional groups, we demonstrate a 
novel method of biomolecule patterning on conducting polymer films. A laminin fragment 
peptide, p20, which is reported to promote neurite outgrowth [50, 120], was conjugated to the 
electrodeposited film. The peptide was covalently attached to the GO/PEDOT film through the 
formation of amide bonds between the carboxyl groups on the surface of GO/PEDOT and the 
amine groups of the p20, with the assistance of cross-linkers EDC and NHS. The presence of p20 
on the film after carbodiimide modification was verified by hydrolysis and amino acid 
quantification (5.37 pmol-mm-1). 
XPS analysis of the GO/PEDOT film evaluated the surface chemistry of the film after 
p20 immobilization with EDC/NHS (Figure 2.7). The deconvoluted C1s region (Figure 2.7a) 
consists of four peaks in addition to the main C-C peak located at 284.8 eV, including a C-O/C-S 
peak at 285.6 eV, an epoxy C-O-C peak at 286.9 eV, a N-C=O peak at 288.2 eV and an O-C=O 
peak at 288.8 eV [130, 131]. The PEDOT contributes to the C-S and C-O-C peaks, the GO 
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sheets contribute to the C-O, C-O-C, and O-C=O peaks, and the peptide contributes to the O-
C=O and N-C=O peaks. Analysis of the C1s region of the PEDOT/GO film treated with p20 in 
the absence of EDC/NHS resulted in a similar deconvolution. During the amide bond formation 
in the presence of EDC/NHS, a carboxylic acid provided by the GO reacts with an amine on the 
peptide, resulting in a net gain of one amide bond and a net loss of one carboxylic acid bond. 
However, since both the GO and peptide contain carboxylic acids, a comparison of the ratio of 
amide to carboxylic acid between the experimental groups cannot be used to verify the formation 
of covalent amide bonds between the peptide and the film with the addition of EDC/NHS. The 
carboxylic acid signal of the GO sheets is likely variable across the film depending on the 
proportion of GO exposed to the surface versus embedded within the polymer matrix, so the ratio 
of amide to carboxyl will not reflect the amount of covalently attached peptide. A more 
appropriate method of evaluating the amide formation is to monitor the ratio of amine to amide 
bonds. During the covalent reaction, one amine in the peptide p20 reacts with a carboxylic acid 
group to form an amide bond, so there will be more amide and less amine after the covalent 
treatment, as compared to the physical adsorption treatment. A high-resolution scan of the N1s 
region of the film treated with p20 and EDC/NHS revealed a peak centered at 388.9 eV, 
corresponding to the nitrogen in the peptide (Figure 2.7b). Deconvolution of the N1s peak 
resulted in a C-N (amine) peak at 399.7 eV, a N-C=O (amide) peak at 400.3 eV, and a protonated 
amine peak at 401.8 eV [130, 132]. The amide/amine ratio is 0.58, compared to 0.19 in the 
absence of EDC/NHS crosslinking, indicating that the EDC/NHS treatment produced covalent 
linkages between the peptide and the GO/PEDOT film. 
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 Figure 2.7. High-Resolution XPS Spectra of the GO/PEDOT Surface after Treatment with p20 in 
Conjugation with EDC/NHS. Deconvoluted peaks of the (a) C1s region (C1: C-C; C2: C-O/C-S; C3: C-O-C; 
C4: N-C=O; C5: O-C=O) and (b) N1s region (N1: C-N; N2: N-C=O; N3: protonated amine). 
 
The electrical properties of the electrodeposited GO/PEDOT films before and after p20 
immobilization were studied using EIS. As shown in Figure 2.8a, coating the electrode with the 
GO/PEDOT film resulted in decreased impedance across all frequencies measured. This 
significant impedance decrease may be attributed to an increase in the effective surface area of 
the electrode due to the network-like surface microstructure of the nanocomposite polymer film 
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[14]. Longer deposition times resulted in a progressive decrease in impedance, demonstrating the 
film properties can be tuned as desired by controlling deposition parameters (Figure 2.9). At 1 
kHz, a frequency relevant to single unit neural recording, the impedance is decreased by an order 
of magnitude after the GO/PEDOT deposition, indicating that the film may be a beneficial 
microelectrode coating to improve the recording and stimulation capability of neural electrodes 
[133]. The Nyquist plot of the impedance (Figure 2.8b) demonstrates that the bare metal has 
mostly capacitive behavior, as indicated by its steep linear curve. The electrodes coated with 
GO/PEDOT films exhibit a knee that separates capacitive behavior at low frequencies and 
diffusive behavior, characterized by a more gradual slope, at higher frequencies [90, 134]. The 
emergence of diffusion-dominated behavior may be attributed to the creation of a diffusion 
barrier by the conducting polymer film. After immobilization of p20 at the surface of the 
polymer film, the impedance increases slightly, a possible result of the creation of a 
nonconductive peptide layer at the electrode surface; however, the impedance remains 
significantly lower than that of the bare metal electrode. 
The bioactivity of the immobilized p20 was assessed with primary neuron culture on the 
functionalized GO/PEDOT films. After 24 h in culture, neuron attachment and average neurite 
length were quantified and compared among GO/PEDOT films unmodified with peptide (bare), 
and films modified with p20 via physical adsorption or covalent immobilization. Representative 
fluorescent images illustrating β-III-tubulin immunoreactivity and neurite outgrowth on each 
film are shown in Figure 2.8a-c. While there are no differences in the density of neurons attached 
to each film (Figure 2.10d), the average neurite length (Figure 2.10e) of the neurons grown on 
the GO/PEDOT films covalently modified with p20 is significantly longer than that on the other 
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 Figure 2.8. Electrochemical Impedance Spectroscopy of p20-Modified GO/PEDOT Films. (a) Bode 
and (b) Nyquist plots of the electrochemical impedance behavior of platinum iridium microwires uncoated 
(black circles), coated with GO/PEDOT (blue squares), and coated with GO/PEDOT covalently modified with 
p20 (red triangles). 
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 Figure 2.9. Electrochemical Impedance Spectroscopy Comparison of Glassy Carbon Electrodes 
Without and With GO/PEDOT Coatings of Different Electrodeposition Times. Longer deposition times result 
in decreased impedance values. 
 
two films (bare: 14.29 ± 0.63 µm; adsorption: 14.59 ± 1.72 µm; covalent immobilization: 20.48 
± 1.45 µm, p < 0.05). This observation can be ascribed to the effect of p20, which is the neurite 
outgrowth domain of laminin protein, and has been shown to enhance neurite outgrowth when 
incorporated into conducting polymer films as a dopant [44, 50]. There was no discernable effect 
of p20 when physically adsorbed on the GO/PEDOT film (Figure 2.10). It is possible that the 
peptide does not retain its bioactivity, potentially due to conformational changes as a 
consequence of the physical adsorption onto the film that may obstruct laminin receptors on the 
neurons from binding to the peptide. Covalent anchoring of p20 to the GO/PEDOT film leaves 
most of the peptide free to interact with the cell, preserving the bioactivity of the peptide. It is 
also possible that the physically adsorbed peptide desorbs over the course of the cell culture 
experiment, resulting in less neurite outgrowth. The covalently conjugated p20 is very stable and 
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continues to support neurite outgrowth after presoaking in PBS at 37°C for 3 d prior to neuron 
culture (data not shown). This simple method of functionalizing GO doped PEDOT films with 
biomolecules and its superior effectiveness over traditional biomolecule adsorption clearly 
demonstrates the potential of the nanocomposite as a bio-interfacing material.  
 
 
Figure 2.10. Neuron Attachment and Neurite Outgrowth on GO/PEDOT Surfaces Modified with p20 
Peptide at 24 h in Culture. Representative 20x fluorescent images of β-III-tubulin immunofluorescent 
reactivity of neurons cultured on (a) bare, (b) physically adsorbed p20 (p20 ADS) and (c) covalently 
immobilized p20 (p20 COV) GO/PEDOT surfaces. Scale bar represents 50 µm. (d) Neuron density (± SEM; n 
= 3) growing on the p20 modified GO/PEDOT surfaces. Modification with p20 did not result in a change in 
cell density. (e) Average neurite length (± SEM; n = 3) of neurons growing on the p20 modified GO/PEDOT 
surfaces (*p < 0.05). Covalent immobilization, but not physical adsorption of p20 on the film surface 
enhanced neurite outgrowth. 
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2.4 CONCLUSIONS 
We have successfully prepared a conducting polymer PEDOT material doped solely with GO. 
The electrodeposited GO/PEDOT films showed good conductivity, and they can significantly 
lower the impedance of the coated electrodes. The GO/PEDOT films possess a network-like 
surface structure due to the presence of partially embedded GO sheets, and they supported the 
growth of neurons with minimal toxicity. Most interestingly, the partially exposed GO pieces on 
the surface of the GO/PEDOT films are rich in free carboxyl groups, which offer the 
GO/PEDOT films active functional groups for surface modification. Functional laminin peptide, 
p20, was successfully bioconjugated to the surface of the GO/PEDOT film through a simple 
cross-linking reaction that may be universally applied to a multitude of biomolecules. It is 
expected that this biocompatible GO/PEDOT material with excellent modifiability will find 
important biological and biomedical applications, such as neural interfacing and biosensing. 
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3.0  DIRECTED NEURAL STEM CELL DIFFERENTIATION WITH A 
FUNCTIONALIZED GRAPHENE OXIDE NANOCOMPOSITE 
3.1 INTRODUCTION 
Neural stem cells (NSCs) are multipotent cells with the potential to generate neurons, astrocytes, 
and oligodendrocytes, the main components of the central nervous system (CNS). In the mature 
brain, NSCs reside primarily in areas of neurogenesis, the subventricular zone of the lateral 
ventricle and the subgranular zone of the hippocampus, where they proliferate and give rise to 
new neurons throughout the lifetime of an animal [135, 136]. In adult neurogenesis, newborn 
neurons respond to a series of environmental cues by migrating to specific locations, sprouting 
axons and dendrites to exhibit mature neural morphologies, and eventually integrate into existing 
circuitry by forming active synapses with local neurons [137-139]. The ability of NSCs to 
generate functionally mature neurons capable of joining existing populations of cells makes 
NSCs, derived from either adult or embryonic tissues, appealing candidates to potentially restore 
function to damaged brain tissue by rewiring broken connections. A major challenge in utilizing 
NSCs for regenerative therapies is the poor control over the survival, differentiation, maturation 
and functional integration of the transplanted cell population [140-143]. Tools that can control 
the behavior of NSCs, both for basic research purposes and therapeutic applications, are needed 
to address the challenges faced along this continuum. 
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NSCs are not intrinsically wired for differentiation to a particular CNS cell type, but 
instead are influenced by extrinsic factors such as growth factors, extracellular matrix 
components, paracrine and juxtacrine signaling from other cells within their niche, as well as 
electrical or mechanical cues from their microenvironment [144-149]. By taking advantage of 
the responsiveness of NSCs, biomimetic scaffolding materials can be engineered to manipulate 
NSC proliferation, differentiation, and maturation pathways to improve their effectiveness in cell 
replacement therapies. One method used to provide functional cues to NSCs is conjugation of 
extracellular matrix proteins or bioactive peptides onto the surface of scaffolding materials to 
drive NSC attachment and preferential differentiation [146, 150-154].  
Conductive substrates that have the ability to stimulate cells with electrical current have 
also been investigated as scaffolding materials because NSCs and CNS progenitor cells are 
exposed to electrical signaling during development that influences their organization and 
maturation into adult tissue [155-157]. Conducting polymers (CPs) such as poly(pyrrole) and 
poly(3,4-ethylenedioxythiophene) (PEDOT) are intrinsically conductive materials that have been 
used to electrically interface with the nervous system and neural stem cells [47, 158-160]. CPs 
are simple to process, biocompatible, and have versatile physical and electrical properties by 
means of their synthesis method, making them attractive materials for cell scaffolding [18, 29-
31, 43]. During their polymerization, anionic molecules are incorporated into the bulk of the CP 
film as dopants, providing a method to incorporate bioactive molecules such as growth factors, 
extracellular matrix proteins, and functional peptides, that can then influence cell attachment and 
growth [38, 40, 42, 44, 50]. However, this method can interrupt the conductivity and mechanical 
stability of the CP or mask the active sites of the biomolecules because they are located within 
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the polymer matrix [42]. For this reason, methods to covalently immobilize biomolecules on the 
surface of CP films are desirable.  
While traditional CPs do not contain free functional groups that can be utilized in 
covalent cross-linking reactions, graphene oxide (GO) nanosheets have been used as dopants in 
order to introduce functional groups to the CP substrates [80]. GO is a two-dimensional 
honeycomb carbon material rich in functional groups such as hydroxyl, epoxide, and carboxylic 
acid [53]. Because of the presence of carboxylic acid groups in its structure, GO nanosheets are 
negatively charged and can therefore be incorporated into the CP films as dopants during their 
synthesis. GO nanocomposite CP films have demonstrated favorable electrical properties, 
biocompatibility, and potential for electrical interfacing with neuronal tissue [80, 90, 117, 161, 
162]. In this work, we investigate the ability of GO/PEDOT nanocomposite films to act as a NSC 
scaffold. The viability, attachment, and differentiation of NSCs on the GO/PEDOT 
nanocomposite surface was compared to NSC behavior on conventional PEDOT films doped 
with poly(sodium-4-styrenesulfonate) (PSS). Additionally, we demonstrate that the surface of the 
nanocomposite can be easily modified with bioactive molecules to selectively drive NSC 
differentiation towards either neuronal or oligodendrocyte lineage.   
3.2 MATERIALS AND METHODS 
3.2.1 PEDOT Film Synthesis 
The GO/PEDOT nanocomposite films were electrochemically deposited onto the surface of gold 
sputtered plastic coverslips from an aqueous solution using a Gamry poteniostat, FAS2 femtostat 
 43 
(Gamry Instruments) and a three-electrode setup with a platinum foil counter electrode and a 
silver/silver chloride reference electrode (CH Instruments). The deposition solution contained 
3,4-ethylenedioxythiophene (0.02 M; Sigma-Aldrich) and either GO (10 mg ml-1) or 
poly(sodium-4-styrenesulfonate) (PSS) (0.1 M; Sigma-Aldrich). GO was synthesized using the 
modified Hummer’s method as previously described and sonicated for 20 min prior to 
electrodeposition into the polymer to ensure nanosheet exfoliation [80, 81]. The films were 
electrodeposited using chronocoulometry at 1 V until a charge density of 100 mC cm2 was 
reached. The synthesized films were washed in dH2O for 3 d prior to cell culture to ensure the 
removal of any loosely adsorbed monomer or dopant. 
3.2.2 Modification of GO/PEDOT Nanocomposite Films with Biomolecules 
GO/PEDOT nanocomposite films were modified using carbodiimide chemistry to create an 
amine bond between the biomolecule and the GO sheets at the surface of the film. The 
nanocomposites were immersed for 3 h in a solution containing either interferon-γ (IFNγ, Sigma-
Aldrich) or platelet-derived growth factor AA (PDGF-AA, Sigma-Aldrich) at a concentration of 
2.5 µg mL-1 with 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC; 0.2 M; Sigma-Aldrich) 
and N-Hydroxysuccinimide (NHS; 0.2 M; Sigma-Aldrich) in sterile dH2O. As a physical 
adsorption control, the nanocomposite films were incubated in either IFNγ or PDGF-AA, as 
above, but in the absence of EDC and NHS. All prepared samples were washed repeatedly with 
sterile phosphate buffered saline (PBS) after the modification procedure. Samples for cell culture 
were stored in PBS until use, and samples for characterization were stored dry. 
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3.2.3 GO/PEDOT Characterization 
The morphology of the electrodeposited GO/PEDOT and PEDOT/PSS films were evaluated 
using scanning electron microscopy (SEM, JEOL JSM6510) with an operating potential of 3 kV. 
Roughness analysis was carried out with a scanning probe microscope in tapping atomic force 
microscopy (AFM) mode (Veeco Dimension V). Root mean square roughness (Rq) was 
calculated using Nanoscope Analysis software (Bruker). 
Fourier-transform IR (FTIR) spectroscopy was used to evaluate the surface of the 
nanocomposite following carbodiimide crosslinking with IFNγ and PDGF-AA. The analysis was 
carried out with a Bruker Vertex 70 spectrometer with a Hyperion 2000 microscope at a 20x 
attenuated total reflectance (ATR) objective. 
3.2.4 NSC Isolation and Culture 
NSCs were isolated from the cortical tissue of E18 Sprague-Dawley rat embryos. Briefly, the 
tissue was triturated in a solution of Hank’s Balanced Salt Solution (HBSS, Sigma-Aldrich) 
containing Glutamax (1%, Invitrogen) and Penicillin-Streptomycin (Pen-Strep; 1%, Invitrogen). 
The tissue was allowed to settle and the supernatant was centrifuged to pellet the cortical cells. 
After resuspension in NeuroCult NS-A proliferation medium (StemCell Technologies) 
supplemented with recombinant human epidermal growth factor (EGF; 20 ng mL-1, Invitrogen), 
recombinant human basic fibroblast growth factor (bFGF; 10 ng mL-1, Invitrogen), Heparin (2 
mg mL-1; StemCell Technologies), and Pen-Strep (1%), the cortical cells were maintained at 
37°C for 3 d or until the formation of neurospheres, at which point they underwent passage. The 
cells were passaged as necessary every 3-4 d and were used for assays within passages 2 to 4. 
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For all NSC culture experiments, the neurospheres were passaged to obtain a single-cell 
suspension and seeded on culture surfaces at a density of 150,000 cells cm-2. The seeded cells 
were maintained at 37°C in NeuroCult NS-A Differentiation medium (StemCell Technologies) 
supplemented with Pen-Strep (1%) in the absence of growth factors to induce differentiation. 
The culture medium was exchanged every 3 to 4 d as necessary. 
3.2.5 Viability Assays 
The viability of differentiating NSCs after exposure to soluble GO nanosheets was assessed with 
the MTT Cell Proliferation Assay. Cells were seeded on the surface of 96-well plates that were 
treated with poly-L-ornithine (PLO, 20 µg ml-1 in PBS, 1 h incubation) and after 24 h were 
treated with GO nanosheets at concentrations of 10, 25, 50, 100, and 200 µg mL-1. The treated 
cells were assayed at 1 d, 3 d or 7 d (n = 5 for each group). The ratio of absorbance signal at 570 
nm to 630 nm was quantified using a spectrophotometer. The experimental groups were 
normalized to controls that contained GO nanosheets without cells, and all data is presented as 
the percent viability compared to positive controls consisting of cells not exposed to the GO 
nanosheets. The viability of NSCs growing on the surface of the GO/PEDOT and PEDOT/PSS 
films was assessed similarly. The cells were assayed at 3 d and 7 d (n = 3 for each group), 
normalized to controls that contained the PEDOT films without cells, and compared to positive 
controls that consisted of cells growing on tissue culture plastic. 
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3.2.6 NSC Attachment and Differentiation on GO/PEDOT Substrates 
NSCs were seeded on the surface of the PEDOT films that were treated with PLO (20 µg ml-1in 
PBS, 1 h incubation) and fixed with paraformaldehyde (4%) at 30 min to evaluate the initial cell 
attachment, or at 7 d to assess differentiation. The samples were immunostained with markers for 
immature neurons (mouse monoclonal anti-β-III-tubulin, TuJ1; 1:500; Sigma-Aldrich), 
astrocytes (rabbit polyclonal anti-glial fibrillary acidic protein, GFAP; 1:500; DAKO) or 
oligodendrocyte precursors (mouse monoclonal anti-O4; 1:500; R&D Systems). Briefly, the cells 
were treated in blocking buffer (5% goat serum in PBS alone for O4 or with Triton-X, 0.02%, for 
TuJ1 and GFAP) for 20 min, then incubated in primary antibody for 2 h at room temperature 
followed by fluorescent secondary antibody (Alexa Fluor 488 anti-mouse or Alexa Fluor 594 
anti-rabbit; Molecular Probes) for 45 min at room temperature. The cells were counterstained for 
nuclei using Hoechst 33342 (Invitrogen). 
TuJ1-immunoreactive (ir) cells or O4-ir cells were quantified to determine the extent of 
neuronal and oligodendrocyte differentiation on each culture substrate (n = 3 for each). Each 
sample was imaged using a 20x objective and 10 random images were taken and used for 
quantification. Values were reported as the percent of differentiation by dividing the number of 
TuJ1-ir or O4-ir cells by the total number of nuclei present in the image. The NeuronJ plugin for 
ImageJ (http://rsbweb.nih.gov/ij/) was used to evaluate neurite growth from neurons. The 
average neurite length was quantified by tracing each neurite extending from each TuJ1-ir cell 
and averaging to obtain the mean length per cell. The total oligodendrocyte area was quantified 
using the ImageJ threshold and measure functions to define the O4-ir area for each cell. 
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3.2.7 Statistical Analysis 
All statistical analyses were performed using GraphPad Prism software. Student’s t tests were 
used to compare two experimental groups, one-way ANOVAs were used to compare three 
experimental groups, and two-way ANOVA was used to compare three experiment groups 
across multiple measures. All data is presented as the mean ± SEM. 
3.3 RESULTS AND DISCUSSION 
3.3.1 Morphological Characterization of GO/PEDOT Nanocomposite Film 
The GO/PEDOT nanocomposite was deposited onto gold macroelectrodes by electrochemical 
polymerization from an aqueous solution containing the EDOT monomer and GO nanosheets. 
The synthesized film exhibited a characteristic surface morphology that included both sub-
micron sheet-like features arising from smaller GO nanosheets engulfed in the polymer and 
larger wrinkle features that are likely the edges of larger GO nanosheets protruding from the 
nanocomposite surface (Figure 3.1a) [163]. The GO/PEDOT morphology differs significantly 
from that of PEDOT films doped with PSS, which exhibit uniform, compact features at the film 
surface (Figure 3.1b). This difference in morphology has implications for its ability to interface 
with cells.  
 48 
 Figure 3.1. Surface Morphology of PEDOT Films. SEM images of PEDOT doped with (a) GO 
nanosheets or (b) PSS illustrating the dopant-dependent surface morphologies of CP films. 
 
Neurons and NSCs have been shown to be highly responsive to various material 
properties such as surface morphology, stiffness, and roughness [128, 146, 164, 165]. This 
responsiveness indicates that creating cell-scaffolding materials with alterable physical 
properties will provide a means to control cell behavior to learn about their physiology or to 
produce appropriate cell behaviors for regenerative therapies. CPs demonstrate a wide array of 
morphological properties depending on their dopants, as demonstrated in Figure 3.1 and in work 
by others [30, 43], or by their synthesis method [14, 15, 23]. To further characterize the 
morphology of the GO/PEDOT nanocomposite, the surface roughness was evaluated with AFM. 
As expected, the GO/PEDOT nanocomposite exhibited a much rougher surface than that of the 
PSS-doped PEDOT film, as a result of the larger peaks and valleys created on the film surface by 
the larger GO nanosheets (Figure 3.2). 
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 Figure 3.2. Surface Roughness Characterization of PEDOT Films. Representative AFM images of 
PEDOT doped with (a) GO or (b) PSS demonstrating the higher root mean square (Rq) surface roughness of 
GO/PEDOT nanocomposite films. 
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3.3.2 Toxicity Assessment of GO/PEDOT Nanocomposite 
The cytotoxicity of nanoparticles has been under scrutiny in recent years with the increasing 
number of nanomaterials investigated for applications in biology and medicine [166-168]. The 
results of GO toxicity testing have been varied, likely as a result of the inconsistent methods used 
during the synthesis of the nanosheets and the variety of different cell types used for the assays 
[93, 169]. In light of these conflicting toxicity reports, we evaluated the effect of soluble GO 
nanosheets applied at varying concentrations to rat embryonic-derived NSCs. The GO 
nanosheets exhibited both time- and dose-dependent toxicity effects on the NSCs, with exposure 
to concentrations under 25 µg ml-1 for 1 d creating no reduction in viability as measured by 
mitochondrial activity (Figure 3.3a). At doses higher than 25 µg ml-1, the NSCs exhibited a large 
decrease in viability after only 1 d, and all doses elicited a decrease in viability after a 3 d or 7 d 
exposure. The mechanism of GO toxicity is still under investigation, though studies have shown 
that the nanoparticles can be endocytosed into the cell to alter gene expression, increase the 
production of reactive oxygen species, and elicit cell apoptosis [96, 167, 170, 171].  
While the safety of soluble GO nanosheets remains questionable, work has demonstrated 
that when GO is contained within a polymer substrate or deposited onto a surface, there are no 
adverse effects on cell viability [73, 80, 172, 173]. The viability of NSCs cultured on the surface 
of the GO/PEDOT nanocomposite film for 3 d and 7 d was assessed and compared to that of 
NSCs growing on the surface of PEDOT doped with PSS, which has demonstrated good 
biocompatibility [18, 105]. At both time points, NSCs growing on the GO/PEDOT 
nanocomposite exhibited no decrease in their viability, similar to cells growing on the PSS-
doped PEDOT substrate (Figure 3.3b).  
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 Figure 3.3. Toxicity Assessment of Soluble GO Nanosheets and GO/PEDOT Nanocomposite Film. (a) 
Viability of NSCs exposed to GO nanosheets for 1, 3, or 7 d at various concentrations. GO exhibits both a 
time- and dose- dependent toxicity effect on the cells (* p < 0.05; n = 6). (b) Viability of NSCs cultured on the 
surface of GO/PEDOT nanocomposite films or PEDOT doped with PSS for 3 d or 7 d. Cells exhibited no 
decrease in viability at either time point on either surface (n = 3). 
3.3.3 NSC Attachment and Differentiation on GO/PEDOT Substrates 
The attachment and growth of NSCs on the surface of the GO/PEDOT nanocomposite was 
evaluated to determine its performance as a cell scaffold. NSCs were seeded on the surface of 
PLO-coated substrates and cultured in differentiation media for either 30 min to evaluate 
attachment onto the substrate or 7 d to evaluate differentiation into neuronal lineages. At the 30 
min time-point, the density of NSCs attached to GO/PEDOT did not differ from the density on 
the surface of the PEDOT doped with PSS, suggesting that initial attachment to the two surfaces 
was similar (Figure 3.4a). However, by 7 d in culture, NSC density on the GO/PEDOT 
nanocomposite surface surpassed that of the PEDOT doped with PSS (Figure 3.4b). Adhesion 
plays an essential role in stem cell maintenance, proliferation and differentiation, and on artificial 
substrates is mediated by a number of factors including surface charge, wettability and 
nanotopography [146, 174]. Because cell density differences occur at the 7 d time point, it is 
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possible that the initial adhesions formed were more stable on the GO/PEDOT nanocomposite 
surface, allowing for better growth during the longer culture. One possible explanation for the 
improved attachment may be that the PLO adsorbed more readily at the GO/PEDOT 
nanocomposite surface. PLO modification is commonly used to create a more hydrophilic 
substrate for improved cell attachment [175]. PLO is positively charged as a result of its multiple 
amine groups, and it might electrostatically interact with the negative carboxylic acid groups 
contributed by the GO at the surface of the nanocomposite. A second possibility for the 
improved cell density at later time points is that extracellular matrix (ECM) proteins secreted by 
the cells may have adsorbed on the GO/PEDOT nanocomposite surface more favorably than at 
the PEDOT doped with PSS surface. Again, electrostatic interactions might play a role, but 
additionally, π-stacking interactions can also occur between aromatic structures in the proteins 
and the benzene rings contained in the GO nanosheets [95, 97]. Proliferation may also play a role 
in the improved density present at the GO/PEDOT surface at 7 d. Compared to the density of 
cells growing on the GO/PEDOT surface at 30 min there is approximately a 7x increase at the 7 
d time point. The NSCs were maintained in differentiation media without growth factors so the 
cells should not continue to proliferate. However, it is possible that the surface of the GO 
provides a mitogenic cue that encourages the NSCs to remain in their proliferative state and 
continue dividing, even in the absence of growth factors. Future work to investigate the effect on 
NSC proliferation will assist in characterizing the influence of the GO/PEDOT nanocomposite 
on NSC behavior. 
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 Figure 3.4. NSC Attachment and Differentiation on PEDOT Scaffolds. Total cell density present on 
PEDOT films doped with GO or PSS at (a) 30 min and (b) 7 d in culture in differentiation media. There are 
no differences between the groups during the initial attachment, but a significantly higher density of cells is 
present on the GO/PEDOT nanocomposite at 7 d (** p < 0.01; n = 3). (c) Percent of neuronal differentiation 
and (d) average length of neurite outgrowth from differentiated neurons on PEDOT films after 7 d. The 
GO/PEDOT film supports a higher yield of differentiated neurons and a longer average neurite length (* p < 
0.05; n = 3). Representative fluorescent images of differentiated NSCs growing on the (e) GO/PEDOT 
nanocomposite and the (f) PEDOT/PSS substrate. Cells were immunolabeled for neuron-specific TuJ1 
(green), astrocyte-specific GFAP (red) and nuclei (blue). Scale bar measures 50 µm in (e) and (f). 
 
For regenerative therapies in the central nervous system, neurons are often the therapeutic 
target population because the normal functioning of these cells drives all behaviors and cognition 
[141, 176]. The dysfunction of neurons and neural circuitry commonly underlies the morbidity of 
neuropsychiatric disorders, neurodegenerative diseases and traumatic brain injury. For this 
reason, engineered scaffold materials that can drive neuronal differentiation and maturation are 
of great interest to improve the therapeutic ability of NSC populations. The differentiation 
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behavior of NSCs growing on the surface of the materials was evaluated at 7 d to determine the 
suitability of the GO/PEDOT nanocomposite as a scaffolding material. The GO/PEDOT 
nanocomposite supported significantly more neuronal differentiation than the PEDOT doped 
with PSS (Figure 3.4c, e, f) and those differentiated neurons extended longer neurites on the 
GO/PEDOT nanocomposite surface (Figure 3.4d, e, f). Improved neuronal differentiation on the 
surface of the nanocomposite may arise from biophysical cues from the rough nanotopography, 
chemical cues provided by the substrate itself or adsorbed ECM proteins secreted from the 
differentiating cells.  
Neural stem cells have demonstrated high sensitivity to nanostructured substrates, with 
nanoscale roughness affecting cell differentiation pathways [146, 164, 177]. NSCs selectively 
differentiate into neurons when seeded on nanoscale fibrous substrates, a morphology that may 
imitate the fibrous ECM structure in vivo [177]. The wrinkle-like morphology of the PEDOT/GO 
nancomposite film may mirror this fibrous morphology (Figure 3.1) and be the driving factor 
behind the improved neuronal differentiation observed on its surface. Additionally, neuronal 
precursor cells are also sensitive to nanoscale features during development, indicating that the 
surface roughness may also contribute to the improved neurite growth exhibited by the cells 
growing on the GO/PEDOT nanocomposite [128]. In addition to the influential surface 
topography of the GO/PEDOT nanocomposite, it is possible that its chemical content may play a 
role in the increased neuronal differentiation. It has been demonstrated that chemical functional 
groups present on a substrate can have a significant impact on NSC growth and differentiation 
[178]. Amine and carboxylic acid groups support neuronal differentiation, while sulfonic acid 
groups will not. On both substrates explored here, the surfaces have been treated with PLO that 
contains amine groups that would promote neuronal differentiation. However, the surface of the 
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GO/PEDOT nanocomposite likely contains free carboxylic acid functional groups that could be 
synergistically contributing to the neuronal differentiation, while the PEDOT doped with PSS 
would have many sulfonic acid groups that are present on the PSS molecules that would be non-
permissive to neuronal differentiation.  
3.3.4 Directed NSC Differentiation on Functionalized GO/PEDOT  
A successful method of engineering scaffolding materials is surface patterning with bioactive 
peptides and proteins to provide cues to seeded cells [179]. In their microenvironment, stem cells 
are exposed to a multitude of soluble and immobilized cues that influence all aspects of their 
behavior [180], creating a need for highly customizable scaffolding materials that can present a 
variety of cues to recapitulate the in vivo environment and enable fine control over NSCs for 
particular therapeutic applications. To explore the potential of the GO/PEDOT nanocomposite 
film as an adjustable scaffold to drive NSC behavior, the surface of the nancomposite was 
modified with either pro-neuronal or pro-oligodendrocyte biomolecules. GO has been noted as a 
highly modifiable material, a property that arises from the plentiful functional groups in its 
structure [53, 64]. The GO nanosheets in the nanocomposite contain multiple carboxylic acid 
groups at their edges, some of which may be accessible at the surface of film, as indicated by the 
wrinkle-like structures in the film morphology that are created by the edges of the nanosheets 
protruding from the polymer surface (Figure 3.1). Previous work described in Chapter 2 has 
shown that these free carboxylic acid groups can be utilized to cross-link a functional peptide 
onto the surface of the nanocomposite to influence neuron growth [80]. Extending these studies, 
the efficacy of cross-linking larger molecules like IFNγ and PDGF-AA using carbodiimide 
chemistry was investigated. IFNγ is a cytokine that is secreted by infiltrating immune cells 
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following brain injury, and has been shown to promote neuronal differentiation [181] while 
PDGF signaling increases oligodendrocyte precursor proliferation and differentiation [182]. Both 
IFNγ and PDGF-AA act on cell surface receptors and do not need to be internalized to initiate 
the intracellular pathways that result in the changes in cell behavior, which suggests that the 
covalent immobilization technique will not interfere with the bioactivity of the molecules. These 
were chosen as model biomolecules to demonstrate the versatility of the GO/PEDOT 
nanocomposite as a NSC scaffold.  
Biomolecules were attached to the surface of the GO/PEDOT nanocomposite using 
carbodiimide crosslinking that creates amide bonds between the carboxylic acid groups of the 
GO nanosheets and the amine groups on the proteins. To verify the presence of biomolecules 
after the crosslinking procedure, the surfaces were analyzed using FTIR (Figure 3.5). The 
unmodified GO/PEDOT nanocomposite film exhibited a spectrum that included characteristic 
GO peaks including carboxylic C=O (1742 cm-1), O-H (1418 cm-1), C-OH (1367 cm-1), epoxide 
(1209 cm-1) and alkoxy C-O (1067 cm-1), as well as characteristic PEDOT peaks including 
thiophene (1520 cm-1, 1487 cm-1, and 1240 cm-1), ethylenedioxy (1142 cm-1, 1093 cm-1, and 930 
cm-1), and C-S (981 cm-1 and 845 cm-1) [161, 183]. The biomolecule-modified surfaces both 
exhibit strong amide I bands around 1650 cm-1 that arise from C=O stretching of the amide 
bonds in their protein structure, and the IFNγ spectrum exhibited an amide III band at 1298 cm-1 
that arises from CN stretching and NH bending [184]. Additionally, on both biomolecule 
modified spectra, the carboxylic C=O shifts to the right, suggesting that the source may no 
longer be the free carboxylic acid groups from the GO nanosheets, which would have been 
consumed during the formation of the amide bond between the biomolecules and the 
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nancomposite surface, but rather the C=O signal from the proteins on the nanocomposite surface 
[185]. 
 
Figure 3.5. Characterization of Immobilized Biomolecules at the Surface of the GO/PEDOT 
Nanocomposite. Representative FTIR spectra of bare, unmodified GO/PEDOT (black), and GO/PEDOT 
modified via carbodiimide chemistry with IFNγ (blue) and PDGF-AA (red). Amide bands appear on the 
protein-modified film spectra, confirming their presence on the film. The carboxylic C=O signal present on 
the bare film shifts to the left, suggesting that the free carboxylic acids bound to the ring structure of the GO 
nanosheets have been consumed during the reaction and the new signal arises from carboxylic acids present 
in the proteins. 
 
The differentiation behavior of NSCs growing on the surface of the modified 
nanocomposite films was evaluated after 7 d in differentiation medium. The surface of the 
nanocomposites was not treated with PLO to ensure that any effect on cell density or 
differentiation was due to the IFNγ or PDGF modification, rather than non-specifically adsorbed 
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PLO. NSCs growing on the film covalently modified with IFNγ through carbodiimide chemistry 
(IFNγ-CM) exhibited significantly more neuronal differentiation than cells growing on an 
unmodified nanocomposite film (bare) or a nanocomposite film modified with IFNγ via 
nonspecific physical adsorption (IFNγ-PA) (Figure 3.6). There was no difference between the 
groups in cell density or length of neurite extension (data not shown). The differentiated neurons 
growing on the surface of the IFNγ-PA and the bare nanocomposite mostly existed within large 
cell clusters containing astrocytes (Figure 3.6a, b), while the differentiated neurons on the IFNγ-
CM surface often localized outside of the cell clusters, indicating a higher affinity for the 
substrate. 
Oligodendrocytes, which produce myelin that insulates neuron axons, are a promising 
cell population for cellular therapies targeted at demyelinating diseases of the nervous system 
such as multiple sclerosis. In vitro, the rate of oligodendrocyte differentiation from NSCs is very 
low, making the development of therapies relying on oligodendrocyte transplantation difficult. 
To address this need, we modified the GO/PEDOT with oligodendrocyte mitogen PDGF-AA to 
assess its ability to drive the NSCs toward the oligodendrocyte lineage. Differentiation was 
evaluated at the surface of PDGF-CM, PDGF-PA, and bare GO/PEDOT nanocomposite 
substrates after 7 d in differentiation medium. As hypothesized, the PDGF-CM surface 
significantly improved the amount of oligodendrocyte differentiation compared to the bare 
nanocomposite surface (Figure 3.7d). Notably, the extent of oligodendrocyte process outgrowth, 
quantified by total cell area, was significantly higher on the PDGF-CM substrates as compared to 
the PDGF-PA and bare substrates (Figure 3.7a, b, c, e). The higher level of process outgrowth 
indicates that the cells have matured further down their differentiation pathway and confirms that 
the cross-linking procedure preserved the bioactivity of the protein. 
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Figure 3.6. Differentiation of NSCs on the IFNγ-Modified GO/PEDOT Nanocomposite. 
Representative fluorescent images of NSCs differentiated for 7 d on the surface of the (a) bare GO/PEDOT 
nanocomposite, or the GO/PEDOT nanocomposite modified with IFNγ by (b) nonspecific physical adsorption 
(PA) or (c) covalent carbodiimide cross-linking (CM). Cells were immunolabeled for neuron-specific TuJ1 
(green), astrocyte-specific GFAP (red) and nuclei (blue). Scale bar measures 50 µm. (d) Percent of neuronal 
differentiation on each surface demonstrating the efficacy of the IFNγ-CM (* p < 0.05; n = 3). 
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Figure 3.7. Differentiation of NSCs on the PDGF-modified GO/PEDOT Nanocomposite. 
Representative fluorescent images of NSCs differentiated for 7 d on the surface of the (a) bare GO/PEDOT 
nanocomposite, or the GO/PEDOT nanocomposite modified with PDGF by (b) nonspecific physical 
adsorption (PA) or (c) covalent carbodiimide cross-linking (CM). Cells were immunolabeled for 
oligodendrocyte precursor cell marker O4 and counterstained for nuclei (blue). Scale bar measures 50 µm. 
(d) Percent of oligodendrocyte differentiation on each surface demonstrating the efficacy of the PDGF-CM (* 
p < 0.05; n = 3). (e) Average spreading area of differentiated oligodendrocytes on each surface showing the 
improved process outgrowth on the PDGF-CM surfaces (** p < 0.01; n = 3). 
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In both cases, the CM biomolecule performed better than the PA biomolecule. This 
demonstrates the superiority of the covalent crosslinking procedure and its ability to present the 
molecules to the cells in a way in which they can still interact with their receptors. Carbodiimide 
cross-linking activates the amine groups present on the arginine, lysine, asparagine, and 
glutamine amino acid residues of the protein for the covalent interaction with the carboxylic acid 
groups at the GO/PEDOT nanocomposite surface. There are multiple potential cross-linking sites 
on both IFNγ (47 residues) and PDGF (25 residues), increasing chances that the cross-linking 
will occur at a site that does not interfere with receptor binding. Although the biomolecules that 
were nonspecifically physically adsorbed were present at the nanocomposite surface after 
repeated washing prior to the start of the cell culture (FTIR data not shown), they did not 
significantly affect NSC differentiation, indicating that the proteins either desorbed over the 
course of the culture period, were denatured as a consequence of adsorption, or the receptor 
binding sites were masked. 
3.4 CONCLUSIONS 
While NSC therapies hold tremendous potential for the treatment of various CNS injuries and 
disorders, shortcomings related to the control of cell differentiation into specific lineages must be 
addressed. We explored the potential of a GO/PEDOT nanocomposite film as a scaffolding 
material to influence the behavior of cultured NSCs in vitro. The unmodified GO/PEDOT 
composite supported higher cell densities and improved neuronal differentiation as compared to 
conventional PEDOT films doped with PSS. By utilizing free carboxylic acid groups donated by 
GO at the surface of the nanocomposite, biomolecules were covalently immobilized at the film 
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surface to preferentially promote either neuronal or oligodendrocyte lineage differentiation. The 
conductive nature of the GO/PEDOT nanocomposite will enable future investigations of the 
influence of electrical stimulation on NSC biology and its potential synergy with the presentation 
of chemical cues. The GO/PEDOT nanocomposite has potential for applications in in vitro 
processing of NSCs for transplantation, exploratory in vitro experimentation to elucidate the 
biology of NSC differentiation and maturation, and in vivo applications in which chemically 
decorated, conductive scaffolding materials can be utilized to explore activation of endogenous 
NSC populations or to improve the transplantation efficacy of exogenous cells. 
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4.0  ELECTRICALLY CONTROLLED DRUG DELIVERY FROM GRAPHENE           
OXIDE NANOCOMPOSITE FILMS 
4.1 INTRODUCTION 
On-demand release of drug molecules from biomedical devices enables precise, targeted dosing 
that can be temporally tuned to meet requirements for a variety of therapeutic applications [186-
188]. Recent advances have facilitated the use of various cues, such as UV- and visible-
wavelength light, NIR radiation, magnetic field, ultrasound and electrical stimulation to trigger 
drug release in vivo from implanted smart materials [186, 189, 190]. These techniques enable 
greater control over drug delivery, compared to traditional in vivo drug-release systems that rely 
on passive delivery that is programmed prior to implantation and cannot be modified in response 
to changing therapeutic needs. To achieve precise, controlled drug delivery, nanomaterial drug 
carriers are increasingly investigated because of their unique structures and tunable properties 
[168, 191]. For example, the large surface area and sp2 carbon lattice associated with carbon 
nanomaterials, such as carbon nanotubes, graphene, and graphene oxide (GO), enable highly 
efficient drug loading, while their capacity for modification provides multiple routes for targeted 
and controlled drug delivery [192, 193].  
GO is a two-dimensional nanomaterial composed of a honeycomb carbon lattice structure 
with hydroxyl, carboxyl and epoxide functional groups [53]. It is known for its exceptional 
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electrical, chemical, and mechanical properties and has been investigated recently as a material 
for a variety of biomedical applications [64, 80, 193-196]. Of these applications, targeted drug 
delivery has been particularly interesting. The presence of reactive functional groups at the basal 
plane and edges of GO nanosheets creates an opportunity to covalently modify the particles for 
use in targeted drug delivery, while the abundance of localized π-electrons at the nanosheet 
surface enables π-π interactions with aromatic drug compounds [197, 198]. Targeted drug 
delivery has been achieved by covalently modifying drug-loaded GO with cancer cell–targeting 
antibodies and molecules or by functionalization with paramagnetic particles for magnetically 
directed delivery [199-203]. However, once at the targeted location, these methods rely on 
desorption of the drug molecules from the GO nanosheets through either passive or pH/redox-
controlled mechanisms, which limits the ability to control the drug dosage in real time [198, 
201]. A drug-loaded hydrogel composed of reduced GO and poly(vinyl alcohol) enabled on-
demand control of dosing via modulation of drug release rate with the application of an external 
electric field [204]. However, this system required the use of large voltages that could be 
damaging to biological tissues, and drug passively diffused from the bulk of the polymer in the 
absence of stimulation because of the porous morphology of the hydrogel.  
In this work, we describe an electrically controlled drug delivery system based on GO 
nanosheets incorporated into a conducting polymer (CP) film. CP-mediated drug delivery 
systems, composed of an electrode coated with a drug-loaded CP thin film, yield highly flexible 
release profiles that are favorable for addressing dosing needs that may change over the course of 
treatment [34]. Drug-loaded CP films release drug molecules in response to electrical 
stimulation, with the amount and duration of release controlled by the type of stimulation applied 
to the film [32, 35, 205]. A major limitation of CP-mediated drug release is the finite amount of 
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drug that can be loaded into and released from the thin films. We address this shortcoming in 
CP-mediated release systems by developing a CP nanocomposite film composed of poly(pyrrole) 
(PPy) doped with graphene oxide (GO) nanosheets for controlled delivery of anti-inflammatory 
drug.  
Nanocomposite films consisting of GO nanosheets and CPs have recently generated 
interest as materials for bioapplications, such as cell scaffolding or chemical sensing, as a result 
of their favorable electrical properties, good stability, neuronal biocompatibility and ease of 
surface modification with bioactive molecules [80, 90, 162, 206, 207]. We demonstrate that, 
when incorporated into PPy along with the anti-inflammatory drug dexamethasone (DEX), the 
GO nanosheets create a highly stable nanocomposite film that releases the drug molecules on-
demand in response to electrical stimulation, without passive diffusion. The CP matrix provides 
a conductive scaffold through which electrical stimulation can be applied in order to elicit drug 
release from the nanocomposite, while the GO nanosheets act as nanocarriers that improve the 
amount of drug loaded into and released from the nanocomposite film.  Furthermore, altering the 
thickness and size of the GO nanosheets by utilizing its unique response to sonication treatment 
changes the physical properties and release profile of the nanocomposite, suggesting that the 
system can be tuned to the needs of various applications, making it a valuable tool for both 
therapeutics and research within the field of biomedicine. 
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4.2 MATERIALS AND METHODS 
4.2.1 Electrochemical Apparatus  
All electrochemical experiments were performed with a Gamry Potentiostat, FAS2/Femtostat 
(Gamry Instruments), using a three-electrode set-up with glassy carbon working electrodes (3 
mm diameter, CH Instruments), a platinum wire counter electrode, and a silver/silver chloride 
reference electrode (CH Instruments). 
4.2.2 GO Synthesis 
GO was synthesized from graphite powder (SP-1, Bay Carbon Inc., Bay City). A pre-oxidation 
step was performed to increase the extent of oxidation of the final product, followed by oxidation 
by the modified Hummer’s method [54, 208]. In brief, a solution of 50 mL H2SO4, 10 g K2S2O8 
and 10 g P2O5 was heated to 80°C. Graphite powder (12 g) was added and reacted for 6 h at 
80°C. The solution was diluted with 2 L dH2O, filtered through a glass filter (pore size: 2.5 – 4.5 
µm), and air-dried overnight. The pretreated graphite (688.5 mg) was added to 23 mL H2SO4 
chilled to 0°C, and 3 g KMnO4 was added while the temperature was controlled below 10°C. 
The solution was reacted for 2 h at 35°C, and then 46 mL dH2O was added while the temperature 
was controlled below 50°C. The solution was reacted for an additional 2 h at 35°C and then was 
diluted with 140 mL dH2O. A 2.5-mL volume of H2O2 (30%) was added, and the mixture was 
allowed to settle overnight. After decanting the supernatant, the GO was washed by 
ultracentrifugation with 500 mL HCl, followed by washing with copious dH2O until the wash 
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solution reached a neutral pH value. The GO was dialyzed for 4 d and then stored in H2O until 
use. 
4.2.3 Nanocomposite Film Synthesis  
GO/PPy-DEX nanocomposite films were electrochemically synthesized on the glassy carbon 
electrodes from an aqueous solution containing pyrrole (0.2 M, Sigma-Aldrich), dexamethasone 
21-phosphate disodium salt (10 mg ml-1, Sigma-Aldrich) and GO nanosheets (5 mg ml-1). The 
GO suspension was ultrasonicated for 30 min or 60 min immediately prior to 
electropolymerization. A constant potential of 0.8 V vs. a silver/silver chloride reference 
electrode was applied until the charge density reached 400 mC cm-1. Conventional PPy-DEX 
films were electrochemically synthesized under the same conditions, with the exclusion of the 
GO nanosheets from the aqueous polymerization solution. 
4.2.4 Electrochemical Measurements   
Electrochemical impedance spectra of prepared films were collected in PBS, in the frequency 
range of 1 to 100 kHz, using an alternating current sinusoid of 5 mV. CV analysis was performed 
in PBS by sweeping the potential from -0.9 V to 0.5 V at 100 mV s-1. 
4.2.5 Nanosheet and Film Characterization  
GO nanosheet thickness and size was evaluated with atomic force microscopy (Bruker 
Dimension V SPM). Nanosheet suspensions were drop coated on mica surfaces, and the height 
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profile was analyzed in tapping mode. Nanoscope Analysis software (Bruker) was used to 
calculate the histograms of sheet thicknesses and mean nanosheet diameter after 30-min or 60-
min sonication treatments. The surface morphology and microstructure of the nanocomposite 
film were evaluated with scanning electron microscopy (JEOL JSM6510). Film surface 
chemistry was evaluated with attenuated total reflectance Fourier transform IR (Bruker Vertex 
70), and elemental analysis was performed by energy-dispersive X-ray spectroscopy (Oxford 
INCA EDS).  
4.2.6 Electrically Controlled Drug Release  
For all drug release experiments, modified electrodes were immersed in PBS and submitted to 
release stimulation. The PBS solutions containing the released drug were analyzed with UV 
spectroscopy at a wavelength of 242 nm to quantify the amount of DEX released. To compare 
the amount of DEX released from conventional PPy-DEX films and the GO/PPy-DEX 
nanocomposite, a square-wave, biphasic voltage pulse (-2 V for 5 s, followed by 0 V for 5 s) was 
applied for 1000 cycles, and the cumulative amount of DEX release was quantified. To 
determine total amount of releasable drug from the GO/PPy-DEX nanocomposite, films 
underwent aggressive voltage pulses (-2 V for 5 s, followed by 0 V for 5 s) until cumulative drug 
release reached a plateau. The plateau value was considered the total amount of releasable drug 
contained in the nanocomposite. To evaluate the release profile in response to repeated stimulus 
application, films were submitted to square-wave, biphasic voltage pulses (-0.5 V for 5 s, 
followed by 0.5 V for 5 s). The amount of drug release was reported as the percentage of total 
drug release (the plateau value) determined using the aggressive voltage stimulation. The 
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negative phase of the stimulus was varied from -2 V to -0.25 V to evaluate the stimulus 
magnitude effect on drug release.  
4.2.7 DEX Loading Capacity Assay  
The amount of DEX loaded on GO sheets was evaluated by incubating DEX (100 µM) with GO 
(0.5 mg ml-1) in H2O for 2 h at room temperature. Prior to incubation with DEX, the GO 
suspension was sonicated for 30 min or 60 min. The mixture was centrifuged for 30 min at 
14,000 RPM to pellet the DEX-loaded GO nanosheets, and the supernatant was analyzed with 
UV spectroscopy at 242 nm to determine the amount of DEX remaining in solution. The amount 
of drug loaded was calculated by subtracting the amount of free DEX in the supernatant from the 
amount of DEX in a sample not incubated with GO.  
4.2.8 Bioactivity Assay  
All animal procedures were approved by the Institutional Animal Care and Use Committee of the 
University of Pittsburgh. Hippocampal tissue was isolated from E18 Sprague Dawley rat 
embryos, treated with a digestion buffer containing 0.025% trypsin, 137 mM NaCl, 5 mM KCl, 7 
mM Na2HPO4, and 25 mM HEPES. For astrocyte cultures, dissociated hippocampal cells were 
maintained in DMEM supplemented with fetal bovine serum and penicillin/streptomyocin, 
grown to confluence in a culture flask, trypsinized and seeded on bare glass coverslips at a 
density of 15k cells/cm2. The cultures were incubated for 1 h at 37°C to allow cell attachment 
and then were treated with release solutions from the GO/PPy-DEX films (rDEX) or a prepared 
DEX solution (DEX). The DEX release solutions were obtained by applying an aggressive 
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voltage stimulation paradigm (-2 V for 5 s, followed by 0 V for 5 s, 1000 cycles) to the GO/PPy-
DEX film. The total amount of DEX in the release solution was quantified using UV 
spectroscopy, and a volume was added to the culture media to create a concentration of 1 µM 
DEX. For neuron cultures, dissociated hippocampal cells were maintained in Neurobasal with 
B27, GlutaMax, horse serum and penicillin/streptomyocin. Glass coverslips were prepared for 
neuron culture by coating with polyethylimine (PEI) followed by laminin, and neurons were 
seeded on the coverslips at a density of 25k cells/cm2. To evaluate any toxic byproduct released 
from the films, control films without drug underwent the same aggressive electrical stimulation 
parameters as the drug-loaded films, and the resulting release solutions were added to the 
neuronal culture at the same volumes as the treatments.  
4.2.9 Immunofluorescence   
After 2 d (neurons) or 4 d (astrocytes), the cultures were fixed in 4% paraformaldehyde for 30 
min. The cells were blocked and permeabilized by immersion in a solution containing 5% 
normal goat serum and 0.2% TritonX. Neuron cultures were immunostained with mouse 
monoclonal anti-ß-III-tubulin (1:500, Sigma-Aldrich), and astrocyte cultures were 
immunostained with polyclonal rabbit anti-glial fibrillary acidic protein (GFAP, 1:500, Dako). 
For both culture types, the samples were incubated in the primary antibody for 2 h, washed with 
PBS, incubated in a goat Alexa Fluor 488 (1:1000, Invitrogen) against the appropriate species for 
45 min, washed in PBS and counterstained for nuclei with Hoechst 33342 (1:1000, Invitrogen). 
Immunoreactive cells were imaged with a Zeiss Axioskop 2 fluorescent microscopic. Six random 
10x images were collected from each sample (n = 4), and mean neuron density, average neurite 
length and astrocyte density were quantified.  
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4.2.10 Statistical Analysis    
All statistical analyses were done using SPSS software (IBM). Student’s t-tests or one-way 
analysis of variance (ANOVA), followed by Tukey’s post hoc analysis, were used to compare 
experimental groups. All data are presented as mean (± SEM). 
4.3 RESULTS AND DISCUSSION 
4.3.1 GO/PPy Nanocomposite Film Synthesis and Characterization 
The DEX-loaded GO/PPy (GO/PPy-DEX) films were electrodeposited onto glassy carbon 
electrodes from a solution containing both GO nanosheets and DEX. During CP film 
polymerization, negatively charged species are loaded into the polymer matrix to balance 
positive charges formed on the backbone of the growing polymer. The GO nanosheets are 
negatively charged as a consequence of carboxylic acid groups formed at their edges during the 
oxidation procedure, enabling them to be incorporated into the CP film as dopant molecules, 
along with anionic drug molecules (Figure 4.1a). During the electropolymerization reaction, the 
GO nanosheets compete with the free anionic DEX, as dopant molecules. Fourier-transform IR 
spectra of the GO/PPy-DEX film display peaks attributable to both GO and DEX, indicating that 
the drug molecules are successfully loaded into the film, along with the GO nanosheets (Figure 
A1.1). GO nanosheets have been noted for their large surface/volume ratio and sp2-hybridized 
carbon structure, which enables efficient loading of aromatic drug molecules, such as DEX [97, 
193]. Therefore, although some DEX molecules are directly doped into the film, a portion of the 
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drug molecules may adsorb on the GO nanosheets and be carried into the synthesized composite 
films as the nanosheets are incorporated as dopant molecules.  
 
 
Figure 4.1. Drug Loading into and Release from the GO/PPy Nanocomposite. Schematic 
representation of (a) the GO/PPy-DEX nanocomposite and (b) DEX release from the GO/PPy nanocomposite 
in response to electrical stimulation. During synthesis, positive charges form on the growing polymer 
backbone and are balanced by anions, such as GO and DEX molecules, present in the deposition solution. 
Reduction of the nanocomposite with voltage stimulation elicits release of small, mobile drug molecules as the 
polymer backbone neutralizes. 
 
The electrical properties of the GO/PPy-DEX film were explored using electrochemical 
impedance spectroscopy and cyclic voltammetry (CV), and compared to conventional PPy-DEX 
films that do not contain GO nanosheets as co-dopants. The electrode modified with GO/PPy-
DEX film exhibited an impedance drop across all measured frequencies compared to both the 
bare electrode and the electrode modified with PPy-DEX, indicating that the nanocomposite film 
improves the capacitance of the electrode/electrolyte interface (Figure 4.2a). CV analysis carried 
out in phosphate buffered saline (PBS) showed that the electrodes modified with GO/PPy-DEX 
film have a higher charge-storage capacity, compared to both bare electrodes and PPy-DEX 
modified electrodes, as determined by comparison of the area underneath the CV curves (Figure 
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4.2b). The CV curve of the GO/PPy-DEX modified electrode exhibits a reduction peak at -0.52 
V that occurs as anionic DEX molecules leave the film as a consequence of the negative 
potential sweep through the film, and an oxidation peak at -0.09 V that is associated with re-
doping by small ions in the PBS or by DEX previously adsorbed on GO [209]. The GO/PPy-
DEX reduction peak is much broader with a higher amount of current passed between 0 V and -
0.5 V. The larger reduction peak area, which reflects the amount of drug molecules leaving the 
film, suggests that the GO/PPy-DEX film will release drug more effectively than the PPy-DEX 
film. The low impedance and high charge storage capacity of the synthesized nanocomposite 
reflect the excellent electrochemical properties of the nanocomposite film; as these properties 
decrease and increase, respectively, more current will pass through the film in response to a 
particular voltage pulse, enabling more efficient drug release. 
 
 
Figure 4.2. Electrical Properties of the GO/PPy-DEX Nanocomposite Film. (a) Electrochemical 
impedance spectra and (b) cyclic voltammograms for the bare glassy carbon electrodes, electrodes modified 
with a PPy-DEX film, and electrodes modified with the GO/PPy-DEX nanocomposite film. The GO/PPy-DEX 
modified electrodes exhibit lower impedance values and higher charge-storage capacity, indicating the 
electroactivity of the nanocomposite. 
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4.3.2 Electrically Controlled Drug Release from GO/PPy Nanocomposite 
Electrically controlled release of DEX molecules can be achieved by utilizing the unique redox 
properties of the GO/PPy-DEX nanocomposite film. When the film is electrochemically reduced, 
the anionic DEX molecules previously associated with the positive charges along the PPy 
backbone in the oxidized form will be released as the charges on the polymer backbone are 
neutralized (Figure 4.1b). Since large dopant molecules are generally immobile within CP films, 
the GO nanosheets, which measure from hundreds of nanometers to microns in the x-/y-
direction, are expected to remain within the CP during film reduction [53, 209]. To evaluate the 
drug-releasing performance of the GO/PPy-DEX nanocomposite film, voltage pulses were 
applied through the nanocomposite when immersed in PBS, and the release solution was 
analyzed by UV absorbance spectroscopy to quantify the amount of DEX expelled from the film. 
Drug release from the GO/PPy-DEX nanocomposite was compared to release from conventional 
PPy-DEX films that do not contain GO nanosheets as co-dopants. The films were stimulated 
with an aggressive, biphasic voltage pulse (-2 V for 5 s, followed by 0 V for 5 s) for 1000 cycles 
to evaluate the total DEX release from the films (Figure 4.3a). When the PPy films were co-
doped with GO nanosheets, the aggressive release paradigm elicited 2.3x the amount of drug 
release of conventional PPy films without GO (209.7 µg cm-2 vs. 88.9 µg cm-2, p < 0.01, n = 3). 
Conducting polymer mediated drug release is thought to be a surface area dependent process, 
with drug releasing more efficiently from the surface than the bulk of the film [33, 205]. The 
nanocomposite film exhibits a much rougher surface morphology than conventional PPy films 
without GO (Figure A1.2), and the difference in the film surface area is a possible cause of the 
significant improvement in drug payload.  
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 Figure 4.3. Electrically Controlled DEX Release from GO/PPy Nanocomposite Film. (a) Total DEX 
release from PPy films with or without GO as a co-dopant in response to an aggressive square wave, biphasic 
voltage stimulation (-2.0 V for 5 s, followed by 0 V for 5 s) repeated for 1000 stimulations. The GO/PPy-DEX 
nanocomposite release a significantly larger quantity of DEX (p < 0.01; n = 3). (b) Cumulative release profile 
of the GO/PPy-DEX nanocomposite in response to aggressive repeated square wave, biphasic voltage 
stimulation (-2.0 V for 5 s, followed by 0 V for 5 s) for 1200 stimulations (n = 6). The release profile reaches a 
plateau at 600 voltage pulses under this aggressive stimulation paradigm, indicating that all available drug 
has been released at this point. (c) Cumulative release profile of the GO/PPy-DEX nanocomposite in response 
to milder release stimulation (-0.5 V for 5 s, followed by 0.5 V for 5 s) and in the absence of electrical 
stimulation (passive diffusion) (n = 3). Electrical stimulation elicited linear release for up to 400 pulses, while 
no drug passively diffused from the film when no voltage stimulation was applied. (d) Effect of voltage 
stimulus modulation on amount of DEX released from nanocomposite films. GO/PPy-DEX nanocomposite 
films were submitted to 100 square wave, biphasic stimulation pulses where the negative phase was varied 
from -2 to -0.25 V, the positive phase was 0.5 V, and the stimulus lingered at each phase for 5 s. Bars labeled 
with nonmatching letters indicate a significant difference between groups (p < 0.01; n = 3). 
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To determine the maximum amount of drug released from the GO/PPy-DEX 
nanocomposite film, the cumulative release profile in response to the aggressive stimulation was 
evaluated. After 600 stimulations, the drug-release profile reaches a plateau, suggesting that no 
more drug can be released from the GO/PPy-DEX film (Figure 4.3b). Small quantities of DEX 
can be repeatedly released from the GO/PPy-DEX film in response to milder electrical 
stimulation (-0.5 V for 5 s, followed by 0.5 V for 5 s), creating a drug-release profile that is 
linear over 400 stimulations, while no observable amount of drug passively diffuses from the 
film in the absence of stimulation (Figure 4.3c). Modulation of the voltage stimulation 
magnitude altered the amount of drug released from the nanocomposite, demonstrating the 
flexibility and high level of dosage control provided by the release system (Figure 4.3d). There 
was no visible cracking or delamination of the GO/PPy-DEX film after 1000 release stimulations 
(-0.5 V for 5 s, followed by 0.5 V for 5 s), reflecting the good stability of the nanocomposite 
(Figure A1.3). The sustained linear release profile, responsiveness to changes in stimulation 
magnitude, and stability following repeated stimulation demonstrate the potential of the GO/PPy 
nanocomposite for applications requiring long-term and temporally precise drug dosing. 
The bioactivity of the released drug was assessed by addition of solutions containing 
DEX released from GO/PPy films to primary astrocyte cultures and evaluation of the extent of 
interruption in cell proliferation. DEX is a synthetic glucocorticoid (GC) commonly used to treat 
inflammation and is used here as a model drug to demonstrate the efficacy of the released drug. 
Chronic DEX exposure has been shown to interrupt astrocyte proliferation, likely by down-
regulating GC receptor expression [210]. Astrocyte cultures exposed to the release solution or a 
prepared DEX solution (1 µM) showed similar reductions in cell density after 4 d of culture, 
compared to control cultures that received no drug treatment (Figure 4.4, p < 0.05). The drug 
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release solutions were obtained using the aggressive stimulation paradigm (-2 V for 5 s, followed 
by 0 V for 5 s, 1000 cycles). These data indicate that the process of loading and stimulated 
release does not detectably alter the bioactivity of DEX molecules. However, it should be noted 
that within the release solution, there are drug molecules that were released during early cycles, 
as well as later cycles. Therefore, it is possible that if some of the drug released during the later 
cycles lost bioactivity as a result of repeated exposure to the voltage stimulation, the loss would 
be obscured by the presence of the more bioactive drug released by earlier cycles. Future work is 
needed to further elucidate the ability of DEX and other drug molecules to withstand chronic 
exposure to voltage stimulation while encapsulated in the nanocomposite film. 
 
 
Figure 4.4. Bioactivity of DEX Released from GO/PPy Nanocomposite Film. Representative 
fluorescent images of astrocyte cultures exposed to (a) no drug (control), (b) DEX released from GO/PPy 
nanocomposite films (rDEX), and (c) prepared solutions of 1 µM DEX (DEX). GFAP (green); Hoechst 33342 
(blue). (d) Density of astrocyte cultures 4 d after exposure to drug treatment. *Indicates significant difference 
from control (p < 0.05, n = 4). 
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The safety of graphene nanoparticles for use in bioapplications has been questioned as a 
result of a growing body of evidence indicating the potential toxicity of soluble nanomaterials 
[167, 169, 195]. To exclude the possibility of potential release of any toxic byproducts from the 
GO/PPy film, including soluble GO nanosheets, DEX release solutions were applied to primary 
neurons, a more sensitive cell population that does not proliferate and should be unresponsive to 
DEX treatment. In addition, GO/PPy films without drug loading underwent the same stimulation 
protocol as drug-loaded films, and the release solution was applied to neuron cultures. No effect 
on neuronal cell density was observed under either condition after 2 d of exposure (Figure 4.5), 
and the cells exhibited robust, interconnected neurite extensions indicative of healthy growth. 
This suggests that the interruption of astrocyte growth in response to the application of released 
DEX was due to specific actions of DEX, rather than non-specific cytotoxicity from components 
of the GO/PPy film, such as monomer or GO nanosheets, that may have delaminated from the 
electrode during electrical stimulation.  
4.3.3 Tuning of Nanocomposite Properties  
During chemical synthesis of GO, oxidized graphite sheets are commonly exfoliated with 
ultrasonication to obtain single- and few-layer GO (s/fGO) nanosheets. During sonication, the 
sheets also are reduced in the x-/y-dimension to create a smaller particle size that can measure as 
few as hundreds of nanometers, depending on the extent of sonication treatment [53, 211]. To 
investigate the effect of altering the GO nanosheet size on the properties of the nanocomposite, 
GO suspensions were submitted to 30 or 60 min of sonication immediately prior to incorporation 
into the nanocomposite film. Atomic force microscopy measurements verified that the sonication 
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 Figure 4.5. Effect of Released DEX on Neuronal Cultures. Representative fluorescent images of 
neurons treated with (a) no drug (control), (b) release solutions from GO/PPy films without DEX loaded 
(rGO), or (c) release solutions from GO/PPy-DEX films (rDEX). β-III-tubulin (green); Hoechst 33342 (blue). 
(d) Neuronal density after 2 d of exposure to drug treatment. The treated cultures showed no significant 
difference compared to control cultures (n = 4). 
 
treatment successfully reduced the size and thickness of the GO nanosheets. After 60 min of 
sonication, the distribution of nanosheet thickness shifted to smaller values, compared to the 
distribution in the 30-min treatment group, indicating that the nanosheets were exfoliated into 
more s/fGO sheets (Figure 4.6a).  As expected, the mean diameter of the GO nanosheets also 
decreased as the duration of sonication treatment increased (467.8 nm vs. 392.7 nm, p < 0.05), 
verifying that the mechanical vibrations created during sonication break the nanosheets into 
smaller pieces (Figure 4.6b). The size and thickness of the GO nanosheets can dictate their 
physiochemical properties, such as surface area, colloidal stability, and surface chemistry, all of 
which can affect the deposition and properties of the nanocomposite film [53, 212].  
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 Figure 4.6. Effect of Ultrasonication on GO Nanosheet Properties. (a) Histogram of nanosheets thickness and 
(b) average diameter of nanosheets after 30-min and 60-min sonication (*p < 0.05; n = 6). (c) Amount of DEX 
adsorbed by free GO nanosheets (***p < 0.001; n = 3). Increasing duration of sonication treatment results in 
GO nanosheets that are thinner and smaller in diameter and that adsorb more DEX molecules. 
 
With longer sonication, the soluble GO nanosheets physically adsorb a larger amount of 
DEX molecules per unit mass (Figure 4.6c). The increase in loading capacity likely stems from 
the larger amount of GO surface area that is created within the suspension as multi-layer GO 
nanosheets are exfoliated into multiple s/fGO particles. The propensity of graphene and GO to 
adsorb drug molecules such as DEX arises from the abundance of 2p orbitals extending from the 
planar surface of the nanomaterial that will readily participate in π−π interactions with aromatic 
compounds [53, 198]. Therefore, it is expected that as surface area increases through exfoliation, 
more active locations are uncovered, and a larger quantity of drug molecules may be adsorbed. 
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The improved loading capacity of GO may enable the nanomaterial to act as a nanocarrier by 
shuttling adsorbed drug into the nanocomposite film and increasing the total drug load. The 
extent to which GO sonication treatment affects drug load into the nanocomposite was evaluated 
by elemental analysis using Energy Dispersive Spectroscopy (EDS). EDS of the DEX-loaded 
nanocomposite films provided a semi-quantitative summary of the amount of drug loaded into 
the film. Each DEX molecule contains one fluorine atom, and each subunit of PPy contains one 
nitrogen atom. Thus, the ratio of fluorine atoms to nitrogen atoms in the film corresponds to the 
amount of drug loading. As expected, nanocomposite films synthesized with GO sonicated for 
60 min loaded more drug than those in the 30-min sonication group, as indicated by the F:N ratio 
(Figure 4.7a, p < 0.01). Interestingly, although increased GO sonication led to higher drug 
loading into the nanocomposite, the rate of DEX released from the film in response to voltage 
pulse stimulation was 38% higher for the nanocomposite synthesized with GO sonicated for 30 
min, compared to the 60-min sonication group (Figure 4.7b, p < 0.05). 
The schematic in Figure 4.7c depicts the proposed mechanism by which controlling GO 
sonication time can tune the amount of drug loaded into and released from the nanocomposite. 
The drug-loaded GO/PPy nanocomposite is electropolymerized from an aqueous solution 
containing GO sheets and DEX molecules, creating an opportunity for the drug to adsorb onto 
the surface of the nanosheets prior to film deposition. With longer sonication treatment, more 
GO sheets are present in the polymerization suspension as each multi-layer GO particle is 
exfoliated into several s/fGO sheets. Prior to electrodeposition, the GO sheets load some DEX 
molecules onto their surfaces through physical adsorption and then compete with the remaining 
free DEX molecules as dopants during the polymerization reaction. When GO undergoes 
sonication, the nanoparticle size decreases in the z-direction as each multi-layered GO exfoliates 
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 Figure 4.7. Effect of GO Sheet Sonication on GO/PPy Nanocomposite Properties. (a) Elemental 
analysis of GO/PPy-DEX nanocomposite film. The F:N ratio reflects the amount of drug loaded into the film. 
Longer sonication treatment yields a higher quantity of drug loading (**p < 0.01; n = 3). (b) Amount of DEX 
released from nanocomposite films in response to 100 voltage pulses (-0.5 V for 5 s, followed by 0.5 V for 5 s). 
Less sonication results in a higher release rate (*p < 0.05; n = 4). (c) Schematic representation of the effect of 
GO sheet sonication on nanocomposite properties. 
 
into multiple s/fGO particles (Figure 4.6a) and in the x-/y-direction as each GO sheet breaks into 
several smaller sheets (Figure 4.6b), creating a larger number of smaller particles that would act 
as more-efficient dopant molecules [209]. In addition, as each multi-layered GO sheet exfoliates 
into multiple s/fGO particles, a larger number of reactive nanosheet edges containing negatively 
charged carboxylic acid groups will be present, leading to more GO nanosheets depositing into 
the nanocomposite film. Because each GO sheet can carry multiple drug molecules into the film, 
a larger total amount of DEX can be loaded as a result of increased sonication treatment. 
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We propose that the strong adsorption of DEX molecules onto the GO sheets is the 
mechanism behind the slowed drug-release rate. Because more GO nanosheets are likely to be 
incorporated into the nanocomposite as the amount of sonication time increases, there is likely to 
be less DEX directly doped into the film. Potentially, the DEX molecules adsorbed onto the 
surface of the GO nanosheet cannot be released from the film as easily as directly doped DEX 
molecules, because of the strength of the π-π interactions, limiting the amount of drug release in 
response to the same electrical stimulation. Potentially, as the directly doped DEX molecules exit 
the film upon electrical stimulation, the GO-adsorbed DEX molecules may desorb from the 
sheets, diffuse through the PPy matrix and replenish the doping sites. By this mechanism, the 
release profile of the nanocomposite would be extended. With future work to explore the GO-
drug adsorption/desorption phenomenon, the unique properties of the GO/PPy nanocomposite 
could be utilized to create a highly tunable release system with the ability to address various 
dosing needs for a multitude of drug delivery applications. 
Along with providing control over drug loading and release, the GO nanosheets create a 
unique opportunity to alter the morphological characteristics of the nanocomposite film. 
Sonication had a significant effect on the morphology of the GO/PPy-DEX film (Figure 4.8). 
With less GO sonication, the film exhibited globular, cauliflower-like features on the scale of 
tens of microns that are characteristic of PPy films (Figure A1.2) [34]. As the amount of GO 
sonication increased from 30 min to 60 min, the large globular features flattened to create a more 
uniform surface (Figure 4.8c). The large features are possibly a result of nucleation sites created 
by the multi-layer GO nanoparticles. As the nanoparticles deposit into the film, they provide a 
scaffold around which the growing polymer can accumulate. After a longer sonication time, the 
smaller s/fGO particles distribute more evenly in the film, creating a smoother surface (Figure 
 84 
4.7c). At a smaller scale, small sheet-like features became more apparent at the surface of the 
film, suggesting that more GO sheets are incorporated into the nanocomposite (Figure 4.8d). At 
the 60-min sonication time point, the sheet-like features reduced in size to sub-micron 
dimensions, as would be expected, because increased sonication treatment fractures GO sheets 
into smaller particles. The ability to subtly alter the nanocomposite surface morphology at 
different length scales can have important implications for applications in which the film 
interacts with tissue or cells. Multiple cell types have demonstrated sensitivity toward 
mechanical and topographical cues in their environment, suggesting that the nanocomposite film 
morphology may be engineered to act synergistically with electrically controlled drug release to 
provide additional signals to the targeted cell population [213-215]. 
 
 
Figure 4.8. Effect of GO Sonication on GO/PPy Film Morphology. SEM images of GO/PPy-DEX 
films prepared with GO sonicated for (a, b) 30 min and (c, d) 60 min. Longer sonication time results in a 
smoother surface morphology and the emergence of more sheet-like features at the surface of the film. 
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4.4 CONCLUSIONS 
The unique properties of GO sheets enable several degrees of customizability to the electrically 
controlled drug release platform. By altering the size and thickness of the nanosheets, significant 
changes can be made to nanocomposite film morphology, drug load, and drug release properties. 
As a nanocarrier, GO may enable loading of a variety of biomolecules, not limited to anionic 
species, into the film. Furthermore, the GO/PPy nanocomposite film exhibits a linear release 
profile that persists over several hundred stimulations, indicating that the release platform could 
be used for long-term drug release applications that require repeated dosing over time. On-
demand controlled drug delivery provides more-effective therapies with less toxicity by tuning 
delivery directly to spatial and temporal requirements for a given application. In addition, 
controlled delivery may be beneficial in various in vitro assays, such as high-throughput drug 
screening or exploratory cell biology experimentation. As a result of its adjustable properties, 
stability, and fine control over dosing, the novel GO nanocomposite release platform described 
here has the potential to advance these drug delivery technologies by enabling tailored drug 
release profiles.  
 86 
5.0  ORIGIN OF IMPROVED ELECTROCHEMICAL DOPAMINE DETECTION BY 
GRAPHENE OXIDE/CONDUCTING POLYMER NANOCOMPOSITE-MODIFIED 
ELECTRODES 
5.1 INTRODUCTION 
Efforts toward the development of detection methods that allow sensitive real-time monitoring of 
neurotransmitter signaling within the central nervous system (CNS), or point of care sampling 
from blood, urine or cerebrospinal fluid (CSF), have received increasing attention in recent 
years. The signaling of one such neurotransmitter, dopamine (DA), within the CNS orchestrates 
many behaviors such as learning, motivation, and motor control [216], and its dysfunction has 
been implicated in multiple diseases such as Parkinson’s [217], schizophrenia [218], and 
addiction [219]. Additionally, DA has been investigated as a peripheral biomarker for the 
diagnosis of Parkinson’s disease [220] and adrenal tumors [221]. The potential of utilizing DA 
signaling for both diagnostic and basic science applications motivates the development of low-
cost tools for monitoring catecholamine levels in biological fluids and high-resolution in vivo 
sensors for use in the CNS [222, 223]. 
Traditional methods of DA detection of biological fluids include chromatography 
analysis, colorimetric detection, and spectroscopic analysis, among others [224-226]. These 
methods require complicated, expensive equipment or reagents, and have slow sample 
87 
processing times that impede their use by clinicians and makes exploratory research slow and 
costly. Electrochemical methods of detection have been developed that take advantage of the 
redox activity of DA molecules and enable simple, rapid analysis of biological samples using 
low-cost electrodes as sensors [222]. However, current electrochemical sensors suffer from 
limited sensitivity and specificity towards DA. Physiological levels of DA range from nanomolar 
to low micromolar, creating a need for highly sensitive tools with very low detection limits. In 
biological samples that contain DA, there also exist a variety of interfering molecules, such as 
ascorbic acid (AA) and uric acid (UA), that exhibit similar redox behavior and can obscure DA 
signals.  
To address the shortcomings in sensor sensitivity and specificity, researchers have 
developed a variety of electrode modifications to improve these properties. Graphene-based 
materials have received much focus as biosensor materials because of their unique electrical and 
chemical properties [227, 228]. Reduced graphene oxide (RGO), synthesized by the chemical or 
electrochemical reduction of graphene oxide (GO), exhibits rapid electron transfer kinetics that 
enables highly sensitive detection of DA [94, 229], and composites of RGO with a variety of 
other materials have demonstrated the ability to selectively detect DA in the presence of 
interfering species [206, 230, 231]. However, little work has been done to characterize the 
potential of its precursor, GO, as a DA sensor. By itself, GO exhibits poor conductivity 
compared to its reduced form, requiring its incorporation into a conductive matrix in order to act 
as an effective electrode coating. Conductive polymers, such as poly(3,4-
ethylenedioxythiophene) (PEDOT) and poly(pyrrole) have been utilized to create stable, 
conductive nanocomposites with GO, and have demonstrated potential for electrical recording 
and biointerfacing applications [80, 81, 90, 161-163]. In this work, we describe a GO/PEDOT 
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nanocomposite material and demonstrate for the first time that GO, in its unreduced form within 
a conductive polymer matrix, creates a sensitive and selective sensor for DA detection. The 
GO/PEDOT nanocomposite selectively amplifies the DA oxidation signal, but not AA or UA 
signals, as a result of electrostatic interactions between DA molecules and the nanocomposite 
surface. In addition, the nanocomposite reduces interference from AA as a result of a significant 
shift in its oxidation potential due to an electrocatalytic effect of the nanocomposite material on 
the AA oxidation reaction. The performance of the GO/PEDOT nanocomposite for selective and 
sensitive DA oxidation along with its electrochemical stability underlines the potential of the 
nanocomposite material as a novel electrode modification for the development of improved DA 
sensors. 
5.2 MATERIALS AND METHODS 
5.2.1 Materials 
L-ascorbic acid (AA), 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-ethylenedioxythiphene 
(EDOT), 3-hydroxytyramine hydrochloride (DA), potassium chloride (KCl), sodium chloride 
(NaCl) and uric acid (UA) were purchased from Sigma-Aldrich. Monosodium phosphate and 
disodium phosphate were purchased from Fisher Scientific. Graphite powder (SP-1) was 
purchased from Bay Carbon, Incorporated. Phosphate buffed saline (PBS, 10x) was purchased 
from EMD Millipore and diluted to a 1X working concentration for all experiments (137 mM 
NaCl, 2.7 mM KCl, 10 mM phosphate buffer). Purified water filtered through a Milli-Q System 
(EMD Millipore) was used throughout all experiments. 
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5.2.2 Graphene Oxide Synthesis 
Graphene oxide was synthesized as previously described using the modified Hummer’s method, 
and stored in H2O until use [54, 81]. Prior to deposition into the nanocomposite, GO nanosheets 
were sonicated with a probe sonicator in H2O for 15 min, 30 min, 60 min, or 90 min to alter the 
thickness and x-y size of the nanoparticles. 
5.2.3 Electrochemical Apparatus 
A Gamry potentiostat, FAS2 femtostat (Gamry Instruments) was used for electrode pretreatment, 
GO/PEDOT nanocomposite film polymerization and impedance measurements. An Autolab 
potentiostat/galvanostat PGSTAT128N was used for all analyte detection assays. All 
electrochemical experiments were carried out using a three-electrode setup consisting of a glassy 
carbon working electrode (GC, 3 mm diameter, CH Instruments), a silver/silver chloride 
reference electrode (CH Instruments) and a platinum foil counter electrode. 
5.2.4 Electropolymerization of GO/PEDOT Films 
Glassy carbon electrodes (GCEs, 3 mm diameter, CH Instruments) were polished with 1.0 and 
0.05 µm alumina slurries and cleaned by ultrasonication in 100% ethanol followed by H2O. The 
GCEs were electrochemically pretreated by applying a cleaning voltage pulse (-2 V, 250 s), 
followed by a cyclic voltammetry sweep (0.3 V to 1.3 V, 100 mV s-1, 5 cycles). Following 
pretreatment, GO/PEDOT nanocomposite films were electrochemically deposited onto GCEs 
from a polymerization solution composed of EDOT (0.2 M) and GO (5 mg ml-1). GO/PEDOT 
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nanocomposite films were synthesized using GO nanosheets that had been sonicated for 15 min 
(GO15), 30 min (GO30), 60 min (GO60) or 90 min (GO90). An oxidizing current of 20 µA was 
applied through the GCE for 200 s to carry out the polymerization reaction. The GO/PEDOT 
modified GCEs were gently rinsed in H2O to remove any adsorbed monomer or GO, and stored 
in H2O until use.  
5.2.5 Nanocomposite Characterization 
GO/PEDOT nanocomposite surface morphology was imaged using a scanning electron 
microscope (SEM, JEOL JSM6510), with an operating potential of 3 kV. The atomic ratio of 
oxygen to sulfur was calculated as a semi-quantitative estimate of the amount of GO contained in 
the nanocomposite film. Elemental analysis was carried out using energy dispersive spectroscopy 
(EDS, Oxford INCA EDS) with an operating potential of 20 kV. For each sample (n = 4 per 
sonication group), the atomic percent of oxygen and sulfur were measured from three separate 
areas, and averaged to obtain the mean value for the sample. 
The chemical bonds in the nanocomposite films were evaluated with attenuated total 
reflectance Fourier-transform infrared spectroscopy (ATR-FTIR) using a Bruker Vertex 70 
spectrometer with a Hyperion 2000 microscope and 20x ATR objective. For each sample (n = 4 
per sonication group), three separate areas were analyzed, and all spectra were averaged to obtain 
one spectrum per group. The areas underneath the alkoxy C-O peak (1064 cm-1) and the C-S 
peak (845 cm-1) on the averaged spectra were calculated using custom MATLAB software to 
evaluate changes in relative alkoxy content with increasing GO sonication treatment.   
Electrochemical impedance measurements were collected in PBS using an alternating 
current sinusoid of 10 mV. Electrochemical stability of the nanocomposite was characterized by 
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collecting impedance measurements in the frequency range between 1 Hz and 100 kHz after 0, 2, 
and 1000 cyclic voltammetry (CV) sweeps from -0.5 V to 0.6 V at 100 mV s-1. The 
electrochemical properties of the nanocomposite synthesized with GO treated for various 
sonication times were evaluated by collecting impedance measurements in the frequency range 
between 10 mHz and 100 kHz (n = 7 per sonication group). 
5.2.6 Electrochemical Detection of DA, AA, UA, and DOPAC 
All electrochemical detection assays were carried out in PBS using CV with a voltage sweep 
from -0.5 V to 0.6 V at a speed of 100 mV s-1. Electrodes were immersed in the electrochemical 
cell, and known concentrations of DA, AA, UA or DOPAC were added to the PBS with a 30 s 
equilibration time prior to CV measurement. The oxidation peak location (Ep) was defined as the 
point at which the oxidation current reached its maximum. The oxidation peak current (Ip) was 
determined after a PBS background subtraction as the maximum current value of the oxidation 
peak. For assays carried out at a basic pH (9.5), PBS was prepared at the appropriate pH by 
altering the ratio of monosodium phosphate to disodium phosphate (3.2 mM monosodium 
phosphate, 2.67 M disodium phosphate), while maintaining the same phosphate buffer strength 
(10 mM) and ionic content (137 mM NaCl, 2.7 mM KCl) as the purchased pH 7.4 PBS. 
5.2.7 Statistical Analysis 
All statistical analyses were carried out in GraphPad Prism software. All data are presented as 
the mean ± standard error of the mean. Comparisons across two experimental groups were made 
with Student’s t-test, and comparisons across greater than two experimental groups were made 
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with one-way analysis of variance followed by Tukey’s post hoc analysis. Dopamine calibration 
curves were analyzed using linear regression.  
5.3 RESULTS AND DISCUSSION 
5.3.1 GO/PEDOT Stability and Electroactivity 
GO/PEDOT nanocomposite films were electrodeposited onto bare GCE electrodes from an 
aqueous solution of monomer and GO nanosheets. During conducting polymer electrodeposition, 
oxidation of the monomer via electrical stimulation elicits free radical polymerization during 
which the polymer deposits onto the anode surface, incorporating negatively charged molecules 
from the polymerization solution as dopants. The GO nanosheets contain negatively charged 
carboxylic acid groups on their edges, enabling their incorporation into the PEDOT film [116, 
162, 163, 205]. The resulting film exhibits a morphology consisting of sub-micron, fuzzy, 
sheetlike features that are likely GO nanosheets engulfed in the PEDOT matrix (Figure 5.1a). 
The nanocomposite also contains sharp wrinkles that are characteristic of pure GO films and can 
be observed in conducting polymer films doped with GO [117, 163]. The wrinkles may be 
formed by larger GO nanosheets protruding from the surface of the PEDOT matrix. The 
resulting nanocomposite film is a conductive, electrochemically stable electrode material. A 
comparison of the CV of the bare GCE electrodes and the GO/PEDOT nanocomposite-modified 
electrodes demonstrated that the modified electrodes exhibit a much higher charge storage 
capacity, as indicated by the total area inside of the curve (Figure 5.1b). This property results 
from an increase in surface area as the nanocomposite film deposits on the surface of the 
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electrode. Additionally, the electrochemical impedance of the electrode drops after modification 
with the nanocomposite, most notably in the lower frequency region (Figure 5.1c). In this low 
frequency range, impedances are influenced by the effective surface area of the electrode, with 
impedance value inversely correlating with surface area [232, 233]. A large effective surface 
area has implications for electrochemical sensing applications in which increased surface area 
may lead to an increased number of active sites for the targeted analyte and result in improved 
sensor properties. 
Electrochemical detection of DA is often carried out in vivo by utilizing repeated CV 
scanning, during which the size of the DA oxidation peak is monitored over time to evaluate 
transient signaling in the central nervous system [222]. To evaluate its stability in response to 
repeated electrical stimulation, the nanocomposite-coated electrode underwent multiple CV 
scans and the electrochemical impedance was monitored (Figure 5.1c). After two CV cycles, the 
low frequency impedance values slightly increased, suggesting that there was a minimal loss of 
surface area from the film, likely due to loosely adsorbed oligomers or GO nanosheets 
delaminating from the nanocomposite surface. After 1000 CV cycles, there was no additional 
increase in the low frequency region, demonstrating the stability of the nanocomposite. 
Interestingly, there was a slight drop in impedance at the higher frequency region following 
multiple CV stimulations. At higher frequencies, impedance is dominated by the electrode 
material, rather than effective surface area, suggesting that the nanocomposite film has become 
more conductive, possibly as a result of small ions from the electrolyte solution moving into the 
polymer matrix during the stimulation [232, 233].  
 
 
 94 
 Figure 5.1. Characterization of the GO/PEDOT Nanocomposite Material. (a) Scanning electron 
micrograph of the GO/PEDOT nanocomposite illustrating its sheetlike morphology. The arrow points out a 
wrinkle feature that is likely due to the protrusion of a GO sheet from the polymer surface. (b) CV of a bare 
GC electrode and the GO/PEDOT-modified electrode in PBS (scan rate: 100 mV s-1) demonstrating the 
increase in charge storage capacity after modification. (c) EIS of the bare GC electrode and the GO/PEDOT-
modified electrodes after repeated CV cycling in PBS (-0.5 V to 0.6 V; 100 mV s-1). The nanocomposite retains 
its stability after 1000 CV cycles. 
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5.3.2 Improved Sensitivity and Selectivity Toward DA Oxidation at the GO/PEDOT 
Nanocomposite 
The electrochemical oxidation of DA, AA, and UA at the surface of the GO/PEDOT 
nanocomposite-modified electrodes was evaluated with CV and compared to the behavior of a 
bare GCE. Electrodes were assayed in solutions containing DA (100 µM), AA (1 mM) or UA 
(100 µM) separately, or in solutions containing all three analytes combined (Figure 5.2a, b). In 
the presence of all three analytes, the CV of the bare GCE exhibits only two distinguishable 
oxidation peaks, a result of the broad AA oxidation peak merging with the smaller DA oxidation 
peak. At the GO/PEDOT nanocomposite, DA exhibited a clear and separate oxidation peak (Ep = 
147 mV) with no overlap from the interfering analyte oxidation peaks located at -28.6 mV for 
AA and and 287 mV for UA (Figure 5.2b). DA, AA, and UA coexist in the CNS and biological 
fluids such as cerebrospinal fluid and blood [222], making accurate quantification of the species 
difficult because of their close oxidation potentials. The GO/PEDOT-modified electrode enables 
more selective discrimination of DA than the bare GCE by increasing the separation between the 
oxidation peaks of DA and AA (Figure 5.2c). The increased separation arises from the 
significant leftward shift (Ep: 65.0 mV for bare GCE vs. -28.6 mV for GO/PEDOT, p < 0.001) 
and decreased width of the AA oxidation peak at the GO/PEDOT nanocomposite surface, that 
are likely a consequence of faster electron transfer to the film or improved electrocatalytic 
activity of the film towards AA oxidation [234, 235]. Neither the DA nor UA molecules exhibit a 
change in their oxidation peak location, and there is no effect on the separation between the two 
species at the GO/PEDOT nanocomposite surface compared to the bare GCE surface (Figure 
5.2d). The absence of effect on the peak location indicates that the DA and UA oxidation 
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reactions are not electrocatalyzed by the GO/PEDOT film surface as is the AA oxidation 
reaction.  
DA calibration curves of GO/PEDOT nanocomposite-modified electrodes and bare 
electrodes were compared to evaluate the sensitivity of the modified electrodes (Figure 5.2e). 
Within the range of 1 µM to 40 µM, the GO/PEDOT nanocomposite-modified electrode 
demonstrated a significant increase in sensitivity toward DA, indicated by the slope of the 
calibration curve (bare: 0.046 ± 0.005 µA µM-1; GO/PEDOT: 0.151 ± 0.005 µA µM-1; p < 
0.001), with an improved accuracy, indicated by the linearity of the curve (bare: R2 = 0.961; 
GO/PEDOT: R2 = 0.995). The limit of detection, calculated assuming a signal-to-noise ratio of 3, 
was 83.0 nM for the GO/PEDOT electrode. This enhanced DA sensing performance may arise 
from a locally increased concentration of DA at the surface of the nanocomposite film as a result 
of interactions between the film surface and the DA molecules. Notably, there is no improvement 
in sensitivity toward AA or UA at the GO/PEDOT nanocomposite, suggesting the mechanism of 
DA interaction is not shared by these molecules (Figure 5.3). 
 
 97 
 Figure 5.2. Electrochemical Oxidation of DA in the Presence of Interfering Species. CVs of the (a) 
bare GC electrode and (b) GO/PEDOT-modified electrode in solutions containing 100 µM DA, 1 mM AA, or 
100 µM UA alone, or in combination. Three separate oxidation peaks are discernable on the CV of the 
GO/PEDOT-modified electrode, but not the CV of the bare GC electrode, in solutions containing all three 
analytes. Total separation between the (c) AA and DA oxidation peaks, and the (d) UA and DA oxidation 
peaks. There is a significant increase in separation between the AA and DA oxidation peaks at the 
GO/PEDOT nanocomposite surface (*** p < 0.001; n = 7). (e) Linear DA detection curves for the bare GC 
and GO/PEDOT-modified electrodes, illustrating the increased sensitivity of the modified electrodes to DA 
(*** p < 0.001; n = 7). 
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Figure 5.3. Selective Sensitivity of the GO/PEDOT Nanocomposite Towards DA. Peak oxidation 
current response of the bare and GO/PEDOT-modified electrodes in (a) 100 µM DA, (b) 1 mM AA, and (c) 
100 µM UA measured to CV (100 mV s-1). The GO/PEDOT nanocomposite selectively increases the DA 
oxidation current compared to the bare GC electrode, but not the AA or UA oxidation current (p < 0.01; n = 
7). 
 
At physiological pH, DA exists as a cation, while both AA and UA are anionic 
molecules. The difference in charge may play a role in the improved sensitivity via concentration 
of DA molecules at the nanocomposite surface through electrostatic interactions. While the bare 
GC electrodes contain some oxygen functional groups formed by polishing and electrochemical 
pretreatment that may impart a negative charge to the surface [236, 237], the GO/PEDOT 
nanocomposite contains a large amount of hydroxyl, carboxyl, and epoxide groups [162], with 
negatively-charged carboxyl groups located at the surface of the film [80]. Elemental analysis of 
the GO/PEDOT film with EDS gave an elemental ratio of oxygen to carbon of 0.309 (± 0.034, n 
= 4), which is higher than reported literature values of 0.22 for electrochemically-pretreated GC 
electrodes [236], indicating that there may be more negative charges at the nanocomposite 
surface provided by the additional oxygen functional groups. Along with electrostatic 
interactions between the anionic GO/PEDOT nanocomposite and the cationic DA molecules, π-π 
interactions may also play a role in the improved sensitivity toward DA. The DA molecule, but 
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neither the AA nor UA molecule, contains a phenol ring that may readily participate in 
noncovalent π-π stacking with the benzene rings present in GO [238, 239].  
5.3.3 Mechanisms Behind Improved DA Sensitivity of the GO/PEDOT Nanocomposite 
The GO nanosheets within the nanocomposite provide a unique way to subtly alter its physical 
properties. By changing the size and shape of the GO nanosheets prior to deposition in the 
nanocomposite, the physical and chemical properties can be controllably altered without grossly 
changing the composition of the nanocomposite. Utilizing this unique property, the mechanism 
by which GO nanosheets contribute to the improved sensitivity to DA can be explored. True GO 
nanoparticles exist as two-dimensional, single-layer nanosheets (ca. 1 nm thickness), ranging in 
size in the x-y-direction from hundreds of nanometers to microns, depending on the extent of 
oxidation. However, during synthesis from graphite via the modified Hummer’s method, many 
layered GO platelets are formed as an intermediate to single-layer GO [53]. The GO platelets 
will persist until exfoliated by mechanical perturbation using sonication into single-layer GO, 
double-layer GO, and few-layer GO (3-10 nanosheet layers). With increasing sonication 
treatments, the distribution of sheet thicknesses shifts toward smaller values and the diameter of 
the sheets decreases [81, 211]. The size and thickness of the GO nanosheets can significantly 
alter the physical and chemical properties of the prepared GO/PEDOT nanocomposite without 
significantly changing its material composition, creating a unique method of probing the 
properties driving the electrochemical detection performance. 
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5.3.3.1 Effect of GO Sonication on the Nanocomposite DA Sensitivity and Chemical 
Properties 
To investigate the effect of GO sonication on the properties of the GO/PEDOT nanocomposite, 
GO suspensions were sonicated for 15 min, 30 min, 60 min and 90 min prior to deposition into 
the nanocomposite. Electrodes modified with the sonication-treated GO/PEDOT nanocomposite 
were assayed for their sensitivity toward 100 µM DA using CV analysis in PBS. The magnitude 
of the peak DA oxidation current increased with increasing GO sonication treatment, with the 30 
min, 60 min and 90 min treatment group exhibiting a significantly larger peak current than a 
bare, unmodified electrode (Figure 5.4a). The chemical composition of the nanocomposite films 
was evaluated using energy dispersive spectroscopy to investigate the source of the improved 
sensitivity toward DA. The oxygen to sulfur (O/S) ratio provides a semi-quantitative measure of 
the amount of GO incorporated into the nanocomposite film. Each PEDOT unit contains a fixed 
O/S ratio (2:1), and the sulfur is present only in the polymer, not the GO nanosheets. As such, 
any increase in the O/S ratio indicates that there are 1) more GO sheets incorporated into the 
film, or 2) GO sheets with higher oxygen content selectively incorporated into the film. With 
increasing sonication treatment, the O/S ratio of the nanocomposite film increases significantly 
(Figure 5.4b). It is most likely that the increased oxygen content arises from a larger number of 
GO nanosheets incorporating into the film. With sonication, the GO nanosheets decrease in size, 
and smaller molecules act as more efficient dopants in the electropolymerization reaction that 
creates the nanocomposite film [209].  
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 Figure 5.4. GO Sonication Improves Sensitivity of GO/PEDOT Towards DA. (a) Peak DA oxidation 
current at the bare GC electrodes and the GO/PEDOT nanocomposite synthesized with GO sonicated for 15 
min (GO15), 30 min (GO30), 60 min (GO60), or 90 min (GO90) prior to electrodeposition into the composite 
(* p < 0.05; n = 7). (b) Atomic ratio of O to S in the nanocomposite synthesized from GO with varying 
sonication treatment prior to electrodeposition (* p < 0.05; n = 5). O/S ratio indicates the density of oxygen 
containing functional groups, donated by GO, in the nanocomposite film. 
 
The increased O/S ratio positively correlates to the magnitude of the DA oxidation current (R2 = 
0.963, p < 0.05), suggesting that the increased amount of GO nanosheets within the film may 
produce the improved sensitivity toward DA. GO nanosheets contain negatively charged 
carboxylic acid groups at its edges that may electrostatically interact with DA, and benzene rings 
within its plane that may interact with the phenol ring of DA via π-π interaction. To evaluate 
which type of interaction causes the improved sensitivity of the GO/PEDOT nanocomposite, CV 
analysis of 100 µM DA was carried out in PBS at pH 9.5. At this more basic pH, the amine 
group on the DA molecule is deprotonated (pKa: 8.9), rendering the molecule either neutral, or 
slightly negative, as the hydroxyl groups become deprotonated [240]. Additionally, at this higher 
pH, the GO/PEDOT nanocomposite film should become more negative as the pH moves further 
from the pKa of the carboxylic acid groups of the GO nanosheets [241]. At these conditions, 
there should be much less electrostatic interaction and possibly some electrorepulsion. As 
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expected, the peak DA oxidation current at pH 9.5 (Figure 5.5a) is less than the current at 
physiological pH (Figure 5.4a) with a significant difference appearing for the nanocomposite 
film synthesized with GO receiving the 90-minute sonication treatment (pH 7.4: 16.18 µA; pH 
9.5: 7.00 µA; p < 0.01). Additionally, the sonication effect present in physiological pH 7.4 
conditions, in which the peak current increases with increased sonication time, is not exhibited at 
pH 9.5, and no differences arise between the electrode groups at the higher pH (p = .1445). 
These data support the hypothesis that the improved DA sensitivity demonstrated by the 
GO/PEDOT nanocomposite-modified electrodes at physiological pH is driven by electrostatic 
interactions between the positively charged amine group present on the DA molecules and the 
negatively charged carboxylic acid groups provided by the GO nanosheets in the GO/PEDOT 
nanocomposite. While π-interactions may exist between the benzene rings in the GO nanosheets 
and the phenol ring structure of the DA molecules, these interactions are clearly not the driving 
force behind the improved nanocomposite sensitivity that appears at higher GO sonication times 
because this effect completely disappears at the higher pH where the π-interactions would still 
persist. 
To further confirm that electrostatic interactions play a role in the improved DA 
sensitivity of the GO/PEDOT nanocomposite, the electrochemical oxidation of DOPAC at the 
surface of the nanocomposite-modified electrodes was investigated with CV in PBS at 
physiological pH 7.4. DOPAC is a metabolite of DA and shares a similar structure to its 
precursor, with the exception that the amine group of DA is replaced with a carboxylic acid 
group to form the DOPAC molecule. At physiological pH, the DOPAC molecules exist as anions 
but retain the phenol ring structure. As such, electrochemical oxidation behavior of DOPAC at 
the surface of the GO/PEDOT nanocomposite provides valuable information regarding the 
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influence of electrostatic interactions vs. π-interactions on the sensitivity of the nanocomposite. 
At the surface of nanocomposite films synthesized with GO sonicated for 30 minutes or greater, 
the DOPAC peak oxidation current was significantly lower than the DA peak oxidation current 
(p < 0.01), demonstrating that the nanocomposite exhibits less sensitivity toward the DOPAC 
molecules. There is no influence of sonication treatment on the nanocomposite sensitivity toward 
DOPAC (Figure 5.5b), as was exhibited toward DA, suggesting that the source of interaction 
between DA and the nanocomposite does not exist between DOPAC and the nanocomposite. The 
structure of DA and DOPAC are identical with the exception of their charged functional groups, 
confirming that electrostatic interactions between the DA amine and the GO carboxylic acid are 
likely the driving force behind the nanocomposite sensitivity.  
 
 
Figure 5.5. GO Sonication Does Not Effect Sensitivity of GO/PEDOT Nanocomposite Toward 
Neutral or Negatively Charged Analytes. (a) Peak DA oxidation current in PBS at pH 9.5 recorded at bare 
GC electrodes and electrodes modified with the GO/PEDOT nanocomposite synthesized with GO sonicated 
for 15 min (GO15), 30 min (GO30), 60 min (GO60) or 90 min (GO90) prior to electrodeposition into the 
nanocomposite (n = 7). (b) Peak DOPAC oxidation current in PBS at pH 7 recorded at bare GC electrodes 
and electrodes modified with the nanocomposite synthesized from GO sonicated for varying amounts of time 
prior to deposition (n = 7). 
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5.3.3.2 Effect of GO Sonication on the Nanocomposite Electrochemical Properties 
The electrochemical properties of the GO/PEDOT nanocomposite film synthesized with 
sonicated GO nanosheets were evaluated with electrochemical impedance spectroscopy to 
further probe the mechanism behind the improved electrochemical DA detection properties. The 
Nyquist plots of the nanocomposite impedance demonstrate characteristic behavior of GO-doped 
conducting polymer nanocomposites (Figure 5.6a) [80, 90, 162]. At low frequencies, the Nyquist 
plots exhibit steep slopes, indicative of highly capacitive behavior, while at high frequencies 
(Figure 5.6a inset) the curves present a more gradual slope that reflects the diffusive behavior of 
the film [90, 134]. Notably, the 15-minute sonication treatment group transitions from diffusive 
to capacitive behavior at a lower frequency than the other treatment groups; that is, it exhibits 
more diffusion-dominated behavior, indicating that the shorter sonication treatment may result in 
a nanocomposite film with slower charge transfer kinetics. The increase in diffusive behavior of 
the 15-minute sonication group may arise from a larger content of few-layer GO in the 
nanocomposite compared to longer sonication times that would contain more single- or double-
layer GO. Inherently, GO is not conductive, a result of the disruption in its π-electron network as 
oxygen functional groups are added to the structure during its oxidation reaction [53]. Any larger 
GO nanosheets contained in the nanocomposite could decrease the charge transfer of the 
nanocomposite film or create a diffusion barrier at the electrode/electrolyte interface that would 
result in the observed Nyquist behavior.  
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 Figure 5.6. Effect of GO Sonication on the Electrochemical Impedence Spectroscopic Behavior of 
GO/PEDOT Nanocomposite. (a) Nyquist plots of the GO/PEDOT nanocomposites synthesized from GO 
sonicated for 15 min (GO15), 30 min (GO30), 60 min (GO60), or 90 min (GO90) prior to electrodeposition. 
Inset: High frequency range of the nyquist plot displaying the increased diffusive behavior of the GO15 
nanocomposite (n = 7). (b) Bode plots of the GO/PEDOT nanocomposites synthesized with GO sonicated for 
varying amounts of time prior to electrodeposition. Inset: Comparision of the 10 mHz impedance behavior 
(** p < 0.01; n = 7). The GO15 nanocomposite demonstrates significantly higher 10 mHz impedance, 
suggesting that it has a larger effective surface area. 
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The impedance modulus of the nanocomposite films differs subtly as a result of GO 
sonication treatment (Figure 5.6b). At high frequencies, no significant changes emerge, but at 
impedances lower than approximately 10 Hz, the 15-minute sonication group diverges from the 
longer sonication groups. At the 10 mHz frequency, the impedance is significantly larger for the 
15-minute sonication group than the longer sonication treatment groups (p < 0.01) indicating that 
both the capacitance and electrochemical surface area are lower (Figure 5.6b inset) [232, 233]. 
The decreased surface area has implications for the sensitivity of the nanocomposite towards DA 
electrochemical oxidation, with a lower surface area likely to produce a decreased DA 
sensitivity. In fact, the 15-minute sonication group does display a lower DA oxidation peak 
current than the longer sonication groups, with no significant improvement over the bare 
electrode that exists for the longer treatments (Figure 5.4a). The difference in nanocomposite 
surface area likely arises from the fact that the sonication treatment alters the size of the GO 
nanosheets, with longer sonication creating smaller, thinner sheets. Increasing GO sonication 
treatment prior to electrodeposition into conducting polymer films results in a rougher 
nanocomposite topography and the appearance of smaller features at the surface, likely due to 
the fact that more small GO nanosheets are preferentially incorporated into the polymer matrix as 
dopants [81]. A rougher surface topography would possibly provide an increased number of 
active sites with which the DA molecules could electrostatically interact, improving the 
sensitivity of the nanocomposite film towards the electrochemical oxidation of DA. The increase 
in surface area supports the finding that increased oxygen content in the nanocomposite 
correlates to a higher sensitivity towards the electrochemical oxidation DA. As more GO 
nanosheets are incorporated into the nanocomposite to increase its roughness and surface area, it 
 107 
is expected that there would be more carboxylic acid groups provided by the GO within the 
nanocomposite that would interact with DA molecules to produce the boosted sensitivity. 
5.3.4 Effect of GO Sonication on the Electrocatalytic Activity Towards AA 
At the surface of the GO/PEDOT nanocomposite, AA exhibits a leftward shift in its oxidation 
potential, demonstrating the electrocatalytic effect of the nanocomposite and its potential as a 
material to improve the specificity of electrochemical detection methods (Figure 5.2b, c). To 
probe the mechanism by which the nanocomposite interacts with AA, GO/PEDOT films were 
synthesized using GO that underwent graded sonication treatment and the effect on 
electrocatalysis of AA was evaluated. The negative shift in AA oxidation potential at the 
nanocomposite surface, as compared to a bare electrode, was significantly less at the longest 
sonication time of 90 min (Figure 5.7a). GO has been noted as a highly catalytic material 
because of the abundance of oxygen functional groups in its structure [59, 61, 62]. The 
electrocatalysis of the AA oxidation reaction by GO relies on the extent of GO oxidation, with 
higher levels of oxygen content correlating with increased electrocatalytic activity [60]. 
Interestingly, the favorable electrocatalysis has been shown to disappear when GO is chemically 
reduced, with the AA oxidation potential moving back towards the same positive voltage 
exhibited by the bare electrodes [60]. This suggests that the ability of GO to electrocatalyze the 
AA reaction lies with its reducible oxygen functional groups, such as hydroxyl or epoxide, but 
not its carbonyl groups that can persist following reduction [58, 242]. To explore the role of GO 
oxygen functional groups, the relationship between negative potential shift and oxygen bonds in 
the nanocomposite films was evaluated using FTIR (Figure 5.7b). The negative potential shift 
significantly correlated with the alkoxy C-O content in the nanocomposite (R2 = 0.967, p < 0.05), 
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but not to the other oxygen functional group content in the nanocomposite, suggesting that the 
electrocatalysis may arise from interactions between the AA molecule and the alkoxy functional 
groups present at the surface of the nanocomposite (Figure 5.7c). The AA electrochemical 
oxidation pathway is a two-step process with AA first directly oxidized into a dehydroascorbic 
acid (DHA) radical that adsorbs onto the electrode surface before further oxidation into the final 
product, DHA, that then desorbs from the electrode [243-245]. The formation of hydrogen bonds 
between the multiple hydroxyl groups on the DHA radical and the alkoxy groups of the GO 
nanosheets may be one way in which the nanocomposite catalyzes the oxidation reaction. The 
hydrogen bond interactions could coordinate the unstable DHA radical to reduce the energy 
barrier needed to carry out the reaction, resulting in a leftward shift in oxidation potential. At the 
longest sonication times, there is a reduction in available alkoxy groups, and a consequent 
reduction in the amount of hydrogen bond-mediated stabilization of the DHA radical would 
reduce the leftward shift observed in the AA oxidation potential as the reduction in the energy 
barrier to complete the reaction is not as large.  
The origin of the decrease in alkoxy groups at the 90-min GO sonication time may be 
attributed to a population of smaller GO nanosheets, with a lower oxygen content per nanosheet, 
being incorporated into the nanocomposite. As the GO nanosheets are broken into smaller pieces 
with sonication treatment, only those that contain a negatively charged carboxylic acid group 
will be able to act as dopants in the electropolymerization reaction of the nanocomposite. 
Therefore, as smaller nanosheet sizes are produced at the longest sonication time, it is likely that 
the ratio of carboxylic acid to alkoxy in the nanocomposite would increase, and total alkoxy 
content would decrease, as small GO nanosheets containing only hydroxyl and epoxide groups 
are selectively omitted from the nanocomposite. 
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Figure 5.7. Alkoxy C-O Content in the GO/PEDOT Nanocomposite Correlates to the Shift in AA 
Oxidation Potential. (a) Negative shift in the AA oxidation potential, compared to a bare GC electrode, at the 
GO/PEDOT nanocomposite synthesized from GO sonicated for 15 min (GO15), 30 min (GO30), 60 min 
(GO60), or 90 min (GO90).  The GO90 nanocomposite exhibits a significant decrease in the magnitude of AA 
oxidation potential shift (p < 0.05; n = 7). (b) Representative FTIR spectrum of the GO90 nanocomposite 
exhibiting peaks corresponding to oxygen containing functional groups donated by the GO and the peak 
corresponding to the sulfur group donated by PEDOT. (c) Linear correlation between the magnitude of the 
AA oxidation potential (Ep) negative shift and the ratio of alkoxy C-O to C-S peaks. The ratio is a semi-
quantitative estimate of the alkoxy content in the nanocomposites. 
 
Notably, at the nanocomposite surface there is no electrocatalysis of the DA and UA 
oxidation reaction, as the location of the oxidation peak does not change for either molecule 
(Figure 5.2). The structure of DA contains fewer hydroxyl groups than the AA structure, and the 
UA molecule contains no hydroxyl groups, potentially decreasing the ability of the 
nanocomposite to catalyze their oxidation reactions. The selective electrocatalysis of the 
oxidation reaction of AA, but not DA, makes the GO/PEDOT nanocomposite a promising 
electrode material for the selective determination of DA in biological solutions that also contain 
AA, such as blood, urine, or cerebral spinal fluid. 
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5.4 CONCLUSIONS 
The electrochemical oxidation behavior of DA, AA, and UA was investigated at the surface of a 
GO/PEDOT nanocomposite material. The nanocomposite selectively amplified the signal of DA 
oxidation as a result of electrostatic interactions between the DA molecules and the negative 
charges at the nanocomposite surface.  Interference from AA was eliminated by electrocatalysis 
of the AA oxidation reaction by the nanocomposite surface, shifting its oxidation potential 
sufficiently away from the DA oxidation potential. These data indicate that this high 
performance nanocomposite material will be useful for the development of more selective and 
sensitive biosensors that will have the potential to improve both diagnostics and exploratory 
science by providing a more reliable and accurate depiction of DA in biological samples and 
tissues. 
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6.0  DEVELOPMENT OF AN IN VITRO PLATFORM FOR THE STUDY OF 
NEURONAL INJURY AND REGENERATION 
6.1 INTRODUCTION 
Traumatic brain injury (TBI) presents a huge public health problem with over 2 million new 
cases each year, and an estimated 5.3 million Americans currently living with a TBI-related 
disability [246]. The challenge of treating TBI lies in the complex pathobiological cascade that 
occurs following injury, including processes such as induction of oxidative stress, excitotoxicity, 
and energy failure that ultimately lead to the activation of apoptotic pathways and widespread 
cell death [247, 248]. Because of the level of complexity embodying the injury response, 
effective clinical therapies are difficult to develop. By taking advantage of in vitro injury models, 
where experimental variables are individually isolated and probed, researchers can achieve a 
better understanding of the mechanisms underlying TBI and ultimately move toward the 
development of targeted, effective therapeutics. 
Several in vitro models of TBI exist that can recapitulate both focal and diffuse damage 
occurring after injury [249, 250]. Focal injury occurs as a direct result of the initial insult, and is 
modeled using transection or compression injuries. Diffuse injury occurs in response to shear 
forces from the brain moving within the skull upon impact and has been modeled using stretch 
injuries. In both of these in vitro models, organotypic slice cultures and dissociated cultured 
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neuronal networks (CNNs) have been used as model systems. While they have added a great 
amount to the understanding of the pathology underlying TBI, most of these injury models rely 
on end-point molecular or genetic analyses and are limited in their ability to follow a single cell 
culture longitudinally after injury. 
Multielectrode arrays (MEAs), consisting of grids of microelectrodes that can stimulate 
or record from CNNs, have been used extensively in the field of neuroscience to study the 
development and plasticity of electrical activity in vitro [251, 252]. Because of their non-
invasive recording ability, the devices can collect information from a CNN over the course of 
several weeks, providing information about the dynamics of network activity. Recently, 
stretchable MEAs, composed of electrode grids on an elastomeric substrate, have been developed 
that can impart a stretch injury to CNNs or slice cultures to evaluate the effects of injury on 
electrical activity [253, 254]. However, because the electrical components and insulation 
materials of MEAs are easily damaged, no models have yet been developed that utilize these 
devices with transection or compression injuries. In this work, we describe an in vitro injury 
model based on commercially available MEAs that uses an elastomeric stamp to introduce a 
focal injury into a mature CNN. The injury creates dysfunctional network activity characterized 
by decreases in the firing rate, asynchronous firing activity and disordered burst patterns for up 
to 7 d following the introduction of damage. This work provides the groundwork for a platform 
that can be used as a tool to assess potential therapeutic interventions, such as cellular therapies, 
without the need of animal models.  
Neural stem cells (NSCs) have the ability to differentiate into functional neurons [138] 
and have been implicated as a potential therapy for TBI and other brain injuries [143, 255]. 
However, there have been conflicting reports about their ability to survive following 
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transplantation and integrate into existing circuitry [140-142]. A reduced model of NSC 
transplantation would create a valuable platform for investigating the physiological events that 
occur when a population of NSCs is introduced into a damage site, and assist in providing 
information that could be used to improve the efficacy of current transplantation methods. Using 
the MEA-based model of neuronal injury, we transplanted a population of embryonic-derived 
NSCs into the injury site and monitored the resultant CNN activity to evaluate any therapeutic 
effects provided by the cells. Injured CNNs treated with NSCs did not exhibit the same activity 
deficits as untreated damaged CNNs, suggesting that the transplanted cells were imparting a 
protective effect to the damaged network. These experiments represent a first step towards 
creating a repeatable in vitro model of neuronal damage and regeneration. 
6.2 MATERIALS AND METHODS 
6.2.1 MEA Preparation  
MEAs with 64 electrodes with a diameter of 50 µm and an inter-electrode distance of 150 µm 
were used for this study (AlphaMED Scientific, Osaka, Japan). The electrodes were patterned 
into two 32-electrode grids located at a distance of 10 mm from each other (Figure 6.1). To 
create a consistent cell culture area over the electrode space, a custom polydimethylsiloxane 
(PDMS) barrier was created to constrain the cell growth to a 15 mm x 3 mm area. The PDMS 
was made using a Sylgard 184 Silicone Elastomer Kit (Dow Corning, Midland, MI) at a ratio of 
10:1 and cured for 48 h at room temperature, and the barrier was cut out using a stencil. The 
PDMS barrier and the polyacrylamide surface of the MEA were activated with a 30 s treatment 
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with a plasma cleaner (PDC-001, HarrickPlasma) operated with ambient air.  A drop of methanol 
was added to the surface of the MEA to aid in the placement of the barrier, then the barrier was 
positioned and bonded to the surface at 37°C for 30 min. Prior to cell culture, the MEA culture 
surface was washed in sterile dH2O and exposed to UV light for 10 min. The culture surface 
within the PDMS barrier was treated with polyethylenimine (PEI, 0.05% in borate buffered 
saline) for 1 h, washed with sterile dH2O, then treated with laminin (20 µg ml-1 in Neurobasal 
medium) overnight at 37°C, washed with sterile phosphate buffered saline (PBS) and stored in 
PBS until culture. 
 
 
Figure 6.1. Schematic Representation of CNN Damage Platform. The device consists of a 
commercially available MEA that contains two grids of 32 electrodes (50 µm diameter, 150 µm inter-
electrode distance) separated by a space of 10 mm. A culture barrier made of PDMS was fixed to the surface 
to constrain the culture area to 45 mm2. A CNN was grown inside of the culture barrier for 22 d prior to the 
introduction of a focal injury using a PDMS stamp that ablated all cells within the damage area. 
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6.2.2 Cell Culture 
Primary hippocampal neurons were isolated from Sprague-Dawley rat E18 embryos as described 
previously [256]. Neurons were seeded within the PDMS culture barrier at a density of 
approximately 11k cells per mm2 and maintained in Neurobasal media supplemented with 2% 
B27 (Invitrogen), 1% Glutamax (Invitrogen), 10% horse serum (Sigma-Aldrich), and 1% 
penicillin-streptomycin (Pen-Strep; Invitrogen). The medium was exchanged every 2 to 3 d, as 
necessary. In experimental groups C2, D2, and D2-tx (Table 1), the neuron media was 
additionally supplemented with cytosine arabinoside (AraC; 5 µM; Sigma-Aldrich) after 8 days 
in vitro (DIV) to restrict glial growth. The AraC treatment was removed at 18 DIV in preparation 
for NSC transplantation.  
 
Table 6.1. Experimental CNN Groups 
Experimental Group Injury AraC NSC-Tx Sample Size 
C1 none - - n = 3 
D1 9 mm2 - - n = 2 
C2 none + - n = 2 
D2 1 mm2 + - n = 2 
D2-tx 1 mm2 + + n = 2 
 
 
Embryonic NSCs were isolated from the cortices of Sprague-Dawley rat E18 embryos. 
Cortices were triturated in Hank’s Buffered Salt Solution (HBSS, Sigma-Aldrich) supplemented 
with 1% GlutaMax (Invitrogen) and 1% Pen-Strep. The suspension was allowed to settle for 5 
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min and the supernatant was collected, centrifuged, and transferred into NeuroCult NS-A 
Proliferation Medium (StemCell Technologies) supplemented with recombinant human 
epidermal growth factor (EGF; 20 ng mL-1, Invitrogen), recombinant human basic fibroblast 
growth factor (bFGF; 10 ng mL-1, Invitrogen), heparin (2 mg mL-1; StemCell Technologies), and 
Pen-Strep (1%). The cells were maintained at 37°C and passaged every 3 to 4 d, as necessary. 
NSCs were used at passages 2 or 3 for cell transplantation. 
6.2.3 CNN Damage and NSC Transplantation 
The neuronal injury was introduced to the cultures at 22 DIV by applying a focal injury to the 
center of the culture area using a PDMS stamp (9 mm2 or 1 mm2). The stamp was lowered into 
the CNN using a micromanipulator until it made contact with the underlying culture surface and 
removed after 30 s. Visual assessment confirmed that the cells underneath the stamp were 
completely ablated. After 30 min the damaged cultures underwent a partial medium exchange to 
alleviate some of the damage-induced chemical cascade [257]. At 3 h after injury, NSCs were 
added to cultures to model cell transplantation. In an effort to restrict the NSC localization to the 
CNN area, all media outside of the PDMS culture barrier was removed from the dish, so that 
approximately 50 µL of media remained, covering only the CNN growth area. NSCs were 
switched from their proliferation media into Neurobasal media, then 50k cells were added to the 
inside of the PDMS culture barrier and allowed to attach for 30 min. After the cell attachment 
phase, Neurobasal media was added to fill the entire MEA culture area. 
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6.2.4 Recording 
Spontaneous extracellular network activity was recorded from the CNNs growing on the MEAs 
using a MED64 system with Conductor Software (AlphaMED, Osaka, Japan). The spontaneous 
activity was recorded from each CNN during 5-minute sessions, 3x per recording day. Each 
channel was recorded from simultaneously and was sampled at a rate of 20 kHz. Prior to 
recording, the CNNs were briefly transferred from the incubator to a sterile culture hood in order 
to place them into the MED64 Connector that interfaces the MEA with the amplifier. The CNNs 
were then placed back in the incubator and recordings took place at 37°C. Prior to starting the 
recording, CNNs were allowed to equilibrate for 10 min to reduce any artificial increase in cell 
firing activity that can occur in response to mechanical perturbations during movement [252].  
Activity was monitored weekly during the first three weeks in vitro to ensure the 
development of healthy network activity. CNNs that did not develop strong synchronous 
bursting activity by the third week in culture were excluded from these experiments. Starting at 
21 DIV, the day prior to damage/NSC-tx, activity recordings were taken daily until 7 d post 
injury (DPI). Control CNNs that received no treatment were recorded from daily during 21 DIV 
through 29 DIV, which corresponded 7 DPI in the damaged cultures, to ensure that the all 
comparisons across CNN groups were at similar points developmentally. 
6.2.5 Data Analysis 
6.2.5.1 Spike Detection  
Neural recording segments were analyzed offline to determine the number of neurons recorded, 
noise levels, and signal amplitudes using custom automated MATLAB (Mathworks Inc., MA) 
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software, as described elsewhere [258, 259]. As an overview, the wide-band recordings were 
filtered in software to isolate the spike data (300–5000 Hz). To identify single- and multi- units, 
the threshold for the high-frequency data was established by using a window set at 3.5 standard 
deviations below the mean of the data. For each peak exceeding the threshold window, 
timestamps recorded and plotted as a raster plot.  
6.2.5.2 Burst Detection and Analysis 
The bursting activity of the CNNs is defined as a period of increased firing activity that occurred 
followed by a brief period of silence. Activity was considered a burst if it met the minimum 
requirement of at least 10 spikes occurring in sequence with an interspike interval (ISI) of less 
than 100 ms [260]. The following measures were used to describe the bursting behavior of the 
CNNs: 
 
Burst rate (BR): defined as the frequency of bursting events, in bursts per second, occurring at an 
electrode during the 5-minute recording 
 
Burst duration (BD): defined as the average length in seconds of bursts occurring at an electrode 
during the 5-minute recording 
 
Intra-burst Frequency (IBF): defined as the average firing rate within bursting events occurring 
at an electrode during the 5-minute recording 
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6.2.5.3 Cross-Correlation 
As a metric to quantify the connectivity of the CNN, the cross-correlation, Cxy(τ), between 
electrodes in the dish was calculated as described previously [260, 261]. In brief, the spike trains 
recorded from two electrodes, x and y, in the CNN were compared. For each spike on x, the 
number of spikes occurring within ± 150 ms on y were summed and separated into 30 ms bins so 
that each cross-correlation vector contained 10 elements. The Cxy(τ) was normalized to spikes s-1 
by dividing each element by the total number of spikes in the x train and the bin size. The cross-
correlation coefficient, Cxy(0),  for each electrode pair was calculated as the total number of 
spikes occurring within the 30 ms bin centered at t = 0. To obtain information about the 
connectivity between the two electrode grids, X and Y, the cross-grid correlation coefficient, 
CXY(0) was calculated by averaging the Cxy(0) between each electrode on grid X and each 
electrode on grid Y.  
6.2.5.4 Statistical Analysis  
For each day, the values obtained from the 3 recordings were averaged together to decrease any 
within network variability. To compare changes that happened after the damage or NSC-tx, all 
metrics were normalized to the mean values of 21 and 22 DIV. All statistical analysis was 
carried out using GraphPad Prism software and presented as the mean ± SEM. For comparisons 
between two experimental groups, Student’s t-tests were used. For comparisons across the three 
experimental groups over the 7 d following injury, two-way ANOVA analysis with Bonferroni’s 
posthoc analysis was employed. 
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6.3 RESULTS AND DISCUSSION 
Embryonic E18 hippocampal neurons were plated on the surface of MEAs, matured for 22 DIV, 
and then injured with a focal injury to determine the effect of neuronal damage on network firing 
patterns. CNNs represent an advantageous model system for the study of injury effects on 
electrophysiological activity. As the networks mature, they begin to develop stereotypical 
synchronous bursting behavior that can be used as a benchmark for comparison after the 
introduction of an injury. In this work, three experimental groups received AraC treatment 
between 8 DIV and 18 DIV (Groups C2, D2, and D2-tx; Table 1), while two groups received no 
AraC treatment (Groups C1 and D1). The AraC treatment was introduced as a method of 
restricting astrocyte proliferation because in CNNs glial cells can overgrow neurons, consume 
the majority of available media nutrients and release acidic byproducts, leading to CNN death. It 
was found that in the C1 and D1 groups that were not treated with AraC, regardless of the 
damage treatment, the CNN quit exhibiting firing activity and perished by 30 - 35 DIV. Because 
the goal of these experiments was to evaluate the effect of the introduced focal injury on the 
network activity, and the overgrowth of astrocytes could contribute to altered network firing 
patterns as the health of the network declined, AraC treatment was introduced in the second set 
of experiments.  
6.3.1 Effect of AraC Treatment on CNN Activity 
Interestingly, the firing activity of control cultures was significantly different depending on AraC 
treatment (Figure 6.2). At 29 DIV, CNNs that did not receive AraC exhibited firing activity that 
was organized into densely packed superbursts, consisting of periods of high activity followed by 
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periods of silence extending for seconds (Figure 6.2a). Within the superburst, the activity is 
organized into smaller bursts lasting for 10 - 50 ms with short periods of silence between bursts 
(Figure 6.2c). Superbursting activity occurs normally during CNN development [252, 262] and 
recapitulates spontaneous activity that occurs in vivo, which is thought to be involved in 
strengthening of synaptic connections [263, 264]. Cultures that underwent AraC treatment 
between 8 DIV and 18 DIV did not display the superbursting behavior at any point during the 
course of the experiment; however, they did exhibit bursting behavior that is organized into a 
less stereotyped pattern (Figure 6.2b). The average firing rate measured across all electrodes in 
the CNN was higher in the AraC-treated culture than the untreated culture (Figure 6.3a), while 
the IBF (i.e. the firing rate within bursts) was higher (Figure 6.3d) and BD was lower (Figure 
6.3c), reflecting the dense organization of firing activity into stereotyped bursting events. 
Although the AraC treatment resulted in a significant reorganization of bursting patterns, the 
cross-grid correlation was not significantly different (Figure 6.3b), implying that the widespread 
synaptic connections across the CNN developed normally and could create the highly correlated 
bursting activity between cells in the network that is characteristic of CNNs [251, 252, 265]. 
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 Figure 6.2. AraC Treatment Alters the Pattern of Neuronal Firing Activity. Representative raster 
plots of control CNN network activity at 29 DIV that received no AraC treatment (a, c) or that received 5 µM 
AraC between 8 DIV and 18 DIV (b, d). Red line delineates electrodes on the left grid of the MEA from 
electrodes on the right grid of the MEA.  
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 Figure 6.3. Effect of AraC Treatment on the Firing Behavior of CNNs. Comparison of (a) firing rate, 
(b) cross-grid correlation coefficient (CXY(0)), (c) burst duration (BD), and (d) intra-burst frequency (IBF) at 
29 DIV in cultures that were treated with AraC between 8 and 18 DIV (AraC+) or that received no AraC 
treatment (AraC-). * p < 0.05; ** p < 0.01. 
 
Astrocytes were historically considered “support” cells of the CNS, with a limited role in 
signaling that leads to the transmission and integration of information [266]. In recent years, 
accumulating evidence depicts astrocytes in a more active signaling role that couples with 
neuron activity. While they cannot fire action potentials like their neuronal counterparts, 
astrocytes do exhibit spontaneous and activity-evoked Ca2+ oscillations [267, 268] that can elicit 
the release of “gliotransmitters” such as neuropeptides, amino acid neurotransmitters, and growth 
factors [269]. Gliotransmission impacts neuronal synaptic transmission, and glutamate release 
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from astroglia activates local neurons in a highly synchronous way, indicating that astrocytes 
play a role in the development of synchronous firing behavior in neurons [270, 271]. In the 
cultures that were treated with AraC between 8 DIV and 18 DIV, astrocyte growth was restricted 
and resulted in a largely different network firing patterns, demonstrating the importance of glia 
in the development of neuron activity. For the future development of the CNN damage model, 
the extent of astrocyte restriction must be carefully considered because unrestricted growth leads 
to unhealthy networks during long-term cultures, while smaller populations of astrocytes hold 
less influence over the formation of synaptic connections and neuronal firing patterns, ultimately 
resulting in different activity patterns in the mature networks. 
6.3.2 Effect of Damage on CNN Firing Activity 
Mature CNNs were damaged with a focal injury inflicted with an elastomeric stamp at 22 DIV. 
The damage site was located approximately equidistant between the two electrode grids. In one 
group, D1, the damage site was 9 mm2, which covered approximately 20% of the total culture 
area, and was considered a severe injury. In a second group, D2, the damage site was 1 mm2, 
which covered approximately 2.2% of the total culture area, and was considered a mild injury. In 
both groups, all cells that were growing under the damage site were completely ablated after the 
injury. The effects of the injuries on the firing activity of the CNN were evaluated for the first 7 
DPI. Experimental group D1 did not receive AraC treatment at any point during the course of the 
experiment and was compared with control C1, which also did not receive AraC treatment 
(Table 1), to determine the effect of damage on the activity of the CNN. Likewise, group D2 that 
was treated with AraC between 8 DIV and 18 DIV was compared with control C2 that also 
received the same AraC treatment. 
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6.3.2.1 Severe Damage 
Severe damage resulted in a marked interruption in the superbursting activity exhibited by C1 
(Figure 6.4a). While correlated bursting activity persists discretely on each grid separately, cross-
grid bursts are no longer present and a large amount of firing activity exists outside of correlated 
bursts. The average firing rate across the entire dish was not significantly different between D1 
and C1 (Figure 6.4b). However, all mean values of D1 were below those of C1, suggesting that a 
trend exists and with a higher sample size, significant differences may emerge. The cross-grid 
correlation coefficient declined over the first 3 DPI, stabilized around 25% of the pre-injury 
value, then exhibited a slight increase at 7 DPI (Figure 6.4c). These data reflect the deteriorating 
connections between the cells in the network, possibly a result of cells continuing to die 
following damage via delayed apoptotic pathways initiated by the insult [272]. Similarly, the BR 
decreased and stabilized at approximately 60% of the pre-injury value, reflecting the disruption 
in connectivity following injury (Figure 6.4d). The increase in cross-grid correlation at 7 DPI 
may be an artifact of the intra-culture variation in activity that occurs across different days [252], 
especially because of the low sample size (n = 2), but it may also indicate the potential of the 
surviving cells to reestablish connectivity. It should be noted that the D1 cultures completely 
ceased to exhibit any firing activity soon after 7 DPI, either because of damage sustained during 
the injury or because of the overgrowth of unrestricted astroglia, so the longer-term response to 
injury could not be monitored.  
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 Figure 6.4. Effect of Severe Focal Injury on CNN Firing Activity. (a) Representative raster plots of 
CNN activity at 7 DPI (29 DIV) exhibiting the interruption in superbursting behavior and decrease in 
correlated activity. Red line delineates electrodes on the left grid of the MEA from electrodes on the right grid 
of the MEA. (b) Normalized average firing rate across all electrodes of the MEA, (c) normalized cross-grid 
correlation coefficient (CXY(0)), and (d) normalized burst rate (BR) over the first 7 DPI for control (C1) and 
damage (D1). All data points are normalized to the pre-damage activity at 22 DIV.  * indicates significant 
difference from C1; p < 0.05. 
 
 127 
6.3.2.2 Mild Damage 
To address the poor long-term survival of the D1 cultures that may arise from unrestricted 
astroglial overgrowth in combination with the severe damage that ablated 20% of the total 
culture area, AraC treatment was given to limit the amount of astrocytes in the CNN and a milder 
damage (2.2%) was introduced to injure the networks. Under this damage condition, D2, the 
networks exhibited a similar disruption in the synchronous behavior that was apparent in D1 
(Figure 6.5a). Some of the correlated intra-grid bursting behavior was retained but, as in D2, 
there was no synchronous cross-grid bursting behavior after injury. Interestingly, some 
electrodes began recording superburst-like behavior with periods of silence in between periods of 
high activity; however, unlike true superbursting activity, the high activity period was not 
organized into small correlated bursts, but instead consisted of disordered firing (Figure 6.5a, left 
grid activity). The mean firing rate across the entire MEA was lower in D2 than in C2, though 
the effect was non-significant, perhaps due to the low sample size (Figure 6.6a), and the cross-
grid correlation coefficient was significantly lower in D2 at several points throughout the first 7 
DPI (Figure 6.6b).  
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 Figure 6.5. Effect of Mild Damage With or Without NSC-Tx on CNN Firing Activity. Representative 
raster plots of CNN activity 7 DIV after mild damage (a) without NSC-tx (D2) or (b) with NSC-tx (D2-tx). 
Red line delineates electrodes on the left grid of the MEA from electrodes on the right grid of the MEA. 
Damage disrupts correlated network-wide bursting activity. In CNNs that received the NSC-tx treatment, 
network-wide superbursting behavior was initiated, and cross-grid bursting was restored. 
 
Bursting behavior in neuronal networks is driven by GABAergic inhibition provided by 
interneurons in the circuit and develops as the synaptic inhibitory drive outweighs the excitatory 
drive [251, 273]. In injured CNNs, it is possible that the GABAergic interneurons are more 
susceptible to the injury, leading to the dysfunctional bursting behavior observed in both D1 and 
 129 
D2. In response to prolonged silencing after the introduction of tetrodotoxin, which interrupts 
spontaneous firing in CNNs, there is a disproportionate decrease in GABA signaling, supporting 
the hypothesis that GABAergic cells may be more sensitive to injury [274]. Additionally, in vivo 
damage caused by lesion or infarction results in prolonged loss of GABAergic inhibition and 
dysfunctional circuitry [275-277], again supporting that GABAergic circuits are targeted during 
damage, and indicating that the model described here may be valid for studying these types of 
injuries. 
 
 
Figure 6.6. Effect of Mild Damage and NSC-Tx on Firing Metrics of CNNs. (a) Normalized average 
firing rate across all electrodes of the MEA and (b) normalized cross-grid correlation coefficient (CXY(0)) over 
the first 7 DPI for control (C2), damage (D2), and damage with NSC-tx (D2-tx). All data points are 
normalized to the pre-damage activity at 22 DIV.  * indicates significant difference from C2; p < 0.05. 
 
The dynamics of the injury were different in experimental groups D1 and D2, with the 
more severely damaged D1 exhibiting dysfunctional firing metrics for at least 6 DPI (Figure 6.4), 
while the more mildly injured D2 showed a possible trend toward recovering to pre-injury values 
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within the 7 DPI period (Figure 6.6). These data indicate the potential of this injury model to 
provide scalable damage to the CNN, with larger crush injuries resulting in more severely 
dysfunctional circuitry. However, it should be noted that these two damage groups received 
different AraC treatments, resulting in differences in the size of astrocyte populations in the 
culture, which could have an effect on their response to injury. Astrocytes contain glutamate 
transporters that can provide protection against excitotoxic glutamate release [278, 279], 
although the expression of astrocytic glutamate transporters is downregulated following injury 
[280], making it difficult to determine how significant the effect of AraC treatment was in the 
injury response of D1 and D2 cultures. Future studies are warranted to evaluate any 
neuroprotective effects of astroglia in this injury model.   
6.3.2.3 NSC Transplantation 
To evaluate the potential of NSCs as a therapy to restore damaged circuitry following neuronal 
injury, embryonic-derived NSCs were transplanted into the damaged CNN 3 h after injury and 
the resulting network activity was evaluated for 7 d. Immediately following injury, there was an 
improvement in both the firing rate and the cross-grid correlation coefficient compared to D2, 
which was not treated with NSCs (Figure 6.6). This effect persisted during the entire 7 DPI, with 
both metrics higher than D2 and slightly lower, but not significantly different than C2. In 
cultures that received the NSC-tx, the activity pattern displayed superburst-like activity, with 
periods of increased activity that were not organized into bursts as seen in D2 (Figure 6.5b). 
However, these superburst-like periods were highly correlated across the two grids of the MEA, 
suggesting that some connections were either protected from the damage, or restored after the 
damage. Additionally, outside of the superburst-like periods, there were very short, highly 
correlated bursts of activity that were present on both electrode grids and generally preceded the 
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onset of the superburst-like period. In healthy developing CNNs, the network undergoes a period 
of superbursting activity prior to transitioning to mature stable bursting behavior characterized 
by abrupt repetitive bursting [252, 262]. Immature superbursting is thought to be associated with 
neural plasticity, as the network connections are being formed and strengthened [263, 264]. The 
superburst-like activity that both D2 and D2-tx display may be indicative of plasticity occurring 
in the damaged networks after injury. 
The existence of these highly correlated activity patterns indicate that the NSCs had a 
therapeutic effect on the damaged network and have the potential to repair the dysfunctional 
circuitry. The origin of the therapeutic effect is likely due to released factors from the NSCs, 
rather than the production of newborn neurons integrating into the damaged network because the 
effect is present as soon as 1 DPI, which would be too soon for the NSCs to differentiate into 
neurons that are functionally mature [138]. NSCs secrete neurotrophic factors and can protect 
damaged neurons from oxidative stress and degeneration in disease states or injury in vivo and in 
vitro [281, 282], supporting the hypothesis that a neuroprotective effect may also occur in the 
D2-tx CNNs. However, it is possible that at later time points, some of the NSCs will differentiate 
into functional cells and integrate into the CNN to further repair the circuitry, and experiments 
are currently underway to investigate this possibility. 
These results indicate that this in vitro damage model has the potential to develop into a 
highly flexible platform for studying neuronal injury and regeneration, especially if coupled with 
the GO/CP nanocomposite described in Chapters 2 – 5. The multifaceted injury pathways 
involve dysfunctions in a multitude of chemical signals, along with the impaired electrical 
signaling described here. By modifying the electrodes of the device with the nanocomposite 
material, the platform can be enabled with the capability to detect chemical signaling to further 
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elucidate the injury cascade, or to release therapeutic agents as a method to test efficacy of novel 
drug molecules. 
6.4 CONCLUSIONS 
This work explored a novel in vitro platform for modeling neuronal injury that has the ability to 
monitor the electrophysiological activity of a network of neurons over time after the introduction 
of an injury. CNNs display stereotyped bursting behavior as they mature that can be used as a 
benchmark for evaluating the effects of damage on cell physiology. The pattern of bursting 
behavior is highly sensitive to the amount of astroglial cells present in the culture, demonstrating 
that astrocytes exhibit influence over the formation and maintenance of synaptic connections 
between neurons. Following injury, the firing rate, cross-grid correlation coefficient and burst 
rate are reduced, while treatment with NSCs can restore the activity to a level that is similar to 
undamaged cultures. While these results must be considered carefully because of the low sample 
size in each group (n = 2), they underscore the potential of this model for studying neuronal 
injury and regeneration. This work lays the foundation for future development and 
characterization of the MEA-based injury platform that can function as a reduced model of the 
complex pathophysiology that occurs following neuronal injury. 
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7.0  CONCLUSION 
7.1 SUMMARY OF RESULTS 
This dissertation describes the development of a conductive neural biomaterial and its versatile 
applications in the field of neural interfacing. The material consists of graphene oxide (GO) 
nanosheets doped into conducting polymer (CP) films that are deposited onto the surface of 
metal or carbon electrodes to improve interfacing capabilities with neurons and neural stem cells 
(NSCs). The GO/CP nanocomposite demonstrated good biocompatibility with both neurons and 
NSCs and could be easily modified with bioactive molecules to influence cell growth. The 
unique electrochemical properties of the GO/CP composite enabled highly controllable, on-
demand drug delivery. The chemical properties contributed by the GO nanosheets created a 
platform for highly sensitive and selective dopamine (DA) detection. With the goal of 
developing a customizable device that incorporates the neural interfacing capabilities of the 
GO/CP, this body of work concludes with the characterization of a repeatable in vitro cultured 
neuronal network (CNN) damage model based on multielectrode arrays (MEAs) for 
investigating the pathobiology of neuronal injury. The studies described in this dissertation 
demonstrate the hugely versatile applications that are possible for the GO/CP nanocomposite 
material, and are indicative of the potential impact that this neural biomaterial can have on the 
fields of bioengineering and medicine. 
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Chapter 2 introduced the GO/CP nanocomposite material and its ability to act as a 
biocompatible substrate for neural cell culture. The GO nanosheets were successfully 
incorporated into an electrochemically synthesized poly(3,4-ethylenedioxythiophene) (PEDOT) 
film as dopants and the resulting nanocomposite film demonstrated great electrical properties. 
Primary neurons cultured on the surface of the nanocomposite material showed no decrease in 
viability, very minimal cell death and exhibited healthy morphology that included plentiful 
neurite outgrowth and branching. As compared to conventional PEDOT films that were doped 
with poly(styrenesulfonate) (PSS), the GO/PEDOT nanocomposite displayed the interesting 
ability to improve the extent of neurite outgrowth, a property that may result from the unique 
morphology of the nanocomposite film. With a simple carbodiimide chemistry procedure that 
utilized the free carboxylic acid groups contributed by the GO nanosheets, the surface of the 
nanocomposite film could be decorated with functional laminin peptide p20 which further 
improved the neurite outgrowth of the neurons cultured on the surface of the nanocomposite.   
To build on the results of Chapter 2 that demonstrated the great scaffolding potential of 
the nanocomposite, Chapter 3 explored the response of NSCs cultured on the surface of 
GO/PEDOT films. The nanocomposite exhibited a huge benefit over conventional PEDOT/PSS 
films in its ability to drive NSC differentiation towards the neuronal phenotype. Further studies 
are warranted to unravel the mechanism behind the improved neuronal differentiation, which 
could include effects caused by chemical or biophysical properties imparted by the 
nanocomposite film. When functionalized with either interferon-γ (IFNγ) or platelet-derived 
growth factor (PDGF), the nanocomposite could selectively drive differentiation toward the 
neuronal or oligodendroglial lineages. This result emphasizes the customizability of the 
nanocomposite as a scaffolding material and demonstrates that along with its subtle intrinsic cues 
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that may be driving NSC behavior, it has the potential to be tailored with chemical modifications 
to direct a wide variety of biological processes. 
With Chapter 2 and Chapter 3 describing the ability of GO/CP nanocomposite to provide 
physical or immobilized chemical cues to cells, Chapter 4 focuses on the exceptional ability of 
GO/CP nanocomposite films to act as highly controlled, on-demand drug delivery systems. 
Conventional CPs have the ability to controllably release anionic drug molecules in response to 
electrical stimulation, as a result of their unique doping and redox properties. With the addition 
of GO nanosheets as co-dopants along with drug molecules, the drug delivery system can release 
larger quantities of drug in response to the same magnitude electrical stimulation. The GO 
nanosheets act as drug nanocarriers, shuttling a larger quantity of drug molecules into the CP 
film during synthesis and improving the drug load, ultimately leading to the increased payload 
delivery. This result has significance for future in vivo applications of the delivery system, in 
which voltage magnitudes must be carefully controlled so the resident tissue is not harmed by the 
electrical release stimulation. While drug release from conventional CP systems can be 
modulated by changing the type of electrical stimulation applied through the film, the GO 
nanosheets provide an additional level of adjustability to the system. Altering the size of the 
nanosheets prior to deposition into the CP film results in additional changes in drug loading and 
release. Clinically, very specific dosage requirements exist and can vary across different 
applications or over time within the same treatment. This work has demonstrated that the GO/CP 
drug release platform has the potential to meet these varied dosage needs. 
In Chapter 5, the focus of the interfacing application changed from the presentation of 
chemical cues to the detection of chemical signals. The performance of the GO/PEDOT 
nanocomposite as a sensitive and selective electrochemical DA sensor was evaluated. Electrodes 
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modified with the nanocomposite detect DA, an important neurotransmitter in the CNS, with 
significantly higher sensitivity than unmodified electrodes. This implies that the nanocomposite 
material could be useful for in vivo detection of DA, where concentrations of the neurochemical 
exist in the nanomolar to low micromolar range. Additionally, interfering signal from ascorbic 
acid (AA) was minimized at the nanocomposite surface as a result of an improved 
electrocatalyzation that separated the signals of the two analytes. Mechanistic studies suggested 
that both of these improvements arose as a result of interactions between the analytes and GO 
nanosheets that were present at the surface of the nanocomposite, clearly demonstrating the 
benefit of the nanomaterial. 
Chapter 6 described a novel neuronal injury platform based on a commercially available 
MEA that has the capability of monitoring the dynamic effects of injury on the firing patterns of 
cultured neurons. CNNs display a stereotypical pattern of highly correlated bursting behavior 
that develops after a few weeks in culture. After the introduction of a focal injury to the CNN, 
this behavior became dysfunctional, with deficits in the firing rate, correlation level, and bursting 
patterns of the cultured cells. Transplantation of a population of NSCs into the injury site 
protected the CNN firing activity, suggesting that the cells had a therapeutic effect on the 
damaged network. This work produced a framework for future studies that will further 
characterize the effect of damage on the network activity and provide a platform for studying the 
effects of damage on the pathophysiology of neural networks. 
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7.2 FUTURE DIRECTIONS AND PRELIMINARY DATA 
7.2.1 Surface Patterning to Direct Cell Growth 
The ability of the GO/CP nanocomposite to act as a highly versatile scaffolding material suggests 
the possibility that it can be adapted for multifunctional surface patterning, in which several 
bioactive cues are presented at distinct areas on the same culture surface. Surface patterning 
technologies have been investigated as methods to pattern cells within a culture to evaluate cell-
cell contacts or to study the interaction between cells and gradients of cues in their environment 
[283]. In these studies, a variety of engineering techniques such as lithography, microfluidic, and 
micro-contact printing are used to attract or confine cell growth to specific regions. To improve 
on these methods, a system that has the ability to not only direct cell growth via chemical 
signaling, but also to probe their electrical responsiveness is currently under development in our 
laboratory. 
We have developed a method of fabricating patterned cell culture electrode arrays using 
photolithography and they are being investigated as a high-throughput method of testing cell 
interactions with biomolecules. The system consists of a sensor chip that contains 16 sets of 
interdigitated stimulating electrodes, each set within a separate cell culture well (Figure 7.1a). 
Each electrode in the pair can be individually addressed and separately patterned with CP. In a 
preliminary experiment, one electrode was patterned with a GO/PEDOT nanocomposite loaded 
with γ-aminobutyric acid (GABA), an inhibitory neurotransmitter involved in neuronal 
differentiation and maturation during development, and the second electrode was deposited with 
PEDOT/PSS (Figure 7.1b). NSCs seeded on the surface of the patterned electrodes in 
differentiation media for 4 d exhibited markedly increased neuronal differentiation and neurite 
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outgrowth on the GO/PEDOT-GABA electrode, compared to the PEDOT/PSS electrode (Figure 
7.1b). These data demonstrate the potential that this system has for patterning cell growth by 
providing spatially specific cues to the cells as immobilized molecules on the surface of the 
electrodes. In this case, GABA molecules were loaded into the CP film as co-dopants with GO 
nanosheets, but this method is limited to small molecules that carry a negative charge, which 
function best as dopants.  Future work will include covalent immobilization of cues on the 
surface of the electrodes using the carbodiimide conjugation method described in Chapter 2 and 
Chapter 3, which will enable the use of larger molecules, such as mitogens or extracellular 
matrix proteins. 
 
Figure 7.1. Cell Patterning on Electrode Arrays. (a) Image of the patterned cell culture array 
showing the 16 separate cell culture locations. Scale bar measure 10 mm. Inset shows the interdigitated 
electrode pattern at each cell culture location. (b) Brightfield image of NSCs on the surface of patterned 
electrodes after 4 d in differentiation media. Electrode (i) is modified with GO/PEDOT-GABA and electrode 
(ii) is modified with PEDOT/PSS.  Cells on electrode (i) exhibit more neuronal differentiation, indicated by 
the extensive neurite outgrowth, compared to cells on electrode (ii) where most cells are spheroid in shape 
and few have extended neurites. 
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Using this cell culture array platform, or MEAs patterned with microelectrodes, a 
plethora of experiments could be designed that integrate cell patterning along with electrical 
stimulation and recording of cultured neuronal networks or NSCs. Important points to consider 
when patterning immobilized cues on the surface of functional electrodes are 1) how electrical 
stimulation will affect the molecule, and 2) how the molecule will affect the recording ability of 
the electrode. There is a possibility that a current passing through the electrode will destabilize 
the linkage between the molecule and the film surface. Additionally, depending on the type of 
biomolecule used, there is a possibility that the electrical stimulation could denature or degrade 
the molecule, rendering it inactive. Future work must establish the stability of candidate 
biomolecules in response to electrical stimulation, ensuring the feasibility of this method of 
surface patterning in conjunction with electrical stimulation. Additionally, after the cross-linking 
procedure, the electrical properties of the CP film must be monitored to ensure that the modified 
electrodes will be able to successfully record electrical signals from populations of cells growing 
on their surface. A common way to evaluate the performance of a recording electrode is by 
measuring the 1 kHz impedance value, which should be less than 1 MΩ to obtain a reliable 
neural signal [4]. The deposition of a non-conductive molecule at the surface of the electrode can 
increase the impedance value of the electrode by blocking charge transfer between the electrolyte 
and electrode surface. Impedance data collected after the covalent immobilization of a small 
peptide p20 on the surface of a microwire electrode slightly increased the 1 kHz impedance 
value, but it still remained well below the 1 MΩ cutoff (Figure 2.8a). There is a possibility that 
larger biomolecules, such as IFNγ or PDGF investigated in Chapter 3, could have a more 
significant effect on the impedance, resulting in poor electrical recording performance. Future 
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work investigating these potential pitfalls is warranted to ensure the success of the integrated cell 
patterning and electrical recording/stimulation platform. 
7.2.2 Controlled Drug Release from GO/CP Nanocomposite 
A major limitation of CP-based drug release platforms is that the system generally functions best 
with anionic drug molecules. In traditional CP-based drug release, the anionic drug molecules 
incorporate into the CP film as dopants. This mechanism provides a great system for controlled 
release of anionic drug molecules, but achieving release of cationic or neutral species is more 
difficult. One approach that has been successful in achieving cationic drug release is to 
synthesize a CP film that is doped with a large, immobile dopant, such as PSS, and then load the 
cationic drug into the intact film during reduction of the backbone [36, 284, 285]. Because the 
large dopant is immobile and cannot move out of the film, the cationic drug molecule will move 
in to balance the charge. In the case of neutral drug molecules, one successful method utilized 
was to create CP films doped with biotin that was then bound to streptavidin, enabling the 
loading of biotinylated NGF [286], which could then be released in response to electrical 
stimulation. In both of these methods, drug loading is limited to the surface of the CP, potentially 
decreasing the quantity of drug that can be release from the film. Additionally, in the case of the 
biotin/streptavidin-mediated drug loading and release, the drug molecules must be biotinylated, a 
process that can potentially interrupt their bioactivity. 
The GO/CP drug delivery system described in Chapter 4 has the potential to enable the 
incorporation and release of both cationic and neutral drug molecules. The GO nanosheets can 
act as “nanocarriers” by adsorbing the drug molecules via electrostatic or hydrophobic 
interactions and then shuttling them into the CP film during synthesis. Preliminary work being 
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carried out in our laboratory is exploring the possibility of using this GO/CP system for loading 
and delivering acetylcholine (ACh), the active neurotransmitter at neuromuscular junctions. The 
results have thus far been promising, indicating the successful loading and release of cationic 
ACh. Future work will investigate the ability of the GO/CP nanocomposite to load and release 
neutral drug molecules, as well as the potential of the system to perform selective release of 
dual-loaded drug molecules exhibiting different charges. 
7.2.3 In vivo DA Detection with GO/CP-Modified Electrodes 
While macroelectrodes are sufficient for assaying DA concentrations in large volume biological 
samples as a general screening tool for disease states [220, 221], these electrodes cannot be used 
in vivo to obtain spatially or temporally precise information about DA levels because of their 
large size. Carbon fiber microelectrodes (CFMEs) are the gold standard used for in vivo analysis 
of DA signaling within the CNS [222]. The concentration of DA within the CNS ranges from 
nanomolar to low micromolar, requiring highly sensitive analytical methods. Traditional CFMEs 
can reach this sensitivity level when their surface area is sufficiently high, a property that is 
controlled by the length of the CFME. However, as the length of the CFME increases to meet 
minimum sensitivity requirements, the size of the population of cells from which the electrode 
assays also increases, resulting in the low spatial specificity of current DA analysis methods. 
Consequently, there is a growing interest in electrode modifications that can improve the 
sensitivity to DA oxidation while maintaining or decreasing the total size of the electrode. 
Our laboratory is currently applying the GO/CP nanocomposite film to CFMEs for use in 
in vivo applications. GO/PEDOT nanocomposite films were deposited onto the CFME and, 
interestingly, exhibited a very different morphology than what was observed on the 
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macroelectrode under similar synthesis parameters (Figure 7.2a; refer to Figure 5.1a for 
macroelectrode morphology). This difference implies that the GO/CP electrodeposition process 
varies significantly depending on the size of the electrode despite the polymerization procedure 
being analogous. We hypothesis that this effect occurs 1) based on the differing geometry of the 
electrodes, with the CFME exhibiting a cylindrical shape, while the macroelectrode exhibits a 
disc shape or 2) based on the relative size ratio between the electrodes and the GO nanosheets, 
which would be much lower in the case of the CFMEs, creating a different deposition pattern. 
However, the true mechanism behind the differences is unknown and will be the subject of future 
investigation. 
 
 
Figure 7.2. In vivo detection of DA signals using GO/CP-modified CFMEs. (a) SEM image of the 
GO/PEDOT-modified CFME showing a wrinkled-sheet morphology. (b) Recorded DA signal in the striatum 
of rat in response to electrical stimulation to the ipsilateral medial forebrain bundle. Stimulation begins at t = 
0 and ends at the arrow marker on the curves. Bare electrode (n = 3); GO/PEDOT electrode (n = 1). 
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Using the GO/CP-modified CFMEs, preliminary in vivo data was collected from the 
striatum of an anesthetized Sprague-Dawley rat at collaborator Dr. Adrian Michael’s laboratory 
in the Department of Chemistry at the University of Pittsburgh. The change in DA signal was 
monitored using fast scan cyclic voltammetry after the application of electrical stimulation to the 
ipsilateral medial forebrain bundle, which contains nigrostriatal DA fibers that project to the 
striatum [287]. The preliminary results indicate that the GO/CP nanocomposite has the 
sensitivity required to detect in vivo DA signals (Figure 7.2b). With future work to optimize the 
deposition parameters of the nanocomposite onto CFMEs, it is possible that we may achieve the 
boosted sensitivity toward DA that was observed using the GO/CP-modified macroelectrodes.  
7.2.4 Neural Recording and Stimulation with GO/CP  
The work described in this dissertation focuses on the chemical interfacing abilities of the 
GO/CP nanocomposite, but the material must also have the ability to stimulate and record 
electrical signals to function as a successful neural interfacing material. The electrical properties 
of the GO/CP nanocomposite described here and by others [161-163] indicate that the material 
should be able to record electrical activity from neurons with high signal-to-noise ratio, but none 
have yet demonstrated this capability, either in vitro or in vivo. We have begun preliminary work 
to evaluate the neural recording performance of the GO/CP both in vitro with CNNs cultured on 
MEAs and in vivo with microwire electrodes implanted into the visual cortex of mice. The 
GO/CP-modified microwire electrodes have successfully recorded spontaneous and visually-
evoked activity from the visual cortex, but it has yet to be determined whether the GO/CP-
modified microwires exhibit higher signal-to-noise ratios than the unmodified microwires. 
Future work to compare the performance of the GO/CP-modified electrodes to bare electrodes is 
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planned and will characterize the full benefit of using the nanocomposite as a multimodal neural 
interfacing material. 
 Electrical stimulation of neural tissue holds great therapeutic potential for a variety of 
neurological disorders and is currently utilized in clinical applications such as deep brain 
stimulation for treatment of Parkinson’s disease [288] or auditory nerve stimulation in cochlear 
implant technologies [289]. Nanostructured polymer materials have been explored as 
modifications to stimulating neural electrodes as a means of improving the surface area and 
charge injection capability, which results in safer stimulation paradigms for biological tissues [4, 
290]. The GO/PEDOT nanocomposite exhibits rough surface morphology (Figures 2.2, 3.1, and 
5.1a) and low impedance (Figures 2.8a and 5.1c) indicating that the material may demonstrate a 
large charge injection capacity that will reduce the voltage excursion of the stimulation and 
reduce potential damage to surrounding tissue. Future studies characterizing the performance of 
GO/CP-modified microelectrodes for neural stimulation are planned to assess its full potential as 
a neural interfacing material.  
7.2.5 Continued Development of CNN Damage Platform  
While the results reported in Chapter 6 regarding the use of the MEA-based CNN as an in vitro 
damage and regeneration model were promising, the sample size for each experimental group 
was low and must be increased to establish a more confident assessment of the injury and 
possible repair by NSCs. Additionally, there are several injury characterizations that would assist 
in validating the model. For example, following an injury to the CNS, secondary molecular 
pathways are initiated that lead to continuing cell necrosis and apoptosis after the initial insult 
[257]. As a method to determine the validity of this in vitro model, the extent of degeneration 
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around the injury should be evaluated, along with the viability of the surviving cells, reactive 
oxygen species production and other characteristic markers of CNS injury. Qualitative 
assessment of the injury site after the injury revealed that the size of the “dead zone,” where 
there were no cells growing, increased for at least the first week after injury. Additionally, cells 
exhibiting morphology associated with astrocytes were seen to infiltrate the damage zone, 
potentially to create a glial scar around the damage site [291]. Inhibitory factors released from 
the glial scar in vivo are thought to impede neurons from regenerating following injury, making 
the glial scar a focus of study in regenerative medicine [292]. If a glial scar is, in fact, forming in 
the in vitro injury model, it could provide a valuable platform for studying the physiology of the 
scar and testing the effect of potential interventions.  
NSC transplantation following injury to the CNS in vivo can result in functional recovery, 
but the mechanism of the therapeutic effect is thought to be largely due to released neurotrophic 
factors protecting existing cells from damage rather than cell replacement bridging damaged 
circuitry [281, 282]. Our in vitro transplantation results support the idea of neuroprotection via 
secreted factors because improved CNN activity is observed as soon as 1 day post injury (DPI), 
too soon for NSCs to differentiate into functional neurons [98]. To confirm that NSCs are 
secreting protective factors, damaged CNNs will be treated with NSC conditioned media or 
neurotrophic factors to evaluate the protective effect on CNN activity. While our data suggest 
that the immediate effects are due to secreted factors, NSCs may differentiate into functional 
cells that will have effects at longer time periods, possibly by integrating into the damaged 
circuitry. Current experiments are underway to evaluate the therapeutic effects of NSCs on 
damaged CNNs for up to 20 DPI. The transplanted NSCs will be tracked using live-cell 
fluorescent labeling coupled with endpoint immunocytochemistry to evaluate their survival and 
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differentiation patterns with the goal of providing information that will lead to more effective 
cellular therapies for the treatment of CNS injury. 
7.2.6 Concluding Remarks: Towards a Highly Customizable Platform for the Multimodal 
Study of Neuronal Injury 
The CNS is a hugely complicated organ system, considered by some to be the “last frontier” in 
science because of the relatively limited amount of understanding we currently have about its 
physiology. This dissertation presents a body of work that demonstrates the highly versatile 
applications of GO/CP nanocomposite-modified electrodes within the field of neural engineering 
that can be used to create a window into the intricate processes that form a basis for human 
behavior and cognition. This work, along with the described in vitro regeneration model, 
provides a framework for studying the complex pathology of neuronal injury or disease in a 
simplified, controllable fashion. By combining the full functionality of the GO/CP 
nanocomposite material with the MEA-based regeneration model, a multimodal platform for 
studying injury can be created that has the ability to monitor electrical and chemical changes 
following injury, in conjunction with testing the efficacy of various soluble or immobilized 
therapeutics that can be presented to the dish in a highly temporally and spatially precise manner. 
Various parameters in the platform (injury severity, cell type, chemical cues) can be tuned, 
making the device a powerful research tool for elucidating the pathology of neuronal injury and 
regeneration.   
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APPENDIX A 
A.1 SUPPORTING INFORMATION FOR CHAPTER 4 
To verify that both GO nanosheets and DEX were incorporated into the PPy film, Fourier 
transform IR (FTIR) spectroscopy was performed on the pure GO nanosheets, and GO/PPy 
nanocomposite films with or without DEX as a co-dopant (Figure A1.1). The GO nanosheet 
spectrum exhibits characteristic peaks arising from oxygen-containing moieties (carboxylic 
C=O: 1736 cm-1; O-H deformation: 1406 cm-1; C-O-H stretch: 1221 cm-1; C-O-C stretching 
vibration: 1043 cm-1)[90]. The electrodeposited GO/PPy film spectrum contains a carboxylic 
carbonyl peak at 1705 cm-1, attributable to GO, along with characteristic PPy peaks at 1472 cm-1 
(C-N stretching vibration) and 964 cm-1 (N-H wag), confirming the successful incorporation of 
the GO nanosheets into the polymer[161]. The spectrum of the film synthesized in the presence 
of both GO and DEX molecules (GO/PPy-DEX) exhibits an additional carbonyl peak at 1657 
cm-1 that arises from the carbonyl group conjugated to the double bond framework of the DEX 
molecule, along with a peak at 1146 cm-1, assigned to the DEX phosphate group[293]. 
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 Figure A1.1. FTIR spectra of GO nanosheets, unloaded GO/PPy, and DEX-loaded GO/PPy. On each 
spectrum, peaks labeled in red are contributed by GO, blue by PPy, and green by DEX. 
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 Figure A1.2. Surface morphology of DEX-loaded PPy films. Representative SEM images of a 
conventional DEX-loaded PPy film (left) and a DEX-loaded GO/PPy nanocomposite film (right). The 
conventional film exhibits a much smoother morphology than the nanocomposite that contains rough sheet-
like protrusions at its surface. 
 
 
 
 
 
 
 150 
 Figure A1.3. Stability of the DEX-loaded GO/PPy nanocomposite film. SEM images of the GO/PPy-
DEX film before (left panel) and after (right panel) 1000 release stimulations (-0.5 V for 5 s, followed by 0.5 V 
for 5 s). There is no visible cracking or delamination of the film post-stimulation, demonstrating the good 
stability of the film. 
 151 
BIBLIOGRAPHY 
[1] Beck EC. Electrophysiology and Behavior. Annu Rev Psychol. 1975;26:233-62. 
[2] Mukamel R, Fried I. Human intracranial recordings and cognitive neuroscience. Annu 
Rev Psychol. 2012;63:511-37. 
[3] Strumwasser F. Long-term recording from single neurons in brain of unrestrained 
mammals. Science. 1958;127:469-70. 
[4] Cogan SF. Neural stimulation and recording electrodes. Annu Rev Biomed Eng. 
2008;10:275-309. 
[5] Schwartz AB, Cui XT, Weber DJ, Moran DW. Brain-controlled interfaces: Movement 
restoration with neural prosthetics. Neuron. 2006;52:205-20. 
[6] Merrill DR, Bikson M, Jefferys JG. Electrical stimulation of excitable tissue: design of 
efficacious and safe protocols. J Neurosci Meth. 2005;141:171-98. 
[7] Letheby H. On the production of a blue substance by the eletrolysis of sulphate of aniline. 
J Chem Soc. 1862;15:161-3. 
[8]  Angelopoulos M. Conducting polymers in microelectronics. IBM J Res Dev. 2001;45:57-
75. 
[9] Feng C, Wan Q, Lv Z, Yue X, Chen Y, Wei C. One-step fabrication of membraneless 
microbial fuel cell cathode by electropolymerization of polypyrrole onto stainless steel 
mesh. Biosens Bioelectron. 2011. 
[10] Gerard M, Chaubey A, Malhotra BD. Application of conducting polymers to biosensors. 
Biosens Bioelectron. 2002;17:345-59. 
 152 
[11] Janata J, Josowicz M. Conducting polymers in electronic chemical sensors. Nature Mater. 
2003;2:19-24. 
[12] Luo SC. Conducting polymers as biointerfaces and biomaterials: A perspective for a 
special issue of polymer reviews. Polym Rev. 2013;53:303-10. 
[13] Ateh DD, Navsaria HA, Vadgama P. Polypyrrole-based conducting polymers and 
interactions with biological tissues. J R Soc Interface. 2006;3:741-52. 
[14] Cui X, Hetke JF, Wiler JA, Anderson DJ, Martin DC. Electrochemical deposition and 
characterization of conducting polymer polypyrrole/PSS on multichannel neural probes. 
Sensor Actuat A-Physical. 2001;93:8-19. 
[15] Cui XT, Zhou DD. Poly (3,4-ethylenedioxythiophene) for chronic neural stimulation. 
IEEE T Neur Sys Reh. 2007;15:502-8. 
[16] Green RA, Lovell NH, Wallace GG, Poole-Warren LA. Conducting polymers for neural 
interfaces: challenges in developing an effective long-term implant. Biomaterials. 
2008;29:3393-9. 
[17] Ludwig KA, Langhals NB, Joseph MD, Richardson-Burns SM, Hendricks JL, Kipke DR. 
Poly(3,4-ethylenedioxythiophene) (PEDOT) polymer coatings facilitate smaller neural 
recording electrodes. J Neur Eng. 2011;8:014001. 
[18]  Richardson-Burns SM, Hendricks JL, Foster B, Povlich LK, Kim DH, Martin DC. 
Polymerization of the conducting polymer poly(3,4-ethylenedioxythiophene) (PEDOT) 
around living neural cells. Biomaterials. 2007;28:1539-52. 
[19] Venkatraman S, Hendricks J, King ZA, Sereno AJ, Richardson-Burns S, Martin D, et al. 
In vitro and in vivo evaluation of PEDOT microelectrodes for neural stimulation and 
recording. IEEE T Neur Sys Reh. 2011;19:307-16. 
[20] Inzelt G. Conducting polymers : a new era in electrochemistry. 1st ed. New York: 
Springer; 2008. 
[21] Malinauskas A. Chemical deposition of conducting polymers. Polymer. 2001;42:3957-
72. 
 153 
[22] Heinze J, Frontana-Uribe BA, Ludwigs S. Electrochemistry of conducting polymers--
persistent models and new concepts. Chem Rev. 2010;110:4724-71. 
[23] Niu L, Kvarnstrom C, Froberg K, Ivaska A. Electrochemically controlled surface 
morphology and crystallinity in poly(3,4-ethylenedioxythiophene) films. Synthetic Met. 
2001;122:425-9. 
[24] Castagnola V, Bayon C, Descamps E, Bergaud C. Morphology and conductivity of 
PEDOT layers produced by different electrochemical routes. Synthetic Met. 2014;189:7-
16. 
[25] Chiang CK, Fincher CR, Park YW, Heeger AJ, Shirakawa H, Louis EJ, et al. Electrical 
conductivity in doped polyacetylene. Phys Rev Lett. 1977;39:1098-101. 
[26] Gill WD, Bludau W, Geiss RH, Grant PM, Greene RL, Mayerle JJ, et al. Structure and 
electronic properties of polymeric sulfur nitride (SN)x modified by bromine. Physical 
Rev Lett. 1977;38:1305. 
[27] Walatka VV, Labes MM. Polysulfur nitiride - A one-dimensional chain with a metallic 
ground state. Phys Rev Lett. 1973;31:1139-42. 
[28] Wallace GG. Conductive electroactive polymers : intelligent polymer systems. 3rd ed. 
Boca Raton: CRC Press; 2009. 
[29] Bredas JL, Street GB. Polarons, bipolarons, and solitons in conducting polymers. 
Accounts Chem Res. 1985;18:309-15. 
[30] Han D-H, Lee HJ, Park S-M. Electrochemistry of conductive polymers XXXV: Electrical 
and morphological characteristics of polypyrrole films prepared in aqueous media studied 
by current sensing atomic force microscopy. Electrochim Acta. 2005;50:3085-92. 
[31] King ZA, Shaw CM, Spanninga SA, Martin DC. Structural, chemical and 
electrochemical characterization of poly(3,4-Ethylenedioxythiophene) (PEDOT) prepared 
with various counter-ions and heat treatments. Polymer. 2011;52:1302-8. 
[32] Kontturi K, Pentti P, Sundholm G. Polypyrrole as a model membrane for drug delivery. J 
Electroanal Chem. 1998;453:231-8. 
 154 
[33] Miller LL, Zinger B, Zhou QX. Electrically controlled release of Fe(Cn)6(4-) from 
polypyrrole. J Am Chem Soc. 1987;109:2267-72. 
[34] Svirskis D, Travas-Sejdic J, Rodgers A, Garg S. Electrochemically controlled drug 
delivery based on intrinsically conducting polymers. J Control Release. 2010;146:6-15. 
[35] Thompson BC, Moulton SE, Ding J, Richardson R, Cameron A, O'Leary S, et al. 
Optimising the incorporation and release of a neurotrophic factor using conducting 
polypyrrole. J Control Release. 2006;116:285-94. 
[36] Tybrandt K, Larsson KC, Kurup S, Simon DT, Kjall P, Isaksson J, et al. Translating 
electronic currents to precise acetylcholine-induced neuronal signaling using an organic 
electrophoretic delivery device. Adv Mater. 2009;21:4442-6. 
[37] Yue Z, Moulton SE, Cook M, O'Leary S, Wallace GG. Controlled delivery for neuro-
bionic devices. Adv Drug Deliver Rev. 2013;65:559-69. 
[38] Asplund M, von Holst H, Inganas O. Composite biomolecule/PEDOT materials for 
neural electrodes. Biointerphases. 2008;3:83-93. 
[39] Collier JH, Camp JP, Hudson TW, Schmidt CE. Synthesis and characterization of 
polypyrrole-hyaluronic acid composite biomaterials for tissue engineering applications. J 
Biomed Mater Res. 2000;50:574-84. 
[40] Cui X, Lee VA, Raphael Y, Wiler JA, Hetke JF, Anderson DJ, et al. Surface modification 
of neural recording electrodes with conducting polymer/biomolecule blends. J Biomed 
Mater Res. 2001;56:261-72. 
[41] Cui X, Wiler J, Dzaman M, Altschuler RA, Martin DC. In vivo studies of 
polypyrrole/peptide coated neural probes. Biomaterials. 2003;24:777-87. 
[42] Green RA, Lovell NH, Poole-Warren LA. Impact of co-incorporating laminin peptide 
dopants and neurotrophic growth factors on conducting polymer properties. Acta 
Biomater. 2010;6:63-71. 
[43] Warren LF, Walker JA, Anderson DP, Rhodes CG. A study of conducting polymer 
morphology: the effect of dopant anions upon order. J Electrochem Soc. 1989;136:2286-
95. 
 155 
[44] Zhang L, Stauffer WR, Jane EP, Sammak PJ, Cui XT. Enhanced differentiation of 
embryonic and neural stem cells to neuronal fates on laminin peptides doped polypyrrole. 
Macromol Biosci. 2010;10:1456-64. 
[45] Balint R, Cassidy NJ, Cartmell SH. Conductive polymers: Towards a smart biomaterial 
for tissue engineering. Acta Biomater. 2014. 
[46] Bendrea AD, Cianga L, Cianga I. Review paper: Progress in the field of conducting 
polymers for tissue engineering applications. J Biomater Appl. 2011;26:3-84. 
[47] Ravichandran R, Sundarrajan S, Venugopal JR, Mukherjee S, Ramakrishna S. 
Applications of conducting polymers and their issues in biomedical engineering. J R Soc 
Interface. 2010;7 Suppl 5:S559-79. 
[48] Weber SG. Signal-to-noise ratio in microelectrode-array-based electrochemical detectors. 
Anal Chem. 1989;61:295-302. 
[49] Abidian MR, Ludwig KA, Marzullo TC, Martin DC, Kipke DR. Interfacing conducting 
polymer nanotubes with the central nervous system: chronic neural recording using poly 
(3,4-ethylenedioxythiophene) nanotubes. Adv Mater. 2009;21:3764-70. 
[50] Stauffer WR, Cui XT. Polypyrrole doped with 2 peptide sequences from laminin. 
Biomaterials. 2006;27:2405-13. 
[51] Novoselov KS, Geim AK, Morozov SV, Jiang D, Zhang Y, Dubonos SV, et al. Electric 
field effect in atomically thin carbon films. Science. 2004;306:666-9. 
[52] Park S, Ruoff RS. Chemical methods for the production of graphenes. Nat Nanotechnol. 
2009;4:217-24. 
[53] Dreyer DR, Park S, Bielawski CW, Ruoff RS. The chemistry of graphene oxide. Chem 
Soc Rev. 2010;39:228-40. 
[54] Hummers WS, Offeman RE. Preparation of Graphitic Oxide. J Am Chem Soc. 
1958;80:1339. 
 156 
[55] Stankovich S, Dikin DA, Piner RD, Kohlhaas KA, Kleinhammes A, Jia Y, et al. 
Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite 
oxide. Carbon. 2007;45:1558-65. 
[56] Park S, Ruoff RS. Chemical methods for the production of graphenes. Nat Nanotechnol. 
2009;4:217-24. 
[57] He HY, Riedl T, Lerf A, Klinowski J. Solid-state NMR studies of the structure of 
graphite oxide. J Phys Chem. 1996;100:19954-8. 
[58] Gao W, Alemany LB, Ci LJ, Ajayan PM. New insights into the structure and reduction of 
graphite oxide. Nat Chem. 2009;1:403-8. 
[59] Pyun J. Graphene Oxide as Catalyst: Application of Carbon Materials beyond 
Nanotechnology. Angew Chem Int Edit. 2011;50:46-8. 
[60] Stergiou DV, Diamanti EK, Gournis D, Prodromidis MI. Comparitive study of different 
types of graphenes as electrocatalysts for ascorbic acid. Electrochem Commun. 
2010;12:1307-9. 
[61] Dhakshinamoorthy A, Alvaro M, Concepcion P, Fornes V, Garcia H. Graphene oxide as 
an acid catalyst for the room temperature ring opening of epoxides. Chem Commun. 
2012;48:5443-5. 
[62] Dreyer DR, Jia HP, Bielawski CW. Graphene oxide: a convenient carbocatalyst for 
facilitating oxidation and hydration reactions. Angew Chem Int Edit. 2010;49:6813-6. 
[63] Chen D, Feng HB, Li JH. Graphene oxide: preparation, functionalization, and 
electrochemical applications. Chem Rev. 2012;112:6027-53. 
[64] Wang Y, Li Z, Wang J, Li J, Lin Y. Graphene and graphene oxide: biofunctionalization 
and applications in biotechnology. Trend Biotechnol. 2011;29:205-12. 
[65] Zhang Y, Nayak TR, Hong H, Cai WB. Graphene: a versatile nanoplatform for 
biomedical applications. Nanoscale. 2012;4:3833-42. 
[66] Bolotin KI, Sikes KJ, Jiang Z, Klima M, Fudenberg G, Hone J, et al. Ultrahigh electron 
mobility in suspended graphene. Solid State Comm. 2008;146:351-5. 
 157 
[67] Eda G, Fanchini G, Chhowalla M. Large-area ultrathin films of reduced graphene oxide 
as a transparent and flexible electronic material. Nat Nanotechnol. 2008;3:270-4. 
[68] Gilgunn PJ, Khilwani R, Kozai TDY, Weber DJ, Cui XT, Erdos G, et al. An ultra-
compliant, scalable neural probe with molded biodissolvable delivery vehicle. Proc IEEE 
Micr Elect. 2012:56-9. 
[69] Chen CH, Lin CT, Hsu WL, Chang YC, Yeh SR, Li LJ, et al. A flexible hydrophilic-
modified graphene microprobe for neural and cardiac recording. Nanomedicine-UK. 
2013;9:600-4. 
[70] Chiu C, He X, Liang H. Surface modification of a neural sensor using graphene. 
Electrochim Acta. 2013;94:42-8. 
[71] Hong SW, Lee JH, Kang SH, Hwang EY, Hwang Y-S, Lee MH, et al. Enhanced neural 
cell adhesion and neurite outgrowth on graphene-based biomimetic substrates. Biomed 
Res Int. 2014;2014:212149. 
[72] Kim SM, Joo P, Ahn G, Cho IH, Kim DH, Song WK, et al. Transparent conducting films 
based on reduced graphene oxide multilayers for biocompatible neuronal interfaces. J 
Biomed Nanotechnol. 2013;9:403-8. 
[73] Li N, Zhang XM, Song Q, Su RG, Zhang Q, Kong T, et al. The promotion of neurite 
sprouting and outgrowth of mouse hippocampal cells in culture by graphene substrates. 
Biomaterials. 2011;32:9374-82. 
[74] Zhou K, Thouas GA, Bernard CC, Nisbet DR, Finkelstein DI, Li D, et al. Method to 
impart electro- and biofunctionality to neural scaffolds using graphene-polyelectrolyte 
multilayers. ACS Appl Mater Interfaces. 2012;4:4524-31. 
[75] Lu CH, Hsiao YS, Kuo CW, Chen P. Electrically tunable organic bioelectronics for 
spatial and temporal manipulation of neuron-like pheochromocytoma (PC-12) cells. 
Biochim Biophys Acta. 2013;1830:4321-8. 
[76] Heo C, Yoo J, Lee S, Jo A, Jung S, Yoo H, et al. The control of neural cell-to-cell 
interactions through non-contact electrical field stimulation using graphene electrodes. 
Biomaterials. 2011;32:19-27. 
 158 
[77] Tang ML, Song Q, Li N, Jiang ZY, Huang R, Cheng GS. Enhancement of electrical 
signaling in neural networks on graphene films. Biomaterials. 2013;34:6402-11. 
[78] Tu Q, Pang L, Chen Y, Zhang Y, Zhang R, Lu B, et al. Effects of surface charges of 
graphene oxide on neuronal outgrowth and branching. Analyst. 2014;139:105-15. 
[79] Tu Q, Pang L, Wang L, Zhang Y, Zhang R, Wang J. Biomimetic choline-like graphene 
oxide composites for neurite sprouting and outgrowth. ACS Appl Mater Interfaces. 
2013;5:13188-97. 
[80] Luo X, Weaver CL, Tan S, Cui XT. Pure graphene oxide doped conducting polymer 
nanocomposite for bio-interfacing. J Mater Chem B. 2013;1:1340-8. 
[81] Weaver CL, Larosa JM, Luo X, Cui XT. Electrically Controlled Drug Delivery from 
Graphene Oxide Nanocomposite Films. ACS Nano. 2014. 
[82] Huang X, Yin ZY, Wu SX, Qi XY, He QY, Zhang QC, et al. Graphene-based materials: 
synthesis, characterization, properties, and applications. Small. 2011;7:1876-902. 
[83] Loh KP, Bao QL, Eda G, Chhowalla M. Graphene oxide as a chemically tunable platform 
for optical applications. Nat Chem. 2010;2:1015-24. 
[84] Zhu Y, Murali S, Cai W, Li X, Suk JW, Potts JR, et al. Graphene and graphene oxide: 
synthesis, properties, and applications. Adv Mater. 2010;22:3906-24. 
[85] Alwarappan S, Boyapalle S, Kumar A, Li CZ, Mohapatra S. Comparative study of single-
, few-, and multi layered graphene toward enzyme conjugation and electrochemical 
response. J Phys Chem C. 2012;116:6556-9. 
[86] Alwarappan S, Erdem A, Liu C, Li CZ. Probing the electrochemical properties of 
graphene nanosheets for biosensing applications. J Phys Chem C. 2009;113:8853-7. 
[87] Alwarappan S, Joshi RK, Ram MK, Kumar A. Electron transfer mechanism of 
cytochrome c at graphene electrode. Appl Phys Lett. 2010;96. 
[88] Alwarappan S, Liu C, Kumar A, Li CZ. Enzyme-doped graphene nanosheets for 
enhanced glucose biosensing. J Phys Chem C. 2010;114:12920-4. 
 159 
[89] Kalbacova M, Broz A, Kalbac M. Influence of the fetal bovine serum proteins on the 
growth of human osteoblast cells on graphene. J Biomed Mater Res A. 2012;100A:3001-
7. 
[90] Zhu CZ, Zhai JF, Wen D, Dong SJ. Graphene oxide/polypyrrole nanocomposites: one-
step electrochemical doping, coating and synergistic effect for energy storage. J Mater 
Chem. 2012;22:6300-6. 
[91] Depan D, Girase B, Shah JS, Misra RDK. Structure-process-property relationship of the 
polar graphene oxide-mediated cellular response and stimulated growth of osteoblasts on 
hybrid chitosan network structure nanocomposite scaffolds. Acta Biomater. 2011;7:3432-
45. 
[92] Pan YZ, Sahoo NG, Li L. The application of graphene oxide in drug delivery. Expert 
Opin Drug Del. 2012;9:1365-76. 
[93] Ruiz ON, Fernando KAS, Wang BJ, Brown NA, Luo PG, McNamara ND, et al. 
Graphene oxide: a nonspecific enhancer of cellular growth. ACS Nano. 2011;5:8100-7. 
[94] Zhou M, Zhai YM, Dong SJ. Electrochemical sensing and biosensing platform based on 
chemically reduced graphene oxide. Anal Chem. 2009;81:5603-13. 
[95] Hu W, Peng C, Lv M, Li X, Zhang Y, Chen N, et al. Protein corona-mediated mitigation 
of cytotoxicity of graphene oxide. ACS Nano. 2011;5:3693-700. 
[96] Wang K, Ruan J, Song H, Zhang JL, Wo Y, Guo SW, et al. Biocompatibility of graphene 
oxide. Nano Res Lett. 2011;6. 
[97] Lee WC, Lim CH, Shi H, Tang LA, Wang Y, Lim CT, et al. Origin of enhanced stem cell 
growth and differentiation on graphene and graphene oxide. ACS Nano. 2011;5:7334-41. 
[98] Singh SK, Singh MK, Kulkarni PP, Sonkar VK, Gracio JJA, Dash D. Amine-modified 
graphene. Thrombo-protective safer alternative to graphene oxide for biomedical 
applications. ACS Nano. 2012;6:2731-40. 
[99] Wojtoniszak M, Chen XC, Kalenczuk RJ, Wajda A, Lapczuk J, Kurzewski M, et al. 
Synthesis, dispersion, and cytocompatibility of graphene oxide and reduced graphene 
oxide. Colloid Surface B. 2012;89:79-85. 
 160 
[100]  Istamboulie G, Sikora T, Jubete E, Ochoteco E, Marty JL, Noguer T. Screen-
printed poly(3,4-ethylenedioxythiophene) (PEDOT): A new electrochemical mediator for 
acetylcholinesterase-based biosensors. Talanta. 2010;82:957-61. 
[101] Rozlosnik N. New directions in medical biosensors employing poly(3,4-ethylenedioxy 
thiophene) derivative-based electrodes. Anal Bioanal Chem. 2009;395:637-45. 
[102] Akoudad S, Roncali J. Modification of the electrochemical and electronic properties of 
electrogenerated poly(3,4-ethylenedioxythiophene) by hydroxymethyl and 
oligo(oxyethylene)substituents. Electrochem Commun. 2000;2:72-6. 
[103] Ali EM, Kantchev EAB, Yu HH, Ying JY. Conductivity shift of 
polyethylenedioxythiophenes in aqueous solutions from side-chain charge perturbation. 
Macromolecules. 2007;40:6025-7. 
[104]  Arias-Pardilla J, Otero TF, Blanco R, Segura JL. Synthesis, electropolymerization and 
oxidation kinetics of an anthraquinone-functionalized poly(3,4-ethylenedioxythiophene). 
Electrochim Acta. 2010;55:1535-42. 
[105]  Luo SC, Ali EM, Tansil NC, Yu HH, Gao S, Kantchev EAB, et al. Poly(3,4-
ethylenedioxythiophene) (PEDOT) nanobiointerfaces: thin, ultrasmooth, and 
functionalized PEDOT films with in vitro and in vivo biocompatibility. Langmuir. 
2008;24:8071-7. 
[106]  Povlich LK, Cho JC, Leach MK, Corey JM, Kim J, Martin DC. Synthesis, 
copolymerization and peptide-modification of carboxylic acid-functionalized 3,4-
ethylenedioxythiophene (EDOTacid) for neural electrode interfaces. BBA-Gen Subjects. 
2013;1830:4288-93. 
[107]  Segura JL, Gomez R, Blanco R, Reinold E, Bauerle P. Synthesis and electronic properties 
of anthraquinone-, tetracyanoanthraquinodimethane-, and perylenetetracarboxylic 
diimide-functionalized poly(3,4-ethylenedioxythiophenes). Chem Mater. 2006;18:2834-
47. 
[108]  Xie H, Luo SC, Yu HH. Electric-field-assisted growth of functionalized poly(3,4-
ethylenedioxythiophene) nanowires for label-free protein detection. Small. 2009;5:2611-
7. 
[109]  Roncali J. Electrogenerated functional conjugated polymers as advanced electrode 
materials. J Mater Chem. 1999;9:1875-93. 
 161 
[110]  Brisset H, Navarro AE, Moustrou C, Perepichka IF, Roncali J. Electrogenerated 
conjugated polymers incorporating a ferrocene-derivatized-(3,4-ethylenedioxythiophene). 
Electrochem Commun. 2004;6:249-53. 
[111]  Doherty WJ, Wysocki RJ, Armstrong NR, Saavedra SS. Electrochemical 
copolymerization and spectroelectrochemical characterization of 3,4-
ethylenedioxythiophene and 3,4-ethylenedioxythiophene-methanol copolymers on 
indium-tin oxide. Macromolecules. 2006;39:4418-24. 
[112]  Yildiz E, Camurlu P, Tanyeli C, Akhmedov I, Toppare L. A soluble conducting polymer 
of 4-(2,5-di(thiophen-2-yl)-1H-pyrrol-1-yl)benzenamine and its multichromic copolymer 
with EDOT. J Electroanal Chem. 2008;612:247-56. 
[113]  Abidian MR, Martin DC. Multifunctional nanobiomaterials for neural interfaces. Adv 
Funct Mater. 2009;19:573-85. 
[114]  Kim DH, Richardson-Burns SM, Hendricks JL, Sequera C, Martin DC. Effect of 
immobilized nerve growth factor on conductive polymers: electrical properties and 
cellular response. Adv Funct Mater. 2007;17:79-86. 
[115]  Jeong H-K, Lee YP, Lahaye RJWE, Park M-H, An KH, Kim IJ, et al. Evidence of 
graphitic AB stacking order of graphite oxides. J Am Chem Soc. 2008;130:1362-6. 
[116]  Shen JF, Hu YZ, Shi M, Lu X, Qin C, Li C, et al. Fast and facile preparation of graphene 
oxide and reduced graphene oxide nanoplatelets. Chem Mater. 2009;21:3514-20. 
[117]  Agarwal S, Zhou X, Ye F, He Q, Chen GC, Soo J, et al. Interfacing live cells with 
nanocarbon substrates. Langmuir. 2010;26:2244-7. 
[118] Lv M, Zhang Y, Liang L, Wei M, Hu W, Li X, et al. Effect of graphene oxide on 
undifferentiated and retinoic acid-differentiated SH-SY5Y cells line. Nanoscale. 
2012;4:3861-6. 
[119]  Ameen S, Akhtar MS, Shin HS. Hydrazine chemical sensing by modified electrode based 
on in situ electrochemically synthesized polyaniline/graphene composite thin film. Sensor 
Actuat B-Chem. 2012;173:177-83. 
[120]  Liesi P, Narvanen A, Soos J, Sariola H, Snounou G. Identification of a neurite outgrowth-
promoting domain of laminin using synthetic peptides. FEBS Lett. 1989;244:141-8. 
 162 
[121] Matsuzawa M, Liesi P, Knoll W. Chemically modifying glass surfaces to study 
substratum-guided neurite outgrowth in culture. J Neurosci Meth. 1996;69:189-96. 
[122]  Mohanty N, Berry V. Graphene-based single-bacterium resolution biodevice and DNA 
transistor: interfacing graphene derivatives with nanoscale and microscale 
biocomponents. Nano Lett. 2008;8:4469-76. 
[123]  Chen D, Li L, Guo L. An environment-friendly preparation of reduced graphene oxide 
nanosheets via amino acid. Nanotechnology. 2011;22:325601. 
[124]  Asplund M, Thaning E, Lundberg J, Sandberg-Nordqvist AC, Kostyszyn B, Inganas O, et 
al. Toxicity evaluation of PEDOT/biomolecular composites intended for neural 
communication electrodes. Biomed Mater. 2009;4:045009. 
[125]  Cui X, Martin DC. Electrochemical deposition and characterization of poly(3,4-
ethylenedioxythiophene) on neural microelectrode arrays. Sensors Actuat A-Physical. 
2003;89:92-102. 
[126]  Huber M, Heiduschka P, Klenle S, Pavlidis C, Mack J, Walk T, et al. Modification of 
glassy carbon surfaces with synthetic laminin-derived peptides for nerve cell attachment 
and neurite growth. J Biomed Mater Res. 1998;41:278-88. 
[127]  Powell SK, Kleinman HK. Neuronal lamininins and their cellular receptors. Int J 
Biochem Cell Bio. 1997;29:401-14. 
[128]  Khan SP, Auner GG, Newaz GM. Influence of nanoscale surface roughness on neural 
cell attachment on silicon. Nanomedicine-UK. 2005;1:125-9. 
[129]  Walsh JF, Manwaring ME, Tresco PA. Directional neurite outgrowth is enhanced by 
engineered meningeal cell-coated substrates. Tissue Eng. 2005;11:1085-94. 
[130]  Hsiao M-C, Liao S-H, Yen M-Y, Liu P-I, Pu N-W, Wang C-A, et al. Preparation of 
covalently functionalized graphene using residual oxygen-containing functional groups. 
ACS Appl Mater Interfaces. 2010;2:3092-9. 
[131]  Jeong H-K, Noh H-J, Kim J-Y, Jin MH, Park CY, Lee YH. X-ray absorption 
spectroscopy of graphite oxide. EPL. 2008;82:67004. 
 163 
[132]  Xiao SJ, Textor M, Spencer ND, Wieland M, Keller B, Sigrist H. Immobilization of the 
cell-adhesive peptide arg-gly-asp-cys (RGDC) on titanium surfaces by covalent chemical 
attachment. J Mater Sci Mater Med. 1997;8:867-72. 
[133]  Pancrazio JJ. Neural interfaces at the nanoscale. Nanomedicine-UK. 2008;3:823-30. 
[134]  Peng C, Jin J, Chen GZ. A comparative study on electrochemical co-deposition and 
capacitance of composite films of conducting polymers and carbon nanotubes. 
Electrochim Acta. 2007;53:525-37. 
[135]  Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J 
Neurosci. 2002;22:629-34. 
[136]  Taupin P, Gage FH. Adult neurogenesis and neural stem cells of the central nervous 
system in mammals. J Neurosci Res. 2002;69:745-9. 
[137]  Kempermann G, Gast D, Kronenberg G, Yamaguchi M, Gage FH. Early determination 
and long-term persistence of adult-generated new neurons in the hippocampus of mice. 
Development. 2003;130:391-9. 
[138]  Song HJ, Stevens CF, Gage FH. Neural stem cells from adult hippocampus develop 
essential properties of functional CNS neurons. Nature Neurosci. 2002;5:438-45. 
[139]  van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH. Functional 
neurogenesis in the adult hippocampus. Nature. 2002;415:1030-4. 
[140]  Andressen C. Neural stem cells: from neurobiology to clinical applications. Curr Pharm 
Biotechnol. 2013;14:20-8. 
[141]  Gage FH, Temple S. Neural stem cells: generating and regenerating the brain. Neuron. 
2013;80:588-601. 
[142]  Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human 
neurodegenerative disorders-how to make it work. Nature Med. 2004;10 Suppl:S42-50. 
[143]  Vishwakarma SK, Bardia A, Tiwari SK, Paspala SAB, Khan AA. Current concept in 
neural regeneration research: NSCs isolation, characterization and transplantation in 
 164 
various neurodegenerative diseases and stroke. J Adv Res. 2013; DOI: 
10.1016/j.jare.2013.04.005. 
[144]  Faigle R, Song H. Signaling mechanisms regulating adult neural stem cells and 
neurogenesis. Biochim Biophys Acta. 2013;1830:2435-48. 
[145]  Keung AJ, Dong M, Schaffer DV, Kumar S. Pan-neuronal maturation but not neuronal 
subtype differentiation of adult neural stem cells is mechanosensitive. Sci Rep. 
2013;3:1817. 
[146]  Keung AJ, Kumar S, Schaffer DV. Presentation counts: microenvironmental regulation 
of stem cells by biophysical and material cues. Annu Review Cell Dev Bi. 2010;26:533-
56. 
[147]  Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. 
J Comp Neurol. 2000;425:479-94. 
[148]  Song H, Stevens CF, Gage FH. Astroglia induce neurogenesis from adult neural stem 
cells. Nature. 2002;417:39-44. 
[149]  Wade A, McKinney A, Phillips JJ. Matrix regulators in neural stem cell functions. 
Biochim Biophys Acta. 2014. DOI: 10.1016/j.bbagen.2014.01.017. 
[150]  Ananthanarayanan B, Little L, Schaffer DV, Healy KE, Tirrell M. Neural stem cell 
adhesion and proliferation on phospholipid bilayers functionalized with RGD peptides. 
Biomaterials. 2010;31:8706-15. 
[151]  Nakajima M, Ishimuro T, Kato K, Ko IK, Hirata I, Arima Y, et al. Combinatorial protein 
display for the cell-based screening of biomaterials that direct neural stem cell 
differentiation. Biomaterials. 2007;28:1048-60. 
[152]  Willerth SM, Rader A, Sakiyama-Elbert SE. The effect of controlled growth factor 
delivery on embryonic stem cell differentiation inside fibrin scaffolds. Stem Cell Res. 
2008;1:205-18. 
[153]  Aizawa Y, Leipzig N, Zahir T, Shoichet M. The effect of immobilized platelet derived 
growth factor AA on neural stem/progenitor cell differentiation on cell-adhesive 
hydrogels. Biomaterials. 2008;29:4676-83. 
 165 
[154]  Leipzig ND, Xu C, Zahir T, Shoichet MS. Functional immobilization of interferon-
gamma induces neuronal differentiation of neural stem cells. J Biomed Mater Res A. 
2010;93:625-33. 
[155]  Kennedy HJ. New developments in understanding the mechanisms and function of 
spontaneous electrical activity in the developing mammalian auditory system. JARO. 
2012;13:437-45. 
[156]  Kilb W, Kirischuk S, Luhmann HJ. Electrical activity patterns and the functional 
maturation of the neocortex. Eur J Neurosci. 2011;34:1677-86. 
[157]  Yamamoto N, Lopez-Bendito G. Shaping brain connections through spontaneous neural 
activity. Eur J Neurosci. 2012;35:1595-604. 
[158]  Guimard NK, Gomez N, Schmidt CE. Conducting polymers in biomedical engineering. 
Prog Polym Sci. 2007;32:876-921. 
[159]  Salto C, Saindon E, Bolin M, Kanciurzewska A, Fahlman M, Jager EW, et al. Control of 
neural stem cell adhesion and density by an electronic polymer surface switch. Langmuir. 
2008;24:14133-8. 
[160]  Bechara S, Wadman L, Popat KC. Electroconductive polymeric nanowire templates 
facilitates in vitro C17.2 neural stem cell line adhesion, proliferation and differentiation. 
Acta Biomater. 2011;7:2892-901. 
[161]  Deng M, Yang X, Silke M, Qiu WM, Xu MS, Borghs G, et al. Electrochemical 
deposition of polypyrrole/graphene oxide composite on microelectrodes towards tuning 
the electrochemical properties of neural probes. Sensor Actuat B-Chem. 2011;158:176-
84. 
[162]  Osterholm A, Lindfors T, Kauppila J, Damlin P, Kvarnstrom C. Electrochemical 
incorporation of graphene oxide into conducting polymer films. Electrochim Acta. 
2012;83:463-70. 
[163]  Tian H, Liu J, Wei D, Kang X, Zhang C, Du J, et al. Graphene oxide doped conducting 
polymer nanocomposite film for electrode-tissue interface. Biomaterials. 2013. 
 166 
[164]  Yang F, Xu CY, Kotaki M, Wang S, Ramakrishna S. Characterization of neural stem 
cells on electrospun poly(L-lactic acid) nanofibrous scaffold. J Biomater Sci Polymer. 
2004;15:1483-97. 
[165]  Zanden C, Erkenstam NH, Padel T, Wittgenstein J, Liu J, Georg Kuhn H. Stem cell 
responses to plasma surface modified electrospun polyurethane scaffolds. Nanomedicine-
UK. 2014. 
[166]  Barreto JA, O'Malley W, Kubeil M, Graham B, Stephan H, Spiccia L. Nanomaterials: 
applications in cancer imaging and therapy. Adv Mater. 2011;23:H18-40. 
[167]  Sharifi S, Behzadi S, Laurent S, Forrest ML, Stroeve P, Mahmoudi M. Toxicity of 
nanomaterials. Chem Soc Rev. 2012;41:2323-43. 
[168]  Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in 
medicine: therapeutic applications and developments. Clin Pharm Ther. 2008;83:761-9. 
[169]  Bianco A. Graphene: safe or toxic? The two faces of the medal. Angew Chem. 
2013;52:4986-97. 
[170]  Liu Y, Luo Y, Wu J, Wang Y, Yang X, Yang R, et al. Graphene oxide can induce in vitro 
and in vivo mutagenesis. Sci Rep-UK. 2013. 
[171]  Zhang YB, Ali SF, Dervishi E, Xu Y, Li ZR, Casciano D, et al. Cytotoxicity effects of 
graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 
cells. ACS Nano. 2010;4:3181-6. 
[172]  Li N, Zhang Q, Gao S, Song Q, Huang R, Wang L, et al. Three-dimensional graphene 
foam as a biocompatible and conductive scaffold for neural stem cells. Sci Rep-UK. 
2013;3. 
[173]  Park SY, Park J, Sim SH, Sung MG, Kim KS, Hong BH, et al. Enhanced differentiation 
of human neural stem cells into neurons on graphene. Adv Mater. 2011;23:H263-7. 
[174]  Chen S, Lewallen M, Xie T. Adhesion in the stem cell niche: biological roles and 
regulation. Development. 2013;140:255-65. 
 167 
[175]  Harnett EM, Alderman J, Wood T. The surface energy of various biomaterials coated 
with adhesion molecules used in cell culture. Colloid Surface B. 2007;55:90-7. 
[176]  Kandel ER. Principles of neural science. 5th ed. New York: McGraw-Hill; 2013. 
[177]  Yang F, Murugan R, Wang S, Ramakrishna S. Electrospinning of nano/micro scale 
poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. 
Biomaterials. 2005;26:2603-10. 
[178]  Ren YJ, Zhang H, Huang H, Wang XM, Zhou ZY, Cui FZ, et al. In vitro behavior of 
neural stem cells in response to different chemical functional groups. Biomaterials. 
2009;30:1036-44. 
[179]  Stevens MM, George JH. Exploring and engineering the cell surface interface. Science. 
2005;310:1135-8. 
[180]  Scadden DT. The stem-cell niche as an entity of action. Nature. 2006;441:1075-9. 
[181]  Wong G, Goldshmit Y, Turnley AM. Interferon-gamma but not TNF alpha promotes 
neuronal differentiation and neurite outgrowth of murine adult neural stem cells. Exp 
Neurol. 2004;187:171-7. 
[182]  Hu JG, Fu SL, Wang YX, Li Y, Jiang XY, Wang XF, et al. Platelet-derived growth 
factor-AA mediates oligodendrocyte lineage differentiation through activation of 
extracellular signal-regulated kinase signaling pathway. Neuroscience. 2008;151:138-47. 
[183]  Murugan AV, Quintin M, Delville MH, Campet G, Vijayamohanan K. Entrapment of 
poly(3,4-ethylenedioxythiophene) between VS2 layers to form a new organic-inorganic 
intercalative nanocomposite. J Mater Chem. 2005;15:902-9. 
[184]  Kong J, Yu S. Fourier transform infrared spectroscopic analysis of protein secondary 
structures. Acta Bioch Bioph Sin. 2007;39:549-59. 
[185]  Ibrahim M, Nada A, Kamal DE. Density functional theory and FTIR spectroscopic study 
of carboxyl group. Indian J Pure Ap Phy. 2005;43:911-7. 
[186]  LaVan DA, McGuire T, Langer R. Small-scale systems for in vivo drug delivery. Nat 
Biotechnol. 2003;21:1184-91. 
 168 
[187] Staples M. Microchips and controlled-release drug reservoirs. Wires Nanomed Nanobi. 
2010;2:400-17. 
[188]  Timko BP, Kohane DS. Materials to Clinical Devices: Technologies for Remotely 
Triggered Drug Delivery. Clin Ther. 2012;34:S25-S35. 
[189]  Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature 
Mater. 2013;12:991-1003. 
[190]  Timko BP, Dvir T, Kohane DS. Remotely triggerable drug delivery systems. Adv Mater. 
2010;22:4925-43. 
[191]  Balmert SC, Little SR. Biomimetic delivery with micro- and nanoparticles. Adv Mater. 
2012;24:3757-78. 
[192]  Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. 
Curr Opin Chem Biol. 2005;9:674-9. 
[193]  Yang K, Feng L, Shi X, Liu Z. Nano-graphene in biomedicine: theranostic applications. 
Chem Soc Rev. 2013;42:530-47. 
[194]  Li M, Yang XJ, Ren JS, Qu KG, Qu XG. Using graphene oxide high near-infrared 
absorbance for photothermal treatment of alzheimer's disease. Adv Mater. 2012;24:1722-
8. 
[195]  Sanchez VC, Jachak A, Hurt RH, Kane AB. Biological interactions of graphene-family 
nanomaterials: an interdisciplinary review. Chem Res Toxicol. 2012;25:15-34. 
[196]  Tao Y, Lin YH, Huang ZZ, Ren JS, Qu XG. Incorporating graphene oxide and gold 
nanoclusters: a synergistic catalyst with surprisingly high peroxidase-like activity over a 
broad pH range and its application for cancer cell detection. Adv Mater. 2013;25:2594-9. 
[197]  Sun XM, Liu Z, Welsher K, Robinson JT, Goodwin A, Zaric S, et al. Nano-graphene 
oxide for cellular imaging and drug delivery. Nano Res. 2008;1:203-12. 
[198]  Yang XY, Zhang XY, Liu ZF, Ma YF, Huang Y, Chen Y. High-efficiency loading and 
controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C. 
2008;112:17554-8. 
 169 
[199]  Depan D, Shah J, Misra RDK. Controlled release of drug from folate-decorated and 
graphene mediated drug delivery system: Synthesis, loading efficiency, and drug release 
response. Mat Sci Eng C-Mater. 2011;31:1305-12. 
[200]  Ma XX, Tao HQ, Yang K, Feng LZ, Cheng L, Shi XZ, et al. A functionalized graphene 
oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal 
therapy, and magnetic resonance imaging. Nano Res. 2012;5:199-212. 
[201]  Yang XY, Wang YS, Huang X, Ma YF, Huang Y, Yang RC, et al. Multi-functionalized 
graphene oxide based anticancer drug-carrier with dual-targeting function and pH-
sensitivity. J Mater Chem. 2011;21:3448-54. 
[202]  Yang XY, Zhang XY, Ma YF, Huang Y, Wang YS, Chen YS. Superparamagnetic 
graphene oxide-Fe3O4 nanoparticles hybrid for controlled targeted drug carriers. J Mater 
Chem. 2009;19:2710-4. 
[203]  Zhang JL, Yang HJ, Shen GX, Cheng P, Zhang JY, Guo SW. Reduction of graphene 
oxide via L-ascorbic acid. Chem Commun. 2010;46:1112-4. 
[204]  Liu HW, Hu SH, Chen YW, Chen SY. Characterization and drug release behavior of 
highly responsive chip-like electrically modulated reduced graphene oxide-poly(vinyl 
alcohol) membranes. J Mater Chem. 2012;22:17311-20. 
[205]  Luo XL, Cui XT. Electrochemically controlled release based on nanoporous conducting 
polymers. Electrochem Commun. 2009;11:402-4. 
[206]  Si P, Chen HL, Kannan P, Kim DH. Selective and sensitive determination of dopamine 
by composites of polypyrrole and graphene modified electrodes. Analyst. 
2011;136:5134-8. 
[207]  Si WM, Lei W, Zhang YH, Xia MZ, Wang FY, Hao QL. Electrodeposition of graphene 
oxide doped poly(3,4-ethylenedioxythiophene) film and its electrochemical sensing of 
catechol and hydroquinone. Electrochim Acta. 2012;85:295-301. 
[208]  Li Y, Wu Y. Coassembly of graphene oxide and nanowires for large-area nanowire 
alignment. J Am Chem Soc. 2009;131:5851-7. 
[209]  Vernitskaya TV, Efimov ON. Polypyrrole: A conducting polymer (synthesis, properties, 
and applications). Russ Chem Rev. 1997;66:489-505. 
 170 
[210]  Unemura K, Kume T, Kondo M, Maeda Y, Izumi Y, Akaike A. Glucocorticoids decrease 
astrocyte numbers by reducing glucocorticoid receptor expression in vitro and in vivo. J 
Pharmacol Sci. 2012;119:30-9. 
[211]  Russier J, Treossi E, Scarsi A, Perrozzi F, Dumortier H, Ottaviano L, et al. Evidencing 
the mask effect of graphene oxide: a comparative study on primary human and murine 
phagocytic cells. Nanoscale. 2013;5:11234-47. 
[212]  Luo J, Kim J, Huang J. Material processing of chemically modified graphene: some 
challenges and solutions. Accounts Chem Res. 2013;46:2225-34. 
[213]  Kolind K, Leong KW, Besenbacher F, Foss M. Guidance of stem cell fate on 2D 
patterned surfaces. Biomaterials. 2012;33:6626-33. 
[214]  Yim EK, Leong KW. Significance of synthetic nanostructures in dictating cellular 
response. Nanomedicine-UK. 2005;1:10-21. 
[215]  Zhang B, Xiao Y, Hsieh A, Thavandiran N, Radisic M. Micro- and nanotechnology in 
cardiovascular tissue engineering. Nanotechnology. 2011;22:494003. 
[216]  Wise RA. Dopamine, learning and motivation. Nat Rev Neurosci. 2004;5:483-94. 
[217]  Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: Dopamine, vesicles and 
alpha-synuclein. Nat Rev Neurosci. 2002;3:932-42. 
[218]  Yang CR, Seamans JK, Gorelova N. Developing a neuronal model for the 
pathophysiology of schizophrenia based on the nature of electrophysiological actions of 
dopamine in the prefrontal cortex. Neuropsychopharmacol. 1999;21:161-94. 
[219]  Volkow ND, Fowler JS, Wang GJ, Swanson JM. Dopamine in drug abuse and addiction: 
results from imaging studies and treatment implications. Mol Psychiatr. 2004;9:557-69. 
[220]  Noelker C, Hampel H, Dodel R. Blood-based protein biomarkers for diagnosis and 
classification of neurodegenerative diseases: current progress and clinical potential. Mol 
Diagn Ther. 2011;15:83-102. 
 171 
[221]  Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic tests and biomarkers for 
pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to 
disease stratification. Endocr Pathol. 2012;23:4-14. 
[222]  Robinson DL, Hermans A, Seipel AT, Wightman RM. Monitoring rapid chemical 
communication in the brain. Chem Rev. 2008;108:2554-84. 
[223]  Bicker J, Fortuna A, Alves G, Falcao A. Liquid chromatographic methods for the 
quantification of catecholamines and their metabolites in several biological samples--a 
review. Anal Chim Acta. 2013;768:12-34. 
[224]  Lee NS, Hsieh YZ, Paisley RF, Morris MD. Surface-enhanced Raman spectroscopy of 
the catecholamine neurotransmitters and related compounds. Anal Chem. 1988;60:442-6. 
[225]  Liu D, Wang Z, Jiang X. Gold nanoparticles for the colorimetric and fluorescent 
detection of ions and small organic molecules. Nanoscale. 2011;3:1421-33. 
[226]  Westerink BH. Analysis of biogenic amines in microdialysates of the brain. J Chromatogr 
B. 2000;747:21-32. 
[227]  Kuila T, Bose S, Khanra P, Mishra AK, Kim NH, Lee JH. Recent advances in graphene-
based biosensors. Biosens Bioelectron. 2011;26:4637-48. 
[228]  Liu Y, Dong X, Chen P. Biological and chemical sensors based on graphene materials. 
Chem Soc Rev. 2012;41:2283-307. 
[229]  Tang L, Wang Y, Li Y, Feng H, Lu J, Li J. Preparation, structure, and electrochemical 
properties of reduced graphene sheet films. Adv Funct Mater. 2009;19:2782-9. 
[230]  Li J, Yang J, Yang ZJ, Li YF, Yu SH, Xu Q, et al. Graphene-Au nanoparticles 
nanocomposite film for selective electrochemical determination of dopamine. Anal 
Methods-UK. 2012;4:1725-8. 
[231]  Zhu X, Liu Q, Zhu XH, Li CL, Xu MT, Liang Y. Reduction of graphene oxide via 
ascorbic acid and its application for simultaneous detection of dopamine and ascorbic 
acid. Int J Electrochem Sc. 2012;7:5172-84. 
 172 
[232]  Duan YY, Clark GM, Cowan RSC. Factors determining and limiting the impedance 
behavior of implanted bio-electrodes. Proc SPIE. 2001;4235:498-508. 
[233]  Karp FB, Bemotski NA, Valdes TI, Bohringer KF, Ratner BD. Foreign body response 
investigated with an implanted biosensor by in situ electrical impedance spectroscopy. 
IEEE Sens J. 2008;8:104-12. 
[234]  Deakin MR, Kovach PM, Stutts KJ, Wightman RM. Heterogeneous mechanisms of the 
oxidation of catechols and ascorbic-acid at carbon electrodes. Anal Chem. 1986;58:1474-
80. 
[235]  Saraceno RA, Pack JG, Ewing AG. Catalysis of slow charge-transfer reactions at 
polypyrrole-coated glassy-carbon electrodes. J Electroanal Chem. 1986;197:265-78. 
[236]  Engstrom RC, Strasser VA. Characterization of electrochemically pretreated glassy-
carbon electrodes. Anal Chem. 1984;56:136-41. 
[237]  Hu IF, Karweik DH, Kuwana T. Activation and deactivation of glassy-carbon electrodes. 
J Electroanal Chem. 1985;188:59-72. 
[238]  Bagherzadeh M, Heydari M. Electrochemical detection of dopamine based on pre-
concentration by graphene nanosheets. Analyst. 2013;138:6044-51. 
[239]  Rochefort A, Wuest JD. Interaction of substituted aromatic compounds with graphene. 
Langmuir. 2009;25:210-5. 
[240]  Armstrong J, Barlow RB. The ionization of phenolic amines, including apomorphine, 
dopamine and catecholamines and an assessment of zwitterion constants. British J 
Pharmacol. 1976;57:501-16. 
[241]  Konkena B, Vasudevan S. Understanding aqueous dispersibility of graphene oxide and 
reduced graphene oxide through pK(a) measurements. J Phys Chem Lett. 2012;3:867-72. 
[242]  Bagri A, Mattevi C, Acik M, Chabal YJ, Chhowalla M, Shenoy VB. Structural evolution 
during the reduction of chemically derived graphene oxide. Nat Chem. 2010;2:581-7. 
[243]  Brezina M, Koryta J, Loucka T, Marsikova D. Adsorption and kinetics of oxidation of 
ascorbic acid at platinum electrodes. J Electroanal Chem. 1972;40:13-7. 
 173 
[244]  Karabinas P, Jannakoudakis D. Kinetic-parameters and mechanism of the 
electrochemical oxidation of l-ascorbic-acid on platinum-electrodes in acid-solutions. J 
Electroanal Chem. 1984;160:159-67. 
[245]  Rueda M, Aldaz A, Sanchez-Burgos F. Oxidation of l-ascorbic acid on a gold electrode. 
Electrochim Acta. 1978;23:419-24. 
[246]  Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic 
brain injury: a brief overview. J Head Trauma Rehabil. 2006;21:375-8. 
[247]  Algattas H, Huang JH. Traumatic Brain Injury pathophysiology and treatments: early, 
intermediate, and late phases post-injury. Int J Mol Sci. 2014;15:309-41. 
[248]  Tran LV. Understanding the pathophysiology of traumatic brain injury and the 
mechanisms of action of neuroprotective interventions. J Trauma Nurs. 2014;21:30-5. 
[249]  Kumaria A, Tolias CM. In vitro models of neurotrauma. British Journal Neurosurg. 
2008;22:200-6. 
[250]  Morrison B, 3rd, Elkin BS, Dolle JP, Yarmush ML. In vitro models of traumatic brain 
injury. Ann Rev Biomed Eng. 2011;13:91-126. 
[251]  van Pelt J, Wolters PS, Corner MA, Rutten WL, Ramakers GJ. Long-term 
characterization of firing dynamics of spontaneous bursts in cultured neural networks. 
IEEE T Bio-Med Eng. 2004;51:2051-62. 
[252]  Wagenaar DA, Pine J, Potter SM. An extremely rich repertoire of bursting patterns 
during the development of cortical cultures. BMC Neurosci. 2006;7:11. 
[253]  Yu Z, Graudejus O, Tsay C, Lacour SP, Wagner S, Morrison B, 3rd. Monitoring 
hippocampus electrical activity in vitro on an elastically deformable microelectrode 
array. J Neurotrauma. 2009;26:1135-45. 
[254]  Yu Z, Lacour SP, Tsay C, Wagner S, Morrison B. A new tool to study post-traumatic 
neuronal dysfunction: Stretchable microelectrode arrays. J Neurotrauma. 2006;23:998. 
[255]  Harting MT, Sloan LE, Jimenez F, Baumgartner J, Cox CS, Jr. Subacute neural stem cell 
therapy for traumatic brain injury. J Surg Res. 2009;153:188-94. 
 174 
[256]  Brewer GJ, Price PJ. Viable cultured neurons in ambient carbon dioxide and hibernation 
storage for a month. Neuroreport. 1996;7:1509-12. 
[257]  Hovda DA, Lee SM, Smith ML, Von Stuck S, Bergsneider M, Kelly D, et al. The 
neurochemical and metabolic cascade following brain injury: moving from animal 
models to man. J Neurotrauma. 1995;12:903-6. 
[258]  Kozai TD, Langhals NB, Patel PR, Deng X, Zhang H, Smith KL, et al. Ultrasmall 
implantable composite microelectrodes with bioactive surfaces for chronic neural 
interfaces. Nature Mater. 2012;11:1065-73. 
[259]  Ludwig KA, Uram JD, Yang J, Martin DC, Kipke DR. Chronic neural recordings using 
silicon microelectrode arrays electrochemically deposited with a poly(3,4-
ethylenedioxythiophene) (PEDOT) film. J Neural Eng. 2006;3:59-70. 
[260]  Chiappalone M, Bove M, Vato A, Tedesco M, Martinoia S. Dissociated cortical networks 
show spontaneously correlated activity patterns during in vitro development. Brain Res. 
2006;1093:41-53. 
[261]  Eytan D, Minerbi A, Ziv N, Marom S. Dopamine-induced dispersions of correlations 
between action potentials in networks of cortical neurons. J Neurophysiol. 2004;92:1871-
24. 
[262]  Stephens CL, Toda H, Palmer TD, DeMarse TB, Ormerod BK. Adult neural progenitor 
cells reactivate superbursting in mature neural networks. Exp Neurol. 2012;234:20-30. 
[263]  Ben-Ari Y. Developing networks play a similar melody. Trend Neurosci. 2001;24:353-
60. 
[264]  Dupont E, Hanganu IL, Kilb W, Hirsch S, Luhmann HJ. Rapid developmental switch in 
the mechanisms driving early cortical columnar networks. Nature. 2006;439:79-83. 
[265]  Pine J. Recording action potentials from cultured neurons with extracellular microcircuit 
electrodes. J Neurosci Meth. 1980;2:19-31. 
[266]  Peters A, Palay SL, Webster Hd. The fine structure of the nervous system : the neurons 
and supporting cells. Philadelphia: Saunders; 1976. 
 175 
[267]  Chen J, Backus KH, Deitmer JW. Intracellular calcium transients and potassium current 
oscillations evoked by glutamate in cultured rat astrocytes. J Neurosci. 1997;17:7278-87. 
[268]  Pasti L, Volterra A, Pozzan T, Carmignoto G. Intracellular calcium oscillations in 
astrocytes: a highly plastic, bidirectional form of communication between neurons and 
astrocytes in situ. J Neurosci. 1997;17:7817-30. 
[269]  Martin D. Synthesis and release of neuroactive substrances by glial cells. Glia. 
1992;5:81-94. 
[270]  Fellin T. Communication between neurons and astrocytes: relevance to the modulation of 
synaptic and network activity. J Neurochem. 2009;108:533-44. 
[271]  Newman EA. New roles for astrocytes: regulation of synaptic transmission. Trend 
Neurosci. 2003;26:536-42. 
[272]  Werner C, Engelhard K. Pathophysiology of traumatic brain injury. British J Anaesth. 
2007;99:4-9. 
[273]  Corner MA, van Pelt J, Wolters PS, Baker RE, Nuytinck RH. Physiological effects of 
sustained blockade of excitatory synaptic transmission on spontaneously active 
developing neuronal networks--an inquiry into the reciprocal linkage between intrinsic 
biorhythms and neuroplasticity in early ontogeny. Neurosci Biobehav Rev. 2002;26:127-
85. 
[274]  Ramakers GJ, van Galen H, Feenstra MG, Corner MA, Boer GJ. Activity-dependent 
plasticity of inhibitory and excitatory amino acid transmitter systems in cultured rat 
cerebral cortex. Int J Dev Neurosci. 1994;12:611-21. 
[275]  Imbrosci B, Mittmann T. Functional consequences of the disturbances in the GABA-
mediated inhibition induced by injuries in the cerebral cortex. Neural Plast. 
2011;2011:614329. 
[276]  Li H, Prince DA. Synaptic activity in chronically injured, epileptogenic sensory-motor 
neocortex. J Neurophysiol. 2002;88:2-12. 
[277]  Paz JT, Christian CA, Parada I, Prince DA, Huguenard JR. Focal cortical infarcts alter 
intrinsic excitability and synaptic excitation in the reticular thalamic nucleus. J Neurosci. 
2010;30:5465-79. 
 176 
[278]  Brown DR. Neurons depend on astrocytes in a coculture system for protection from 
glutamate toxicity. Mol Cell Neurosci. 1999;13:379-89. 
[279]  Rosenberg PA, Aizenman E. Hundred-fold increase in neuronal vulnerability to 
glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci Lett. 
1989;103:162-8. 
[280]  Yi JH, Hazell AS. Excitotoxic mechanisms and the role of astrocytic glutamate 
transporters in traumatic brain injury. Neurochem Int. 2006;48:394-403. 
[281]  Carletti B, Piemonte F, Rossi F. Neuroprotection: the emerging concept of restorative 
neural stem cell biology for the treatment of neurodegenerative diseases. Curr 
Neuropharmacol. 2011;9:313-7. 
[282]  Llado J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD. Neural stem cells protect 
against glutamate-induced excitotoxicity and promote survival of injured motor neurons 
through the secretion of neurotrophic factors. Mol Cell Neurosci. 2004;27:322-31. 
[283]  Goubko CA, Cao XD. Patterning multiple cell types in co-cultures: A review. Mat Sci 
Eng C-Mater. 2009;29:1855-68. 
[284]  Miller LL, Zhou QX. Poly(N-methylpyrrolylium) poly(styrenesulfonate). A conductive, 
electrically switchable cation exchanger that cathodically binds and anodically releases 
dopamine. Macromolecules. 1987;20:1594-7. 
[285]  Hepel M, Mahdavi F. Application of the electrochemical quartz crystal microbalance for 
electrochemically controlled binding and release of chlorpromazine from conductive 
polymer matrix. Microchem J. 1997;56:54-64. 
[286]  George PM, LaVan DA, Burdick JA, Chen C-Y, Liang E, Langer R. Electrically 
controlled drug delivery from biotin-doped conductive polypyrrole. Adv Mater. 
2006;18:577-81. 
[287]  Wightman RM, Amatore C, Engstrom RC, Hale PD, Kristensen EW, Kuhr WG, et al. 
Real-time characterization of dopamine overflow and uptake in the rat striatum. 
Neurosci. 1988;25:513-23. 
 177 
[288]  Oh MY, Hodaie M, Kim SH, Alkhani A, Lang AE, Lozano AM. Deep brain stimulator 
electrodes used for lesioning: proof of principle. Neurosurg. 2001;49:363-7; discussion 7-
9. 
[289]  Sparreboom M, van Schoonhoven J, van Zanten BG, Scholten RJ, Mylanus EA, Grolman 
W, et al. The effectiveness of bilateral cochlear implants for severe-to-profound deafness 
in children: a systematic review. Otol Neurotol. 2010;31:1062-71. 
[290]  Luo X, Weaver CL, Zhou DD, Greenberg R, Cui XT. Highly stable carbon nanotube 
doped poly(3,4-ethylenedioxythiophene) for chronic neural stimulation. Biomaterials. 
2011;32:5551-7. 
[291]  Li Y, Li D, Ibrahim A, Raisman G. Repair involves all three surfaces of the glial cell. 
Prog Brain Res. 2012;201:199-218. 
[292]  Kawano H, Kimura-Kuroda J, Komuta Y, Yoshioka N, Li HP, Kawamura K, et al. Role 
of the lesion scar in the response to damage and repair of the central nervous system. Cell 
Tissue Res. 2012;349:169-80. 
[293] Rodrigues LB, Leite HF, Yoshida MI, Saliba JB, Cunha AS, Faraco AAG. In vitro 
release and characterization of chitosan films as dexamethasone carrier. Int J Pharm. 
2009;368:1-6. 
 
 
 178 
